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Hippocampal synaptic transmission is an intricate and flexible entity that can be modulated, 
both directly and indirectly, by a variety of different signaling molecules and cell types. The 
peptide diazepam binding inhibitor (DBI) has complex physiological functions and is capable of 
both enhancing and attenuating inhibitory synaptic transmission in different brain regions. 
However, whether DBI modulates hippocampal synaptic transmission or hippocampal-dependent 
behaviors has not previously been studied. In addition, astrocytes are increasingly recognized as 
dynamic regulators of excitatory synaptic transmission. However, the extent to which astrocytes 
modulate inhibitory transmission remains unknown. The overall goal of this dissertation is to 
investigate the degree to which hippocampal synaptic transmission is modulated by both DBI and 
by optogenetic stimulation of local astrocytes. Chapter 2 investigates the role of DBI in modulating 
hippocampal synaptic inhibition using a constitutive DBI knockout animal. Chapter 3 continues to 
use the DBI knockout animals to examine the role of DBI in regulating both hippocampal-
dependent and hippocampal-independent behavior. Chapter 4 utilizes a novel astrocyte-specific 
Gq-coupled optogenetic construct (Optoα1AR) to probe astrocytic modulation of hippocampal 
synaptic excitation and inhibition. The results here indicate that DBI differentially modulates 
hippocampal synaptic transmission in CA1 versus dentate gyrus, and plays a notable role in spatial 
navigational memory. Furthermore, optogenetic stimulation of Optoα1AR in astrocytes modulates 
both hippocampal synaptic excitation and inhibition. However, this modulation depends on the 
characteristics of the optical stimulation paradigm. Taken together, these studies provide new 
evidence of DBI-dependent modulation of hippocampal synaptic inhibition and behavior, and 





 First and foremost, I would like to thank my family for their unending love and 
encouragement throughout this journey: My parents, Mary and Stu, who allowed me the freedom 
to eventually discover my deep passion for neuroscience, for which I will be forever grateful. My 
sister Leigh, who provided me with significant emotional support over the years in addition to 
many delicious meals. Lastly, my dogs Jack and Moxie, who never ceased to put a smile on my 
face over the past six years, especially during the darkest days of the COVID-19 pandemic. I would 
not be here without all your support, and I appreciate you all more than I can ever express.   
 Next, I would like to acknowledge my mentor Dr. Catherine Christian-Hinman for being, 
by no stretch of the imagination, the consummate mentor. Over the past six years, Catherine 
instilled in me, through both outstanding mentorship and elegant example, what it means to be a 
scientist. Put simply, I owe my entire scientific career to Catherine. I will never be able to thank 
her enough, nor will I ever be able to satisfactorily repay her for her monumental investment in 
me. I hope, thus, to someday have the opportunity to pay it forward instead. Thanks for taking a 
chance on me, Catherine.  
I would also like to thank everyone else who has assisted me in some capacity along the 
way: my dissertation committee, my lab mates, and my friends from various walks of life. Thank 







TABLE OF CONTENTS 
 
CHAPTER 1: INTRODUCTION ....................................................................................................1 
 
CHAPTER 2: SUBREGION-SPECIFIC IMPACTS OF GENETIC LOSS OF DIAZEPAM 
BINDING INHIBITOR ON SYNAPTIC INHIBITION IN THE MURINE HIPPOCAMPUS ...30 
 
CHAPTER 3: DIFFERENTIAL IMPACTS ON MULTIPLE FORMS OF SPATIAL AND 
CONTEXTUAL MEMORY IN DIAZEPAM BINDING INHIBITOR KNOCKOUT MICE .....55 
 
CHAPTER 4: EVALUATING THE EFFICACY OF OPTO1AR ACTIVATION IN 
ASTROCYTES IN MODULATING BASAL HIPPOCAMPAL SYNAPTIC EXCITATION 
AND INHIBITION ........................................................................................................................88 
 




APPENDIX A: GENETIC LOSS OF DIAZEPAM BINDING INHIBITOR IN MICE IMPAIRS 













CHAPTER 1: INTRODUCTION  
1.1: Synaptic transmission in the hippocampus 
1.1.1: Function, anatomy, and circuitry of the hippocampus  
 The hippocampus is one of the most primitive structures in the brain and has been studied 
intensively for decades. Both its distinctive curved appearance, as well as its major intrinsic 
circuitry, are well conserved across mammalian species (Strange et al., 2014). The hippocampus 
is perhaps best known for its critical role in memory formation, and research into the hippocampus 
was stimulated greatly in the mid-1900s by the study of human amnesiac patients such as H.M. 
(Scoville and Milner, 1957). It is now known that the hippocampus is required for declarative and 
episodic memory (Cohen and Squire, 1980; Tulving and Markowitsch, 1998; Eichenbaum, 2001). 
The hippocampus is also uniquely crucial for its role in spatial learning and navigation, and many 
hippocampal neurons act as “place cells” that are active whenever an animal occupies a specific 
location. Due to the collective activity of place cells, the hippocampus is often considered to act 
as a “cognitive map” (O’Keefe and Nadel, 1978; Moser et al., 2008, 2015). Importantly, the 
structure and function of the hippocampus is impaired in many pathological conditions, including 
Alzheimer’s disease and epilepsy, among others (Small et al., 2011; Anand and Dhikav, 2012; 
Bartsch and Wulff, 2015).  
 The anatomy and circuitry of the hippocampus are exceptionally well organized, making 
it an ideal location to study a variety of general neuroscientific questions. Although the specific 
anatomical structures of the hippocampus are clearly defined, the nomenclature used to describe 
these structures is still not universally accepted. The term “hippocampus” is often used vaguely to 
describe either the “hippocampus proper,” which consists of the CA1, CA2, and CA3 regions, or 
the “hippocampal formation,” which includes the CA regions plus the dentate gyrus (DG), 
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subiculum, presubiculum, parasubiculum, and the entorhinal cortex (Andersen et al., 2006). Since 
the experiments in this manuscript target either CA1 pyramidal cells or DG granule cells, the term 
“hippocampus” will be used here to refer to the CA regions as well as the DG, with subregion 
specificity stated as necessary. Although the hippocampus is generally considered to be one unified 
structure, strong evidence supports striking differences between dorsal and ventral hippocampal 
regions in rodents. Physiological and genetic data suggest that the dorsal hippocampus in rodents 
is imperative for spatial learning and memory, while the ventral hippocampus plays a larger role 
in emotional memory, such as fear learning (Fanselow and Dong, 2010).  
 Early investigations into the intrinsic circuitry of the hippocampus primarily focused on its 
serial network of major excitatory synapses. The hippocampal “trisynaptic circuit,” coined by Per 
Anderson in 1971, describes the organization of these synapses, which form distinct unilateral 
connections. This arrangement generally contrasts with synaptic connections formed within and 
between other neocortical regions, which are often reciprocal (Andersen et al., 2006). Andersen 
and colleagues provided the first physiological evidence supporting the lamellar and unidirectional 
organization of these synapses (Andersen et al., 1971). The canonical trisynaptic circuit of the 
hippocampus consists of three sequential synapses (Figure 1.1): 1) pyramidal neurons of the 
entorhinal cortex (typically from layer II) project to dendrites of granule cells of the DG (the 
perforant pathway); 2) the granule cells synapse onto apical dendrites of CA3 pyramidal cells 
(mossy fiber pathway); and 3) CA3 pyramidal cells project to both apical and basal dendrites of 
CA1 pyramidal cells (Schaffer collateral pathway). Though not mentioned in the original 
description, CA1 pyramidal cells then project to the subiculum and the entorhinal cortex, thereby 
completing the circuit.  
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Although the concept of the trisynaptic circuit remains in use today, our current 
understanding of intrinsic hippocampal circuitry as well as its extrinsic projections paints a 
significantly more complex picture. For example, it is now clear that the entorhinal cortex 
innervates all of the major hippocampal regions, not just the DG. Furthermore, extrinsic 
projections from the hippocampus are quite extensive. In short, the dorsal hippocampus sends 
strong projections to many regions including the subiculum (Witter and Amaral, 1991), the anterior 
cingulate and retrosplenial cortices (Cenquizca and Swanson, 2007), and the anterior thalamic 
complex (Fanselow and Dong, 2010). The ventral hippocampus projects to the olfactory bulb and 
olfactory cortical areas (Cenquizca and Swanson, 2007), several amygdalar nuclei (Pitkänen et al., 
2000), and several regions of the hypothalamus (Fanselow and Dong, 2010), among other regions. 
These projection patterns further suggest unique roles for the dorsal and ventral hippocampus, as 
well as the critical importance of the hippocampus in many forms of spatial and emotional learning 
and memory.  
 
1.1.2: Inhibitory transmission in the hippocampus  
γ-Aminobutyric acid (GABA) typically acts as the major inhibitory neurotransmitter in the 
mammalian brain. Fast phasic inhibition is mediated through type A-GABA receptors (GABAARs) 
that are synaptically located. GABAARs are pentameric proteins consisting of five subunits that 
surround a central pore that is selectively permeable to chloride ions (Olsen and Sieghart, 2009). 
Upon binding of GABA to synaptic GABAARs, the receptor undergoes a conformational change, 
opening the pore and typically allowing an inward conduction of chloride into the cell. This influx 
of chloride leads to hyperpolarization of the cell’s membrane potential. To date, there are 19 
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identified GABA subunits (α1-6, β1-3, γ1-3, δ, ε, θ, π, and ρ1-3), and the combination of these receptor 
subunits leads to extraordinary heterogeneity of GABAARs.  
The primary binding site for GABA is located extracellularly at the interface of α and β 
subunits (Olsen and Sieghart, 2009; Uusi-Oukari and Korpi, 2010) (Figure 1.2). Most GABAARs 
possess two α subunits and two β subunits, meaning the majority of GABAARs possess two 
individual GABA binding sites. While the binding of GABA to a single site is sufficient to activate 
the receptor, the binding of GABA to both sites drastically increases the probability of channel 
opening (Baumann et al., 2003). Decades of research has been spent investigating the properties 
of specific GABAAR subunits, as well as the overall functionality of various subunit 
conformations. Certain subunit combinations are more common than others, with the most 
abundant GABAARs in the brain containing two α, two β, and one γ2 subunit (Pirker et al., 2000). 
Importantly, different subunit conformations determine the overall biophysical properties of the 
receptor, including its channel conductance, decay kinetics, and responsiveness to allosteric 
modulators (Hevers and Lüddens, 1998; Mody and Pearce, 2004). In addition to synaptic 
inhibition, GABA can diffuse from the synaptic cleft and bind to high-affinity extrasynaptic 
GABAA receptors, leading to tonic inhibition (Farrant and Nusser, 2005). Furthermore, GABA can 
also bind to metabotropic GABAB receptors, which are G protein-coupled receptors and mediate 
slow inhibitory postsynaptic potentials (Connors et al., 1988).  
 Although GABA is canonically considered to be an inhibitory neurotransmitter, the 
ultimate effect of GABA binding depends on several factors, including the intracellular chloride 
concentration of the cell ([Cl-]i). [Cl-]i has a direct impact on the reversal potential for GABA 
(EGABA). If EGABA becomes more depolarized compared to the resting membrane potential of the 
cell, the actions of GABA can be depolarizing, and even excitatory if EGABA is more depolarized 
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than the action potential threshold. Two critical transporters are responsible for regulating [Cl-]i in 
neurons. During development, [Cl-]i is high due to increased expression of the Na-K-2Cl 
cotransporter (NKCC1), which acts to import chloride ions into cells. Due to the elevated [Cl-]i, 
activation of GABAA receptors leads to an extrusion of chloride from cells, which acts to 
depolarize the cell. Thus, in immature neurons during development, the effects of GABA via 
GABAA receptors are generally excitatory in nature due to the actions of NKCC1 (Plotkin et al., 
1997). However, with continuing maturation, there is a dramatic downregulation of NKCC1 
expression coupled with a concomitant upregulation of the potassium chloride cotransporter 2 
(KCC2). KCC2 is responsible for pumping chloride ions out of cells against its concentration 
gradient, keeping [Cl-]i low and promoting a hyperpolarizing influx of chloride into the cell during 
fast phasic inhibition (Rivera et al., 1999). Thus, the increased expression of KCC2 in promotes 
inhibitory actions of GABA in mature neurons by keeping [Cl-]i low. Although excitatory actions 
of GABA are most commonly seen in immature neurons, there is an increase in excitatory GABA 
effects in mature neurons in several disease states, most notably epilepsy (Miles et al., 2012), often 
due to dysfunction of KCC2.   
 
1.1.3: Interneurons of the hippocampus 
 Neurons that use GABA as a neurotransmitter are generally referred to as “interneurons,” 
as the majority of these neurons project locally. In the hippocampus, GABAergic interneurons 
make up around 15% of the total neuronal population. Despite this small percentage, interneurons 
play critical roles in overall network function (Kepecs and Fishell, 2014). There is staggering 
diversity among hippocampal interneurons, and at least 15 major interneuron subtypes have been 
confirmed (Figure 1.3) (Freund and Buzsaki, 1996; Pelkey et al., 2017). Interneurons are located 
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in all strata layers of the hippocampus and typically have dense axon collaterals and dendritic 
arborizations, allowing for synaptic contacts with numerous principal cells. Although valiant 
attempts have been made to specifically classify interneuron subtypes, there remains no perfect 
way to organize these cells, as there is substantial overlap in their molecular, electrophysiological, 
structural, developmental, and functional characteristics (Freund and Buzsaki, 1996; Pelkey et al., 
2017). Here, several important subtypes of inhibitory interneurons will be discussed, classified by 
the subcellular compartment of the postsynaptic target.  
 Certain interneurons preferentially form synaptic contacts perisomatically (defined as 
synapses located on cell somata, proximal dendrites, or axon initial segments). The general 
functionality of perisomatic inhibitory neurons is to control neuronal output, synchronizing the 
action potentials of principal cells (Miles et al., 1996; Freund and Katona, 2007). Two notable 
examples are the parvalbumin (PV)- and cholecystokinin (CCK)-containing basket cells. While 
sharing several similarities, these two cell types are believed to provide separate functional roles. 
PV basket cells are fast-spiking neurons that receive nearly ten times as much excitatory synaptic 
input as inhibitory input, mostly from local sources (Halasy et al., 1996). These cells are thought 
to mediate fundamental network oscillations, and a breakdown in the function of these cells would 
be expected to lead to drastic impairments in overall cortical function (Freund, 2003). Meanwhile, 
CCK basket cells display regular spiking patterns and receive a far greater proportion of inhibitory 
inputs compared to PV interneurons (Mátyás et al., 2004), suggesting a greater diversity of afferent 
inputs. Supporting this assertion is the fact that CCK cells receive inputs from several subcortical 
regions, most notably from serotonergic fibers, and a disruption in CCK cell function can lead to 
mood disorders (Freund, 2003). A third perisomatic interneuron subtype are the axo-axonic 
chandelier cells, which receive excitatory inputs from numerous afferent inputs and preferentially 
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form synapses onto the axon initial segments of principal cells, thus allowing for precise control 
over the generation of action potentials (Pelkey et al., 2017).  
 A second extensive, diverse family of interneurons form synapses onto dendrites of 
principal cells. The expression of somatostatin (SOM) is often considered to be associated with 
dendritic-targeting interneurons; however, interneurons from this family often co-express other 
molecular markers such as PV, and SOM expression is not restricted to these cells (Pelkey et al., 
2017). In general, these neurons function to organize and control the vast local glutamatergic 
inputs on principal cells. This family of cells includes Oriens Lacunosum-Moleculare interneurons 
(O-LMs), one of the best-studied interneuron subtypes that are primarily responsible for providing 
a feedback inhibitory circuit. The primary excitatory input to O-LMs is from CA1 pyramidal cells 
(Blasco‐Ibanez and Freund, 1995), while the axons of O-LMs project back onto the dendrites of 
pyramidal cells, forming a loop that provides inhibitory inputs that dampen excitation (Samulack 
et al., 1993). Other dendrite-targeting interneurons include the bistratified cells, named for their 
ability to form an equal number of synaptic contacts onto both apical and basal dendrites of 
principal cells, as well as a subfamily of CCK-expressing interneurons that are preferentially 
located in specific subregions of the hippocampus (Pelkey et al., 2017; Booker and Vida, 2018).  
  Certain interneurons also preferentially synapse onto the dendrites of other interneurons 
(IS-INs), providing a means of network disinhibition. These neurons are classified into three 
subsets, and commonly express either calretinin and/or vasoactive intestinal polypeptide (VIP). 
Type I IS-INs express calretinin and preferentially target calbindin-expressing interneurons from 
the CCK-expressing interneuron subfamily mentioned above, while avoiding PV-expressing 
basket cells. Type II IS-INs express VIP and similarly target calbindin- and CCK-expressing 
interneurons. Type III IS-INs express both calretinin and VIP, and their major postsynaptic target 
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are O-LMs, while less frequently synapsing onto bistratified cells and PV basket cells. (Freund 
and Buzsaki, 1996; Pelkey et al., 2017; Booker and Vida, 2018). While it is evident that different 
classes of interneurons play varying roles in hippocampal function, less is known about how 
certain interneuron subtypes may respond to different neuromodulators.  
 
1.1.4: Excitatory transmission in the hippocampus    
The neurotransmitter glutamate functions as the major excitatory neurotransmitter in the 
mammalian brain. Glutamate is released from principal cells in the hippocampus, and therefore is 
the neurotransmitter that is utilized in the synapses that make up the trisynaptic circuit. While 
GABAergic interneurons are located in all hippocampal strata layers, the cell bodies of 
glutamatergic principal cells are restricted to the pyramidal cell layer (pyramidal cells) or the 
granule cell layer of the DG (granule cells). Pyramidal cells, named for their triangular cell body 
morphology, are tightly compacted within the pyramidal cell layer and all aligned in the same 
orientation. They possess both apical and basal dendrites, with the apical dendrites extending into 
stratum radiatum and basal dendrites into stratum oriens (Spencer and Bland, 2019). Granule cells 
have smaller, oval-shaped cell bodies with a single dendritic tree that fills the molecular layer of 
DG. The synapses that mediate excitatory neurotransmission are typically located on the heads of 
dendritic spines (Harris and Weinberg, 2012).  
As with inhibition, excitatory synaptic transmission is modulated both through ionotropic 
and metabotropic receptors. The majority of fast synaptic excitation arises from ionotropic α-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs). AMPARs are 
assemblies of four subunits, GluA1-4 (Keinanen et al., 1990; Nakanishi et al., 1990), and are 
primarily permeable to Na+ and K+ ion flux. Interestingly, the GluA2 subunit is critical for the 
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overall biophysical properties of the receptor, as this subunit determines both the single channel 
conductance as well as its permeability to Ca2+ ions (Gouaux, 2004; Pelkey et al., 2017). Receptors 
containing the GluA2 subunit are impermeable to Ca2+, due to the presence of an arginine amino 
acid at the M2 reentrant transmembrane loop, whereas GluA1, GluA3, and GluA4 subunits contain 
a glutamine at that location (Greger et al., 2003; Traynelis et al., 2010). AMPARs play important 
roles in the induction of long-term potentiation (LTP), and these receptors are upregulated in the 
postsynaptic membrane following LTP (Hayashi et al., 2000; Shi et al., 2001). A second major 
form of ionotropic glutamate receptors involved in fast synaptic transmission are N-methyl-D-
aspartate receptors (NMDARs). Similar in structure to AMPARs, NMDARs are heteromers 
consisting of GluN1, GluN2A, GluN2B, GluN2C, and GluN2D subunits, with all native receptors 
requiring the GluN1 subunit (Traynelis et al., 2010). NMDARs display two unique traits: 1) their 
activation requires coincident ligand binding to the receptor to allow the passage of ions, coupled 
with strong depolarization of the postsynaptic cell to remove a voltage-dependent Mg2+ ion 
blocking the pore (Ascher and Nowak, 1987), and 2) they require the binding of two separate 
agonists: glutamate binding specifically to the GluN2 subunit, and glycine or D-serine binding to 
the GluN1 subunit (Kleckner and Dingledine, 1988). NMDARs allow passage of Na+, K+, and 
Ca2+ through their pore, and the Ca2+ influx through NMDARs is both necessary and sufficient for 
expression of LTP (Lynch, 2004). The final form of ionotropic glutamate receptor is the kainate 
receptor (KAR). KARs are also permeable to Na+ and K+ ions, though typically play only a minor 
role in synaptic signaling (Song and Huganir, 2002). Interestingly, KARs can also signal 
noncanonically through metabotropic mechanisms (Lerma and Marques, 2013). The receptors that 
are primarily responsible for GPCR-mediated excitation are the metabotropic glutamate receptor 
family (mGluRs), which are classified into three groups. Group I mGluRs comprise mGluR1 and 
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mGluR5, which are typically found postsynaptically and activate intracellular Ca2+ through the 
Gq-coupled pathway. Group II mGluRs consist of mGluR2 and mGluR3, while Group III mGluRs 
include mGluRs 4, 6, 7, and 8; these mGluR subgroups are generally found on presynaptic neurons 
and are coupled to Gi/o proteins (Traynelis et al., 2010).    
 
1.1.5: Neuromodulatory activity in the hippocampus  
 In addition to the amino acid neurotransmitters, hippocampal activity can also be 
modulated by a variety of other signaling molecules, most notably neuropeptides. While 
neuropeptides were previously thought to be released from unusual neuron types that specifically 
released the peptide, it is now understood that peptides are often co-released with amino acid 
transporters, and that most neurons in the brain likely possess the ability to secrete peptides (van 
den Pol, 2012). Additionally, astrocytes are also heavily involved in peptidergic signaling; they 
express peptide receptors and can secrete several prevalent neuropeptides (Verkhratsky and 
Nedergaard, 2017). Neuropeptides commonly seen in the hippocampus include neuropeptide Y, 
cholecystokinin, stomatostatin, leptin, galanin, and corticotropin-releasing hormone (Spencer and 
Bland, 2019). This is certainly not an exhaustive list, however, and modulatory activity by 
signaling molecules in the hippocampus continue to be discovered, including the peptide diazepam 
binding inhibitor (see Chapter 2). Additionally, there is growing evidence that glial cells, 
specifically astrocytes, can regulate hippocampal synaptic transmission (see section 1.3, Chapter 
4).  
 
1.2: Benzodiazepines, “endozepines,” and diazepam binding inhibitor  
1.2.1: Benzodiazepine binding on GABAAR function  
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 In addition to the aforementioned canonical GABA binding site between the α and β 
subunits, GABAARs have many other binding sites and are thus capable of being allosterically 
modulated by dozens of compounds. Among the best-known modulators of GABAARs are 
neurosteroids, barbiturates, ethanol, anesthetics, and cannabinoids (Sieghart, 2015). Perhaps the 
most commonly studied modulators of GABAARs, however, are benzodiazepines (BZs). Used 
therapeutically for their anxiolytic, anticonvulsant, and sedative effects, BZs are commonly 
prescribed to patients suffering from insomnia, muscle spasms, or epilepsy. They bind to BZ-
specific sites on GABAARs located extracellularly between α and γ subunits (Sigel and Buhr, 
1997), typically exerting positive allosteric modulatory effects that lead to a strengthening of 
inhibition. However, whether or not BZs can bind to GABAARs, as well as the nature and potency 
of any potential effect, depends on the subunit composition of the GABAAR in question.  
 The binding of BZs to the GABAAR typically leads to an increase in the affinity of GABA 
binding to the receptor, subsequently increasing the frequency of the chloride channel opening and 
an overall potentiation of inhibitory postsynaptic currents (Rogers et al., 1994; Bianchi, 2010). 
Specific subunits are critical for BZ binding to GABAARs; receptors containing α1, α2, α3, and 
α5 subunits are sensitive to BZs, while receptors containing α4 or α6 subunits are insensitive. BZ-
sensitive subunits contain a histidine amino acid residue at position 101, 101, 126, and 105 on α1, 
α2, α3, and α5, respectively. Conversely, α4 and α6 have arginine residues at those same locations, 
leading to BZ-insensitivity (Wieland et al., 1992; Rudolph et al., 1999). Since benzodiazepines 
bind at α/γ interfaces, their modulatory effects are typically uninfluenced by β subunits 
(Hadingham et al., 1993). The γ2 subunit is also critical for BZ binding (Pritchett et al., 1989; Sigel 
and Buhr, 1997; Sieghart and Sperk, 2002). Interestingly, however, one study indicated that the 
benzodiazepine diazepam can modulate GABAARs via two distinct mechanisms: one mechanism 
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that responds to nanomolar concentrations and requires the γ2 subunit, and a separate micromolar 
component that does not require γ2 (Walters et al., 2000), indicating that the effects of BZ binding 
may have concentration- and subunit-specific effects.  
 
1.2.2: The search for endozepines and diazepam binding inhibitor   
 The discovery of a BZ-specific binding site on GABAARs in the late 1970s motivated the 
hypothesis that the brain may be producing its own endogenous BZ-binding site ligands, now 
referred to as “endozepines” (Iversen, 1977; Costa and Guidotti, 1985; Farzampour et al., 2015). 
The search for these elusive signaling molecules gained traction with the development of 
flumazenil (FLZ), a BZ-binding site-specific antagonist (Hunkeler et al., 1981). In the 
hippocampus, the amplitude of inhibitory postsynaptic potentials was reduced following FLZ 
application, suggesting the presence of an endogenous ligand that binds to the BZ binding site and 
enhances inhibition (King et al., 1985). Additionally, FLZ reduced the amplitude of electrically 
evoked IPSCs in CA1 pyramidal cells following induction of long-term potentiation (Xu and 
Sastry, 2005), and reduced miniature IPSC decay time in the DG of pilocarpine-treated epileptic 
rats (Leroy et al., 2004). In other brain regions, application of FLZ reduced IPSC decay time in 
the thalamic reticular nucleus (Christian and Huguenard, 2013; Christian et al., 2013) and in 
cultured cortical neurons (Vicini et al., 1986), while also reducing IPSP amplitude in rat cortical 
slices (Ali and Thomson, 2007). These data suggest the presence of an endogenous ligand capable 
of binding to GABAAR BZ-binding sites and promoting inhibition.     
The best studied of these potential endozepines is the peptide diazepam binding inhibitor 
(DBI). Named for its ability to displace the BZ diazepam from BZ-binding sites on GABAARs 
(Guidotti et al., 1983), DBI is a 10 kDa protein that is highly conserved across species and 
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expressed in most cell types in the body (Sandberg et al., 2005). Its near-ubiquitous expression in 
cells suggests a role for DBI in important housekeeping functions (Mandrup et al., 1992), and DBI 
also plays critical roles in lipid metabolism (Neess et al., 2015). In the brain, DBI protein 
immunoreactivity is seen in several brain regions, including the hippocampus (Ball et al., 1989; 
Ferrarese et al., 1989). The release of DBI is thought to be done primarily by astrocytes through 
unconventional secretion mechanisms that bypass the endoplasmic reticulum. In yeast, Acb1 (an 
orthologue to DBI) was found to be secreted through an unconventional method via 
autophagosomes (Duran et al., 2010). Further experiments in cultured rat brain astrocytes 
demonstrated DBI secretion via a similar autophagy-related unconventional mechanism (Loomis 
et al., 2010). In slices, pharmacological poisoning of astrocytes leads to a loss of DBI-dependent 
enhancement of inhibition, suggesting that DBI is primarily released by astrocytes (Christian and 
Huguenard, 2013). In astrocyte cultures, DBI secretion can be induced by application of steroid 
hormones (Loomis et al., 2010) or elevated K+ (Ferrarese et al., 1987; Qian et al., 2008), whereas 
treatment with somatostatin and/or GABAB receptor activation can inhibit DBI release (Masmoudi 
et al., 2005). In addition, DBI has several cleavage products that are biologically active and capable 
of displacing BZs from GABAARs, including octadecaneuropeptide (ODN), 
triakontatetraneuropeptide, and octapeptide (Costa and Guidotti, 1991).  
Studies investigating how DBI and its cleavage products modulate GABAARs have yielded 
mixed results. In embryonic spinal cord neurons, application of DBI alone did not induce 
GABAAR-mediated currents. However, application of DBI reduced the amplitude of GABAAR-
mediated currents in a dose-dependent fashion, an effect that was reversed by FLZ application, 
suggesting that DBI acts as a negative modulator of GABAergic transmission specifically at the 
BZ-binding site (Bormann, 1991). Additionally, negative allosteric modulation of GABAARs by 
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DBI plays a critical role in neurogenesis. In transit-amplifying cells of the subventricular zone, the 
peptide fragment ODN enhances neurogenesis through inverse agonistic actions on GABAAR-
mediated currents (Alfonso et al., 2012). A similar phenomenon was seen in the hippocampal 
subgranular zone, in which a DBI-dependent reduction of GABAAR currents promoted stem cell 
proliferation (Dumitru et al., 2017). Surprisingly, however, DBI acts as a positive allosteric 
modulator of GABAARs in the thalamic reticular nucleus but not the neighboring ventrobasal 
nucleus. The DBI-dependent enhancement of GABAAR-mediated currents disappeared in mice 
lacking the Dbi gene, and viral reintroduction rescued the effect (Christian et al., 2013). Thus, it 
appears that DBI can exert multifaceted effects on GABAARs in different brain regions, and that 
these effects can even be subregion-specific.  
It is important to note that while there is a wealth of evidence demonstrating that DBI can 
directly modulate GABAARs, DBI can also indirectly modulate inhibitory transmission via the 
mitochondrial benzodiazepine receptor. Also known as translocator protein, the binding of DBI to 
this receptor has been demonstrated to stimulate biosynthesis of neurosteroids, which are known 
modulators of GABAARs (Korneyev et al., 1993). Currently, the role that DBI plays in modulating 
GABAARs in other critical brain regions, such as the adult hippocampus, have not previously been 
explored. Behaviorally, DBI appears to play a role in several hippocampal-dependent tasks. Mice 
with an overexpression of DBI display impaired spatial learning and memory performance in the 
Morris water maze task (Siiskonen et al., 2007). In addition, animals who displayed enhanced 
retention memory in a contextual fear conditioning task following corticotropin-releasing hormone 
treatment had the phenotype reversed following intracerebroventricular injection of DBI (Sherrin 
et al., 2009). Altogether, these data suggest potentially important roles for DBI in modulating 
hippocampal function.  
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1.3: The role of astrocytes in modulating synaptic transmission  
1.3.1: Astrocyte characteristics and CNS supporting roles    
 Astrocytes are the most prevalent type of glial cell in the central nervous system, providing 
imperative homeostatic roles critical for proper brain function. Two main subpopulations of 
astrocytes exist: protoplasmic astrocytes, which inhabit gray matter and display extensive 
spongiform morphologies that enwrap synapses, and fibrous astrocytes, which are found in white 
matter and frequently contact nodes of Ranvier (Peters et al., 1991). Both subtypes share many 
similarities, including the expression of the commonly used astrocyte marker glial fibrillary acid 
protein (GFAP) (Eng, 1985; Eng et al., 2000), and the ability to form gap junctions with the 
processes of neighboring astrocytes (Brightman and Reese, 1969). In this manuscript, however, 
the term “astrocyte” will henceforth refer to protoplasmic astrocytes.  
Structurally, astrocytes are distributed in a tiled organization of non-overlapping domains 
in the hippocampus (Bushong et al., 2002; Ogata and Kosaka, 2002). Each individual astrocyte 
can enwrap between 4-8 neuronal somata, contact several hundred dendrites, and interact with 
over 100,000 synapses (Ventura and Harris, 1999; Bushong et al., 2002; Ogata and Kosaka, 2002; 
Halassa et al., 2007b). This extraordinary breadth allows astrocytes to be ideally situated to provide 
support to neurons, a role to which astrocytes had been previously considered to be limited. 
Physiologically, astrocytes are electrically silent and do not display propagated electrical signals. 
They have a high resting K+ conductance that leads to hyperpolarized resting membrane potentials 
that remain very close to the reversal potential for K+ (approximately -80 mV), and display a 
remarkably predictable 57-mV depolarization for each tenfold increase in extracellular K+ 
(Kuffler, 1967). Additionally, astrocytes have an extremely low membrane resistance, typically 
below 5 MΩ (Khakh and Deneen, 2019). 
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One major supporting role for astrocytes is the regulation of ion homeostasis in synaptic 
clefts. Astrocytes express high levels of K+ transporters that remove excess K+ from the synapse 
and can distribute the K+ laterally to neighboring astrocytes via gap junctions in a process known 
as spatial buffering (Holthoff and Witte, 2000; Walz, 2000; Kofuji and Newman, 2004). Astrocytes 
also express transporters that clear neurotransmitters from synapses, including glutamate and 
GABA (Marcaggi and Attwell, 2004; Robel and Sontheimer, 2016). These transmitters can then 
be degraded into their precursor forms via enzymatic breakdown and subsequently reconverted 
into functional neurotransmitters. These buffering processes are crucial in promoting normal 
synaptic function and preventing excitotoxicity. Astrocytes also play important roles in the 
formation and maintenance of the blood-brain-barrier (Abbott et al., 2006), as well as in the 
development, preservation, and pruning of synapses (Ullian et al., 2001; Barres, 2008; Chung et 
al., 2015). It is important to note that astrocytes display distinct heterogeneity in structural, 
morphological, and molecular properties, and this likely leads to diversity in the functionality of 
different astrocyte subpopulations. The recognition of astrocyte heterogeneity is still very much in 
its infancy, however (Zhang and Barres, 2010; Khakh and Deneen, 2019). 
Astrocytes are capable of expressing nearly all known receptor types in the central nervous 
system, although the expression of certain receptors/receptor subtypes depends on the brain region 
(Porter and McCarthy, 1997). In the hippocampus, there is functional expression of AMPA 
receptors primarily expressing the GluA2 and GluA4 subunits (Seifert and Steinhäuser, 1995). 
Despite functional expression in cortex, the presence of functional NMDA receptors in 
hippocampus lacks conclusive evidence and remains controversial (Verkhratsky and Nedergaard, 
2017; Skowrońska et al., 2019). Metabotropic glutamate receptors, specifically mGluR3 and 
mGluR5, are richly expressed in hippocampal astrocytes. Interestingly, however, there is a 
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developmental downregulation of mGluR5 in astrocytes, and these receptors almost completely 
vanish in the adult brain (Sun et al., 2013). GABAARs mediate inward Cl- currents in astrocytes 
of the hippocampus (MacVicar et al., 1989). The subunit compositions of GABAARs in 
hippocampal astrocytes are not well established, but receptors containing α1 and β1 subunits have 
been detected (Fraser et al., 1995). Functional ionotropic and metabotropic purinergic receptors 
are expressed in hippocampal astrocytes, including all four adenosine receptors (A1, A2A, A2B, and 
A3) and the dominantly expressed P2-type receptors (P2Y1,2,4, P2X7). Importantly, functional α1-
adrenergic receptors are highly expressed in hippocampal astrocytes (Duffy and MacVicar, 1995). 
The majority of these receptor subtypes have been linked to intracellular Ca2+ dynamics in 
astrocytes of the hippocampus, and either have been previously demonstrated, or are currently 
hypothesized, to contribute to astrocytic modulation of hippocampal synaptic transmission.  
 
1.3.2: Intracellular Ca2+ signaling in astrocytes and the tripartite synapse  
In the 1990s, several exciting investigations into astrocytes gave rise to the burgeoning 
field of neuron-astrocyte interactions. The first findings reported that exogenously applied 
glutamate resulted in rises in intracellular Ca2+ levels in cultured astrocytes, indicating that 
astrocytes may have the ability to respond to neuronal activity (Cornell-Bell et al., 1990; Porter 
and McCarthy, 1995). Subsequently, further studies made the important distinction that cultured 
astrocytes display Ca2+ elevations in response to synaptically released neurotransmitter, and not 
simply from exogenously applied ligands (Porter and McCarthy, 1996; Pasti et al., 1997). These 
discoveries led to the hypothesis that astrocytes, despite being electrically silent, are not 
functionally silent at synapses, with intracellular Ca2+ spikes representing a form of astrocytic 
“excitability” (Bazargani and Attwell, 2016). These data, along with the previously established 
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supporting roles of astrocytes, led to the formulation of the “tripartite synapse” concept, positing 
that astrocytes engage in bidirectional communication with pre- and postsynaptic neurons (Figure 
1.4). The tripartite synapse remains critically important in modern neuroscience, and many reviews 
have covered the topic extensively (Araque et al., 1999, 2014; Halassa et al., 2007a; Perea et al., 
2009; Santello et al., 2012)  
The primary mode of evoking intracellular Ca2+ in astrocytes is via GPCR activation, 
typically through activation of the Gq-signaling pathway. Gq activation leads to hydrolyzation of 
phosphatidylinositol 4,5-bi-sphosphate (PIP2) by phospholipase C, generating diacylglycerol 
(DAG) and inositol trisphosphate (IP3), which subsequently induces Ca2+ release from IP3 
receptor-mediated intracellular stores in the endoplasmic reticulum. In astrocytes, only the type 2 
IP3 receptor (IP32R) is expressed (Sharp et al., 1999), implying that these receptors are primarily 
responsible for astrocytic Ca2+ signaling. Indeed, the initial study utilizing transgenic mice with a 
knockout of IP32Rs demonstrated a near-complete abolishment of somatic Ca2+ signals. These 
mice also displayed no alterations in neuronal excitability or synaptic currents (Petravicz et al., 
2008), or in excitatory synaptic plasticity (Agulhon et al., 2010), suggesting that astrocytic Ca2+ is 
not an intrinsic readout of neuronal activity. However, later studies utilizing 2-photon (2P) Ca2+ 
imaging with genetically encoded calcium indicators (GECIs) provided new insight into Ca2+ 
signaling within the microdomains of astrocyte processes. Using advanced imaging techniques, 
Srinivisan and colleagues (2015) found that only ~60% of total Ca2+ signaling is abolished in IP32R 
knockout animals in slices and in vivo, and that the vast majority of total Ca2+ fluctuations actually 
take place in the microdomains of astrocytes rather than the somata. Furthermore, these IP32R-
independent, microdomain Ca2+ transients persisted following astrocyte GPCR activation in slices 
as well as after startle responses in vivo, whereas these signals were mostly lost in astrocyte somata 
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(Srinivasan et al., 2015). This suggests that somatic and microdomain Ca2+ transients are distinct 
properties, and that Ca2+ signals located in astrocyte processes are more relevant for encoding 
astrocyte/neuron crosstalk. These studies proved critical in shifting attention from Ca2+ signals 
located in astrocyte somata to those located in microdomains.    
Currently, it is recognized that astrocytes display several distinct types of Ca2+ events, with 
putative functional diversity. These events can be characterized as either somatic or restricted to 
astrocyte processes (microdomains), can be evoked spontaneously or in direct response to 
neuromodulation or behavioral activity, and can be driven by a variety of cellular mechanisms. In 
the hippocampus, Ca2+ signals found in astrocyte somata are primarily elicited in response to 
protracted neuronal stimulation, and commonly are considered “global” signals when they 
encompass the entire astrocyte. Not all spontaneous Ca2+ events found in the soma are global, 
however (Khakh and Sofroniew, 2015). As mentioned above, these somatic signals are largely 
reduced in IP32R knockout animals. Similarly, in vivo behavioral stimulation (locomotion, whisker 
stimulation, or startle response) induce intense global Ca2+ signals that are driven by the release of 
neuromodulators (Nimmerjahn et al., 2009; Ding et al., 2013; Paukert et al., 2014). 
Importantly, the vast majority of basal Ca2+ activity takes place in astrocyte processes 
(Bindocci et al., 2017). In these microdomains, spontaneous Ca2+ transients are highly localized 
and, despite one noted exception, are not mediated by IP32R-dependent intracellular stores 
(Shigetomi et al., 2012, 2013; Haustein et al., 2014; Nett et al., 2017; Stobart et al., 2018). Some 
established mechanisms mediating these events include Ca2+ entry through TRPV4 channels 
(Dunn et al., 2013) and through opening of the mitochondrial permeability transition pore 
(Agarwal et al., 2017). Occasionally, some microdomain Ca2+ transients display local waves that 
extend tens of micrometers through the main astrocyte branches and occasionally to the soma; 
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these Ca2+ waves are considered distinct from the highly localized signals (Haustein et al., 2014; 
Jiang et al., 2016). Additionally, neuronally-derived Ca2+ signals can also be detected in astrocytic 
processes (Di Castro et al., 2011; Panatier et al., 2011), and these signals display varying rise and 
decay properties. Interestingly, with regard to inhibitory neurotransmission, astrocytes display 
different Ca2+ dynamics in microdomains in response to optogenetic stimulation of parvalbumin- 
and somatostatin-expressing interneurons, in which astrocytes show weak Ca2+ elevations 
following parvalbumin interneuron stimulation yet show robust Ca2+ signaling following 
somatostatin interneuron activation (Mariotti et al., 2018).  
 
1.3.3: Astrocytic modulation of synaptic transmission and plasticity  
Nearly 30 years after the initial studies demonstrating intracellular Ca2+ elevations in 
astrocyte cultures, the relevance of astrocytic intracellular Ca2+ signaling on the modulation of 
synaptic function is still controversial. This debate is mostly focused around the concept of 
“gliotransmission” and its reliance on astrocytic Ca2+ signaling, and extensive reviews both 
supporting (Savtchouk and Volterra, 2018) and contradicting (Fiacco and McCarthy, 2018) the 
phenomenon have been published. Many studies have demonstrated astrocytic release of several 
signaling molecules in a Ca2+-dependent fashion, including glutamate (Parpura et al., 1994; Bezzi 
et al., 1998; Kang et al., 1998; Angulo et al., 2004; Fellin et al., 2004), GABA (Lee et al., 2010; 
Yoon and Lee, 2014), ATP (Newman, 2003; Pryazhnikov and Khiroug, 2008), and D-serine 
(Mothet et al., 2005; Henneberger et al., 2010). However, the experimental methodology used in 
some of these seminal studies may require critical re-evaluation (see section 1.3.4).  
 The bulk of research examining roles for astrocytes in modulating synaptic transmission 
has investigated glutamatergic transmission and/or excitatory synaptic plasticity. In the 
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hippocampus, documented evidence for modulation of excitatory transmission includes: 
alterations in properties of spontaneous or miniature EPSCs (Araque et al., 1998a, 1998b; Jourdain 
et al., 2007; Santello et al., 2011; Han et al., 2012a; Adamsky et al., 2018); modulation of LTP via 
astrocytic release of D-serine (Yang et al., 2003; Zhang et al., 2008; Henneberger et al., 2010); 
modulation of LTP via astrocytic release of glutamate (Perea and Araque, 2007; Navarrete and 
Araque, 2010; Navarrete et al., 2012); modulation of LTP via astrocytic release of ATP/adenosine 
(Pascual et al., 2005; Lee et al., 2010; Schmitt et al., 2012; Mederos et al., 2019); and mediation 
of long-term heterosynaptic depression (Zhang et al., 2003; Pascual et al., 2005; Serrano et al., 
2006; Andersson et al., 2007; Chen et al., 2013; Boddum et al., 2016). Additionally, recent studies 
have indicated an enhancement of memory performance in vivo following astrocyte activation 
using advanced tools (Adamsky et al., 2018; Mederos et al., 2019; Mederos et al., 2021).       
 Fewer studies have directly investigated the role of astrocytes in the modulation of 
inhibitory neurotransmission (Mederos and Perea, 2019). An early seminal study found that 
mechanical stimulation of astrocytes stimulated the release of glutamate, which led to an 
enhancement of synaptic inhibition (a reduction in inhibitory synaptic failures) (Kang et al., 1998). 
Another study found that astrocyte-derived glutamate binds to presynaptic mGluRs on 
hippocampal interneurons, increasing the frequency of IPSCs (Liu et al., 2004). In addition to 
glutamate, astrocytic release of ATP/adenosine can also modulate inhibitory transmission. 
Activation of somatostatin-expressing interneurons in CA1 stimulates the release of 
ATP/adenosine from astrocytes, subsequently leading to an enhancement of synaptic inhibition 
via activation of A1Rs on pyramidal cells (Matos et al., 2018). Furthermore, one recent study found 
that high-frequency firing of interneurons induced Ca2+ signaling in the somata of hippocampal 
astrocytes, leading to both glutamate and ATP/adenosine release. Interestingly, these transmitters 
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distinctly mediated biphasic modulation of excitatory plasticity, such that the release of glutamate 
stimulated transient synaptic potentiation, whereas the release of ATP mediated long-term synaptic 
depression (Covelo and Araque, 2018). 
In addition, the activity of the astrocytic GABA transporter GAT-3 can also regulate both 
excitatory and inhibitory transmission. For example, GAT-3 activation leads to the release of 
ATP/adenosine from hippocampal astrocytes, which acts to reduce the release of glutamate 
through activation of presynaptic A1Rs (Boddum et al., 2016). Additionally, resting astrocytic Ca2+ 
levels can be decreased following opening of transient receptor potential A1 (TRPA1) channels, 
which increases extracellular GABA levels via inhibition of GAT-3 (Shigetomi et al., 2012). To 
our knowledge, however, no study has investigated the role of astrocytes on the modulation of 
basal inhibitory transmission using advanced tools that specifically target the activity of astrocytes.  
 
1.3.4: Techniques and tools used for selective manipulation of astrocytes 
 Since the development of the field in the 1990’s, research investigating neuron-astrocyte 
interactions has been greatly hampered by a lack of available tools that selectively and accurately 
modulate astrocytes. Criticisms of previous techniques used to selectively activate astrocytes 
generally fall under two non-mutually-exclusive categories: 1) the technique used had off-target 
neuronal effects and thus was not entirely specific to astrocytes, or 2) the technique used does not 
accurately recapitulate in vivo physiological astrocyte function, and thus any effects seen are likely 
to be an experimental artifact. Consequently, there has been tremendous controversy regarding the 
interpretation of previous data, and many seminal studies in the field have required re-examination 
in recent years (Agulhon et al., 2008). Though there is still no perfect tool, recent technological 
advancements have led to improvements in both respects.   
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 The earliest investigations into the role of astrocytic Ca2+ signaling on neuronal activity 
were done in culture and typically used pharmacological approaches to stimulate astrocytes. While 
these studies were groundbreaking for the initial discovery of Ca2+ waves in astrocytes, it is now 
understood that cultured astrocytes do not display similar morphologies to astrocytes in vivo and 
display significantly altered gene expression profiles (Agulhon et al., 2008; Barres, 2008), making 
them poor models for study. Furthermore, when these experiments were replicated in slice 
preparations, they were plagued by a lack of specificity because the astrocytic receptors used to 
stimulate Ca2+ elevations are also present in neurons. Attempts to rectify this issue using more 
refined techniques, including mechanical stimulation of astrocytes, chelation of Ca2+ using 
BAPTA, and Ca2+ uncaging in astrocytes have also been criticized as unphysiological and prone 
to off-target effects. Therefore, it quickly became clear that more precise tools were necessary to 
conduct studies with fewer confounding variables.  
In an effort to combat these issues, prominent labs in the field switched to using transgenic 
mouse models with a primary emphasis on uncovering the importance of intracellular Ca2+ 
elevations in astrocytes on neuronal activity. For example, the IP32R knockout mouse line was 
developed to artificially eliminate Ca2+ signaling specifically in astrocytes (Petravicz et al., 2008). 
While IP32R KO mice have provided important insights into the role of somatic-specific astrocytic 
Ca2+ on neuronal synaptic transmission, they do not help with our current understanding of neuron-
astrocyte interactions in intact systems. Additionally, the McCarthy lab developed a primitive 
chemogenetic mouse model for studying neuron-astrocyte interactions, the Mas-related gene A1 
(MrgA-1) mouse line (Fiacco et al., 2007). MrgA-1 is a Gq-linked GPCR that is activated by the 
peptide ligand FMRF; MrgA-1 is not endogenously expressed in the brain, and FMRF does not 
bind to brain GPCRs. Using transgenic manipulations, the group developed animals in which 
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MrgA-1 receptors were expressed only in glial cells. Seen as a major advancement in the field, 
several major studies utilized this transgenic line (Fiacco et al., 2007; Agulhon et al., 2010; Wang 
et al., 2012, 2013; Devaraju et al., 2013). Though considered to be an important advancement, a 
major limitation is that the ligand FMRF does not cross the blood-brain-barrier (BBB), thereby 
rendering in vivo studies impossible (Xie et al., 2015).  
 The BBB limitation was overcome with the development of the chemogenetic receptor 
family of DREADDs (Designer Receptors Exclusively Activated by Designer Drugs) (Roth, 
2016), offering an immediate improvement over the MrgA-1 mouse line. First introduced in 
Agulhon et al., 2013, the GFAP-hM3D DREADD viral approach is arguably the current standard 
for selective astrocytic manipulation of Gq signaling and has been utilized in several recent studies 
(Agulhon et al., 2013; Yang et al., 2015; Chen et al., 2016; Martin-Fernandez et al., 2017; 
Adamsky et al., 2018, Durkee et al., 2019). This method does come with its own limitations, 
however. As with all pharmacological manipulations, the use of GFAP-hM3D in astrocytes has 
important temporal limitations, both in the time it takes to exert an effect and in the duration of the 
effect.   
The development of optogenetics, specifically the light-activated nonspecific cation 
channel channelrhodopsin2 (ChR2), revolutionized studies in neurons by offering cell-type 
specificity coupled with relatively precise temporal and spatial control (Deisseroth, 2015). 
Unsurprisingly, constructs inserting ChR2 specifically into astrocytes were quickly developed and 
utilized in several prominent studies (Gourine et al., 2010; Perea et al., 2014; Yamashita et al., 
2014; Masamoto et al., 2015; Tan et al., 2017). However, the use of ChR2 in astrocytes is not ideal 
due to its lack of direct physiological relevance. As mentioned earlier, astrocytes are electrically 
silent and have few, if any, voltage-gated ion channels; thus, the dramatic depolarization of 
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astrocytes using artificially inserted ion channels does not come close to recapitulating any normal 
physiological function. Therefore, studies utilizing ChR2 to drive intracellular Ca2+ elevations in 
astrocytes have important limitations and should be viewed with a critical lens.  
Taken altogether, the astrocyte field has taken great steps to improve the methodologies 
used to precisely and accurately study astrocyte-neuron interactions. However, there remains a 
need for tools that can selectively modulate astrocytes in a physiologically-relevant manner with 
precise temporal precision. Recently, an astrocyte-specific light-sensitive melanopsin coupled to 
the Gq signaling pathway has been developed (Mederos et al., 2019), which appears to drive 
intracellular Ca2+ elevations in astrocytes with improved temporal specificity.  
  
1.4: Advantages of two-photon excitation microscopy and GECIs for astrocyte Ca2+ 
imaging 
 The development of 2P excitation microscopy (Denk et al., 1990) has proved invaluable to 
the study of Ca2+ signaling in astrocytes. 2P imaging allowed, for the first time, the ability to image 
deep brain tissue in live tissue/animals with single cell resolution (or better) (Svoboda and Yasuda, 
2006). The primary advantage of 2P imaging over other imaging techniques, including confocal 
microscopy, is dramatically reduced phototoxicity and photobleaching of tissue samples. Because 
2P excitation only generates fluorescence at the focal plane, there is no absorption and fluorescence 
of photons above or below the plane of focus. Furthermore, since there is no out-of-focus 
absorption, more excitation light can penetrate the sample and directly reach the focal plane, 
making 2P excitation a highly efficient mechanism. Thus, 2P imaging offers the unparalleled 
ability to image in thick samples. This is critical for the imaging of live tissue, especially when 
imaging over longer periods of time (Benninger and Piston, 2013). Prior to the use of 2P excitation 
microscopy, astrocyte biologists used standard 1P imaging techniques that do not offer the spatial 
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resolution to properly image astrocyte microdomains. Therefore, many early imaging studies of 
astrocytes were limited to imaging astrocyte somata, ignoring the critically important microdomain 
Ca2+ transients.   
Early Ca2+ imaging experiments in astrocytes required the use of Ca2+ indicator dyes. 
Previous imaging studies widely used the bulk-loading of acetoxymethyl ester (AM) Ca2+ dyes 
into cultures or tissue samples. However, bulk-loading techniques are ineffective in astrocytes 
from adult tissue (Haustein et al., 2014). Additionally, only astrocyte somata reliably absorb 
enough of the dye for imaging, and thus do not allow imaging of astrocyte processes (Reeves et 
al., 2011). These limitations can be partially overcome by using the patch-clamp method to dialyze 
individual astrocytes with cell-impermeable Ca2+ dyes. However, this method is technically 
demanding and generally low-throughput.  
The invention of genetically encoded calcium indicators (GECIs), Ca2+ indicators that can 
be genetically transfected into cell or mouse lines, revolutionized the field. GECIs can now be 
expressed in specific transgenic mouse lines for global expression in astrocytes or can be virally 
injected for region specificity. Importantly, standard GECIs also offer improved expression within 
astrocyte microdomains compared to Ca2+ dyes. Thus, the use of GECIs in combination with 2P 
excitation imaging is currently the gold standard for imaging Ca2+ dynamics in astrocytes.  
 
1.5: Summary and overview 
 In my Ph.D. research, I have pursued two distinct research projects, united under the theme 
of investigating the modulation of synaptic transmission in the hippocampus, with an emphasis on 
synaptic inhibition. During the first half of my Ph.D., I studied roles for the neuropeptide and 
putative endozepine DBI using a constitutive knockout mouse model. DBI plays roles in multiple 
complex physiological processes, and previous literature suggested that DBI can differentially 
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modulate GABAARs in different brain regions, acting as a positive allosteric modulator in the 
thalamus and a negative modulator in other regions. However, the extent to which DBI modulates 
synaptic transmission in a critical brain structure, the hippocampus, had not been investigated. In 
Chapter 2, I use patch-clamp electrophysiology to demonstrate diametric modulation of synaptic 
transmission by DBI in a subregion-specific manner, in which synaptic inhibition is enhanced in 
DG and attenuated in CA1 in mice lacking DBI signaling. In Chapter 3, I demonstrate that DBI 
KO mice are impaired in multiple hippocampal-dependent behavioral assays, including the Barnes 
maze and a contextual fear conditioning task. Furthermore, I was critically involved in the work 
described in Appendix A, in which we used our DBI KO mouse line to identify a novel role for 
DBI in modulating social interest behavior.  
In addition, growing evidence suggests that astrocytes are capable of modulating synaptic 
transmission, most notably glutamatergic signaling. However, far less work has been published 
investigating roles for astrocytes in modulating synaptic inhibition in the hippocampus. During the 
latter half of my Ph.D., I investigated roles for astrocytes in the modulation of synaptic 
transmission in the hippocampus using a novel optogenetic tool expressed specifically in 
astrocytes. In Chapter 4, I demonstrate that high-frequency stimulation of Optoα1AR in astrocytes 
modulates synaptic excitation and inhibition in CA1 pyramidal cells, whereas low-frequency 0.5 
Hz stimulation has no effect. These experiments demonstrate that Optoα1AR may be a valuable 


















Figure 1.1: The hippocampal trisynaptic circuit. Figure is adapted from “Mature granule cells of 
the dentate gyrus—Passive bystanders or principal performers in hippocampus function?” 













Figure 1.2: Diagram of a typical GABAA receptor with specific binding sites labeled. Figure is 
adapted from “Regulation of GABAA Receptor Subunit Expression by Pharmacological Agents” 




Figure 1.3: Typical somata locations and axon trajectories (yellow, green lines) of major 
interneuron subtypes of the hippocampus. Figure is adapted from “Hippocampal GABAergic 






















Figure 1.4: Diagram of the tripartite synapse. Figure is adapted from “Interactions between 
astrocytes and the reward-attention circuit: A model for attention focusing in the presence of 




CHAPTER 2: SUBREGION-SPECIFIC IMPACTS OF GENETIC LOSS OF DIAZEPAM 
BINDING INHIBITOR ON SYNAPTIC INHIBITION IN THE MURINE 
HIPPOCAMPUS 
 
This work was published in Neuroscience; 2018, 388:128-138 




Benzodiazepines are commonly prescribed to treat neurological conditions including epilepsy, 
insomnia, and anxiety. The discovery of benzodiazepine-specific binding sites on γ-aminobutyric 
acid type-A receptors (GABAARs) led to the hypothesis that the brain may produce endogenous 
benzodiazepine-binding site ligands. An endogenous peptide, diazepam binding inhibitor (DBI), 
which can bind these sites, is thought to be capable of both enhancing and attenuating GABAergic 
transmission in different brain regions. However, the role that DBI plays in modulating GABAARs 
in the hippocampus remains unclear. Here, we investigated the role of DBI in modulating synaptic 
inhibition in the hippocampus using a constitutive DBI knockout mouse. Miniature and evoked 
inhibitory postsynaptic currents (mIPSCs, eIPSCs) were recorded from CA1 pyramidal cells and 
dentate gyrus (DG) granule cells. Loss of DBI signaling increased mIPSC frequency and amplitude 
in CA1 pyramidal cells from DBI knockout mice compared to wild-types. In DG granule cells, 
conversely, the loss of DBI decreased mIPSC amplitude and increased mIPSC decay time, 
indicating bidirectional modulation of GABAAR-mediated transmission in specific subregions of 
the hippocampus. eIPSC paired-pulse ratios were consistent across genotypes, suggesting that 
alterations in mIPSC frequency were not due to changes in presynaptic release probability. 
Furthermore, cells from DBI knockout mice did not display altered responsiveness to 
pharmacological applications of diazepam, a benzodiazepine, nor flumazenil, a benzodiazepine-
binding site antagonist. These results provide evidence that genetic loss of DBI alters synaptic 
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inhibition in the adult hippocampus, and that the direction of DBI-mediated modulation can vary 
discretely between specific subregions of the same brain structure. 
 
2.1: Introduction 
Benzodiazepines (BZs) are among the most commonly prescribed medications and are 
used to treat a variety of disorders including anxiety, insomnia, muscle spasms, and epilepsy. BZs 
bind to specific sites located at the interface between α and γ subunits of type-A receptors for the 
neurotransmitter γ-aminobutyric acid (GABAARs) (Braestrup and Squires, 1977; Mohler and 
Okada, 1977; Sieghart, 2015). When bound, BZs typically promote the enhancement of synaptic 
inhibition by increasing GABA affinity and the frequency of channel opening, thus potentiating 
inhibitory postsynaptic currents (IPSCs) (Twyman et al., 1989; Bianchi, 2010). The discovery of 
BZ-specific binding sites on GABAARs fueled the hypothesis that the brain may produce 
endogenous BZ-binding site ligands (Iversen, 1977; Costa and Guidotti, 1985). Despite decades 
of research, however, only modest advancements were made in the search for these “endozepines” 
(Farzampour et al., 2015).  
The presence of endozepines in the brain is supported by in vitro studies utilizing the BZ-
binding site antagonist flumazenil (FLZ) (Hunkeler et al., 1981). In the hippocampus, the 
amplitude of inhibitory postsynaptic potentials in rat CA1 pyramidal cells was reduced after FLZ 
application (King et al., 1985), suggesting that the blockade of the GABAAR BZ-binding site 
impeded the potentiation of inhibition by an endogenous ligand. Additionally, FLZ reduced IPSC 
decay time in the thalamic reticular nucleus (Christian and Huguenard, 2013; Christian et al., 2013) 
and in cultured cortical neurons (Vicini et al., 1986). Similarly, FLZ reduced the amplitude of 
electrically evoked inhibitory postsynaptic currents (eIPSCs) in CA1 pyramidal cells following the 
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induction of long-term potentiation (Xu and Sastry, 2005). In dentate gyrus (DG) granule cells, 
FLZ reduced miniature IPSC (mIPSC) decay time in pilocarpine-treated epileptic rats but not in 
control rats (Leroy et al., 2004), suggesting putative region-specific effects of endozepines in the 
hippocampus in both pathological and non-pathological states. 
The endogenous peptide diazepam binding inhibitor (DBI) appears to exert endozepine 
actions. DBI, also known as acyl-CoA binding protein, is a 10 kDa protein initially identified for 
its ability to displace radiolabeled diazepam from BZ-binding sites on GABAARs (Guidotti et al., 
1983). Although DBI also has a role as an intracellular signaling molecule critical in fatty acid 
biosynthesis (Neess et al., 2015), several studies indicate that DBI can be secreted extracellularly 
in the brain and modulate GABAAR function. DBI protein immunoreactivity is seen in both 
neurons  (Alho et al., 1985, 1989; Christian and Huguenard, 2013) and astrocytes (Alho et al., 
1991; Malagon et al., 1993; Vidnyánszky et al., 1994; Christian and Huguenard, 2013) and can be 
detected in several brain regions, including the hippocampus (Ball et al., 1989; Ferrarese et al., 
1989). Multiple DBI cleavage products, including octadecaneuropeptide (ODN), 
triakontatetraneuropeptide, and octapeptide (Ferrero et al., 1986), are biologically active and 
capable of displacing BZs from the BZ binding site. However, the precise physiological roles that 
DBI and its processing products play in the modulation of GABAergic neurotransmission are 
largely undefined.    
The extent to which DBI is capable of modulating GABAARs remains controversial, as 
DBI-dependent modulation of inhibition appears to be specifically localized to certain brain 
regions, and both agonistic and inverse agonistic actions have been reported. Exogenous 
application of DBI reduced IPSC amplitude in cultured spinal neurons, and this effect was reversed 
after FLZ application (Bormann, 1991), suggesting negative allosteric modulation of GABAARs 
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at the BZ-binding site. Similarly, inverse agonistic actions were demonstrated in the subventricular 
zone, in which ODN, a DBI fragment, enhanced neurogenesis via negative allosteric modulation 
of GABAAR-mediated currents (Alfonso et al., 2012). The negative allosteric modulatory role of 
DBI as a critical component in neurogenesis was further demonstrated in the hippocampal 
subgranular zone, in which DBI-dependent attenuation of GABAAR currents promoted stem cell 
proliferation (Dumitru et al., 2017). By contrast, we recently demonstrated that DBI acts as a 
positive allosteric modulator of GABAARs in the thalamic reticular nucleus (Christian et al., 2013). 
GABAAR potentiation in this region was absent in mice genetically lacking DBI signaling, and 
this effect was rescued after viral reintroduction of DBI. DBI endozepine effects were not seen in 
the neighboring ventrobasal nucleus of the thalamus, providing further evidence that DBI 
modulatory effects may be subregion-specific within larger brain structures. In summary, it 
appears that DBI is capable of both enhancing and attenuating inhibitory neurotransmission in the 
brain, and that DBI-dependent modulation of GABAergic inhibition likely varies across different 
brain areas. Whether DBI is capable of modulating synaptic inhibition in the hippocampus has not 
been investigated, despite evidence of a role for DBI in modulating hippocampus-dependent 
behaviors (Liu et al., 2005; Siiskonen et al., 2007; Sherrin et al., 2009).  
The purpose of this study was to determine the effects of genetic loss of DBI signaling on 
synaptic inhibition in the murine hippocampus. We hypothesized that a lack of DBI signaling 
would lead to altered inhibitory neurotransmission in the hippocampus, and tested this hypothesis 
using whole-cell patch clamp electrophysiology and pharmacology. Our findings demonstrate that 





2.2: Experimental Procedures 
2.2.1: Animals  
The Institutional Animal Care and Use Committee of the University of Illinois at Urbana-
Champaign approved all animal procedures. DBI heterozygous (DBI+/-) knockout founder mice on 
the C57BL/6BomTac background strain were obtained from Dr. Susanne Mandrup (University of 
Southern Denmark). The production of these mice by the Mandrup laboratory was described 
previously (Neess et al., 2011). At the University of Illinois, the colony was re-derived and 
backcrossed to the C57BL/6J background (Ujjainwala et al., 2018). Breeding pairs consisted of 
DBI+/- females crossed with DBI+/- males, yielding DBI+/+, DBI+/-, and DBI-/- pups (Neess et al., 
2011). Mice were bred and housed on a 14:10 h light:dark cycle with food and water available ad 
libitum. Electrophysiology experiments were performed using both male and female DBI+/+ and 
DBI-/- mice 53 to 167 days old.  
 
2.2.2: Brain Slice Preparation 
 Mice were deeply anesthetized via intraperitoneal (i.p.) injection of pentobarbital (55 
mg/kg) and euthanized by decapitation. Brains were immediately dissected and placed in an 
oxygenated (95% O2/5% CO2) ice-cold sucrose slicing solution containing 234 mM sucrose, 11 
mM glucose, 2.5 mM KCl, 1.25 mM NaH2PO4, 10 mM MgSO4, 0.5 mM CaCl2, and 26 mM 
NaHCO3. Acute coronal hippocampal slices 300 μm in thickness were prepared using a VT1200S 
vibratome (Leica Biosystems, Buffalo Grove, IL). Slices were subsequently incubated in 
oxygenated artificial cerebrospinal fluid (ACSF) containing 2.5 mM KCl, 10 mM glucose, 126 
mM NaCl, 1.25 mM NaH2PO4. 1 mM MgSO4, 2 mM CaCl2, and 26 mM NaHCO3 at 298 mOsm. 
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Slices were incubated at 32 °C for 1 hour before being transferred to room temperature (21-23 °C) 
for at least 15 minutes before recording.  
 
2.2.3: Electrophysiology 
Slices were transferred to a fully submerged recording chamber on the stage of a BX51WI 
fixed-staged microscope (Olympus America, Center Valley, PA), and continuously superfused 
with room-temperature oxygenated ACSF at 2.5 mL/min. Patch-clamp recordings were made 
using a MultiClamp 700B amplifier, Digidata 1550 digitizer, and Clampex 10.4 software 
(Molecular Devices, Sunnyvale, CA). For all patch-clamp recordings, pipettes were filled with a 
near-isotonic CsCl-based intracellular solution containing 135 mM CsCl, 10 mM HEPES, 10 mM 
EGTA, 2 mM MgCl2, and 5 mM QX-314, pH 7.3 and 290 mOsm. Recording pipettes were created 
from borosilicate glass using a P-1000 Flaming/Brown micropipette puller (Sutter Instrument, 
Novato, CA). Pipettes were pulled to have an open-tip resistance of 2-5 MΩ when filled with the 
internal pipette solution. Individual neurons were visually targeted for recording using differential 
infrared contrast optics through an sCMOS camera (OrcaFlash 4.0LT, Hamamatsu, Japan).     
Whole-cell patch-clamp recordings in both CA1 pyramidal cells and DG granule cells were 
made in voltage-clamp mode with the membrane potential clamped at -60 mV. Inhibitory 
postsynaptic currents (IPSCs) were recorded with a 20 kHz sampling rate, low-pass filtered at 4 
kHz, and gain set at 10 mV/pA. Series resistance (Rs) was <20 MΩ for all recordings and was not 
compensated. Rs was monitored every 2-6 minutes by applying 60 5-mV depolarizing steps 20 ms 
in length from a holding potential of -70 mV, and was calculated by measuring the baseline to the 
peak of the averaged current responses. Cells with >20% change in Rs during recording were 
excluded from analyses.  
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Miniature IPSCs (mIPSCs) were recorded with tetrodotoxin (TTX, 0.5 µM, Abcam, 
Cambridge, MA) added to the bath solution to limit presynaptic contributions. Evoked IPSCs 
(eIPSCs) were elicited by electrical stimuli delivered via a bipolar tungsten stimulating electrode 
(FHC, Bowdoin, ME) placed in either stratum radiatum (CA1) or the DG molecular layer (DG). 
Stimulus timing and duration was controlled in Clampex and stimulus intensity was controlled 
using an ISO-Flex stimulus isolator (A.M.P.I., Jerusalem, Israel). For eIPSC experiments, 
threshold was defined as the intensity at which failures were observed at a rate of approximately 
50%, and recordings were made at 1.5x threshold. Paired-pulse ratio (PPR) recordings were made 
every 20 seconds using a 100-ms inter-stimulus interval between 2 electrical stimuli delivered.  
To isolate GABAergic IPSCs, ionotropic glutamate receptors were blocked by either 
kynurenic acid (1 mM, MilliporeSigma, St. Louis, MO) or a combination of 2-amino-5-
phosphonovaleric (APV, 5 µM, Abcam) and 6,7-dinitroquinoxaline-2,3-dione (DNQX, 20 µM, 
Abcam). Where noted, diazepam (DZP, 1 µM, MilliporeSigma) or flumazenil (FLZ, 1 µM or 5 
nM, MilliporeSigma) was added to the bath ACSF solution. Recordings involving DZP/FLZ 
application were performed by establishing a 6-minute baseline, followed by a 10-minute 
application of the drug, and a 10-minute washout period.  
 
2.2.4: Data Analysis and Statistics 
mIPSCs were analyzed using MiniAnalysis 6.0.7 software (Synaptosoft, Decatur, GA). An 
event detection threshold was set at 4 pA above baseline. Decay time was calculated as the time 
for the current to recover from 90% of peak amplitude to 10%. Events that did not recover to 
baseline before the initiation of a subsequent event or that began during the decay phase of a 
previous event were excluded from amplitude and decay analyses, but were included in frequency 
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analyses. Evoked IPSCs were analyzed using Clampfit 10.4 (Molecular Devices), and the 
amplitude of the first response was normalized to peak amplitude to compensate for the variation 
in eIPSC amplitude across cells. PPR from eIPSCs for each cell was calculated as (mean amplitude 
of the second response [A2])/(mean amplitude of the first response [A1]) to eliminate the potential 
of spurious paired-pulse facilitation (Kim and Alger, 2001). Passive electrical properties were 
calculated using Clampfit 10.4 (Molecular Devices), and no differences were seen between groups 
in input resistance, series resistance, or cell capacitance.   
Data from MiniAnalysis were subsequently transferred to OriginPro 2016 (OriginLab, 
Northampton, MA) and Excel (Microsoft, Redmond, WA) for statistical analysis. Shapiro-Wilk 
tests were used to evaluate if data were normally distributed. If data were not normally distributed, 
log transformations were used to improve normality as noted in the text. For cumulative probability 
distributions, up to 100 randomly selected mIPSCs per cell were selected so that no individual 
cells were overrepresented in any group. Probability distribution comparisons were made using 
two-sample Kolmogorov-Smirnov (KS) goodness-of-fit tests. Group comparisons were made by 
using either two-way analysis of variance (ANOVA), with sex and genotype as independent 
variables, or by two-tailed independent (Student’s) or paired t-tests. Statistical significance was 
set at p<0.05 for comparisons of means, and at p<0.001 for KS tests. 
 
2.3: Results 
2.3.1: Divergent effects of loss of DBI on mIPSC frequency and amplitude in CA1 and dentate 
gyrus  
To determine if the genetic removal of DBI alters synaptic inhibition in the hippocampus, 
we used whole-cell patch clamp electrophysiology to record mIPSCs in cells from both DBI+/+ and 
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DBI-/- mice of either sex. In CA1 pyramidal cells, two-way ANOVA revealed no significant effect 
of sex nor a genotype-by-sex interaction in either mIPSC amplitude or frequency (p>0.05). 
Therefore, data from males and females were analyzed together. mIPSC frequency in CA1 
pyramidal cells from DBI-/- mice (27 cells from 10 mice) was increased compared with DBI+/+ 
mice (28 cells from 11 mice) (p<0.02, Student’s t-test) (Figures 2.1A-B). Additionally, a modest 
yet significant increase in mIPSC amplitude was seen in CA1 pyramidal cells from DBI-/- mice 
(2700 events from 27 cells from 10 mice) compared with DBI+/+ mice (2800 events from 28 cells 
from 11 mice) (p<0.001, KS test) (Figures 2.1C-D). Two-way ANOVA for mIPSC decay time 
showed a significant effect of sex (p<0.05), in which males displayed increased mIPSC decay time 
compared to females (not shown). However, this effect was seen in both genotypes, and no 
significant differences in mIPSC decay time were observed between DBI+/+ (2800 events from 28 
cells from 11 mice) and DBI-/- mice (2700 events from 27 cells from 10 mice) when collapsed 
across sex (Figures 2.1E-F). Together, these results reveal that a genetic loss of DBI is capable of 
modulating GABAergic neurotransmission in adult CA1 pyramidal cells both pre- and 
postsynaptically.     
DBI-mediated effects on inhibition can be specifically localized to distinct subregions of 
larger brain structures (Christian et al., 2013). To determine if DBI-mediated modulation of 
hippocampal GABAARs is specific to CA1, we also recorded mIPSCs from DG granule cells. 
Analysis of mIPSC frequency data in DG revealed that the data were not normally distributed. 
Therefore, a log transformation was used to improve normality. Two-way ANOVA of the 
transformed data yielded no main effect of sex (p>0.6) and no sex-by-genotype interaction 
(p>0.05), so males and females were analyzed together. Additionally, there was no main effect of 
genotype (p>0.45), indicating that mIPSC frequency was not different between DBI+/+ and DBI-/- 
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mice in DG granule cells. Indeed, a Student’s t-test found no difference in mIPSC frequency 
between DBI+/+ (43 cells from 15 mice) and DBI-/- cells (31 cells from 10 mice) (Figures 2.2A-
B). Two-way ANOVA of mIPSC amplitude and decay in DG found no main effect of sex (p>0.35) 
and no sex-by-genotype interaction (p>0.2) for either parameter, so males and females were 
analyzed together. In contrast to CA1 pyramidal cells, mIPSC amplitude was decreased in DG 
granule cells from DBI-/- mice (2929 events from 31 cells from 10 mice) compared to DBI+/+ mice 
(4025 events from 43 cells from 15 mice) (p<0.001, KS test) (Figures 2.2C-D). Furthermore, we 
found that the loss of DBI increases mIPSC decay time in DG granule cells (p<0.001, KS test) 
(Figures 2.2E-F). These data further demonstrate that genetic loss of DBI is capable of modulating 
GABAARs in the adult hippocampus, and indicate that DBI-dependent modulation of inhibition is 
subregion-specific.  
 
2.3.2: Changes in mIPSC frequency are not due to alterations in vesicular release probability 
The frequency of miniature postsynaptic currents is typically regarded as a readout of 
activity-independent presynaptic neurotransmitter release. We thus hypothesized that the changes 
seen in mIPSC frequency in CA1 pyramidal cells could be due to either alterations in vesicle 
release probability and/or modifications in synaptic connectivity. To determine if the changes in 
mIPSC frequency in mice lacking DBI signaling were due to alterations in synaptic vesicle release 
probability, we investigated the paired-pulse ratio (PPR) of evoked IPSCs in both CA1 pyramidal 
cells and DG granule cells in DBI+/+ and DBI-/- mice. Analysis of PPR is a tool to indirectly 
measure presynaptic release probability (Dobrunz and Stevens, 1997; Thomson, 2000). A series 
of two rapidly-induced postsynaptic currents in principal cells of CA1 or DG were evoked using a 
stimulating electrode placed in either the stratum radiatum or the DG molecular layer, with an 
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inter-stimulus interval of 100 ms. Two-way ANOVA yielded no effect of sex and no sex-by-
genotype interaction in either CA1 or DG, so males and females were analyzed together. In CA1 
pyramidal cells, there was no significant difference in the PPR between DBI+/+ (8 cells from 7 
mice) and DBI-/- mice (8 cells from 5 mice) (p>0.8, Student’s t-test) (Figures 2.3A-B). As 
expected, we also found no significant difference between DBI+/+ mice (17 cells from 8 mice) and 
DBI-/- mice (18 cells from 8 mice) in the PPR of DG granule cells (p>0.1, Student’s t-test) (Figures 
2.3C-D). Furthermore, there were no significant differences between DBI+/+ and DBI-/- mice in the 
coefficient of variation (CV), a measure of response variability (Olmos-Serrano et al., 2010), in 
either CA1 (p>0.35 Student’s t-test) or DG (p>0.1, Student’s t-test) (Figures 2.3E-F). Taken 
together, these results suggest that the release probability of synaptic vesicles in both CA1 and DG 
is unaltered in mice with a genetic loss of DBI. 
 
2.3.3: Response to DZP and FLZ application is unaltered in DBI-/- mice 
DBI binds with high affinity to the BZ binding site on GABAA receptors (Costa and 
Guidotti, 1991; Möhler, 2014) and is capable of displacing DZP from the GABAAR BZ binding 
site (Guidotti et al., 1983). Therefore, we hypothesized that an absence of DBI signaling would 
render GABAergic synapses more sensitive to DZP modulation via removal of a competitor at BZ 
binding sites. CA1 pyramidal cells of both genotypes displayed increases in mIPSC amplitude 
(Figures 2.4A-B) and decay (Figure 2.4D-E) in response to DZP compared with baseline control 
values (all p<0.01, paired t-tests). However, no differences between DBI+/+ (8 cells from 4 mice) 
and DBI-/- mice (9 cells from 5 mice) were observed in the strength of the response to DZP; both 
genotypes exhibited similar increases in mIPSC amplitude (p>0.7, Student’s t-test) (Figure 2.4C) 
and decay time (p=0.4 Student’s t-test) (Figure 2.4F). Similar results were seen in DG; granule 
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cells of both genotypes showed increased mIPSC amplitude (Figures 2.5A-B) and decay (Figures 
2.5D-E) with DZP (all p<0.01, paired t-tests), but there was no genotype difference in response 
strength for either parameter (DBI+/+: 9 cells from 3 mice; DBI-/-: 7 cells from 2 mice) (both p>0.85, 
Student’s t-test) (Figures 2.5C, F). No changes in mIPSC frequency with DZP were seen in either 
genotype (not shown). These results indicate that the genetic loss of DBI signaling does not alter 
GABAAR sensitivity to DZP in either CA1 or DG of the hippocampus.  
Although we did not observe a difference between genotypes after an application of the 
BZ-site agonist DZP, we decided to investigate the impacts of the BZ-site antagonist FLZ on 
synaptic inhibition in DBI+/+ and DBI-/- mice. In CA1, no significant differences in mIPSC 
amplitude were observed between baseline control and after 1 µM FLZ application in cells from 
either DBI+/+ (p>0.2, paired t-test) or DBI-/- mice (p>.1, paired t-test) (Figure 2.6A), and there was 
no genotype difference between DBI+/+ and DBI-/- mice in the degree of response to 1 µM FLZ 
(p>0.5, Student’s t-test) (Figure 2.6B). There was also no significant change in mIPSC decay after 
the application of 1 µM FLZ in CA1 pyramidal cells from either DBI+/+ or DBI-/- mice (Figure 
2.6C, paired t-test), and there was no genotype difference in the response to 1 µM FLZ (Figure 
2.6D, Student’s t-test). DG granule cells from both DBI+/+ and DBI-/- mice, however, exhibited an 
increase in mIPSC amplitude with 1 µM FLZ (both p<0.05, paired t-test) (Figure 2.7A), although 
the strength of the response was not significantly different between DBI+/+ and DBI-/- mice 
(p>0.25, Student’s t-test) (Figure 2.7C). No significant change after 1 µM FLZ application was 
seen in mIPSC decay in DG granule cells from either DBI+/+ or DBI-/- mice (both p>0.1, paired t-
test) (Figure 2.7D), and the degree of response in DG granule cells was not different between 
genotypes (Figure 2.7F, Student’s t-test). No changes in mIPSC frequency were seen with 1 µM 
FLZ in either genotype (not shown).  
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Although no significant differences were seen in the magnitude of the effect of 1 µM FLZ 
on mIPSC amplitude between DBI+/+ and DBI-/- mice, it is possible that this relatively elevated 
concentration may have masked a potential endozepine effect. Therefore, we also tested the effects 
of 5 nM concentration of FLZ in DG granule cells. 5 nM is the EC50 for flumazenil actions on α2-
containing GABAARs (Ramerstorfer et al., 2010), which are highly expressed in DG granule cells 
(Sperk et al., 1997). Similarly to 1 µM FLZ, application of 5 nM FLZ increased mIPSC amplitude 
in DG granule cells from both DBI+/+ mice (10 cells from 4 mice) and DBI-/- mice (9 cells from 3 
mice) compared to baseline (both p<0.001, paired t-test) (Figure 2.7B). As with the 1 µM 
concentration, however, no differences were seen between genotypes in the strength of the 
response (p=0.3, Student’s t-test) (Figure 2.7C). Additionally, no differences were seen in mIPSC 
decay time after 5 nM FLZ application in either DBI+/+ or DBI-/- mice (both p>0.05) (Figure 2.7E-
F). Together, these data demonstrate that the loss of DBI signaling does not change GABAAR 
response to FLZ in either CA1 or DG.  
 
2.4: Discussion 
The primary goal of these studies was to determine the effects of genetic loss of DBI on 
synaptic inhibition in the murine hippocampus. Our data show that the loss of DBI results in an 
enhancement of inhibition in CA1 pyramidal cells, as demonstrated in increased mIPSC frequency 
and amplitude. Surprisingly, we found that the loss of DBI leads to decreased mIPSC amplitude 
in DG granule cells, providing novel evidence of a diametric modulation of inhibition by DBI 
within the hippocampus. Additionally, we determined that the changes in mIPSC frequency in 
CA1 pyramidal cells in DBI-/- mice are not due to alterations in vesicular release probability, 
suggesting that the loss of DBI may alter the number of synaptic contacts onto principal cells. We 
  
 43 
also found that loss of DBI did not impact the responsiveness of either CA1 pyramidal and DG 
granule cells to DZP or FLZ application. These results provide evidence that DBI is capable of 
bidirectionally modulating GABAergic transmission in the hippocampus, and support the 
conclusion that DBI-mediated modulation of inhibition is distinctly localized in specific 
subregions of brain structures.   
DBI appears to be a complex and multifunctional peptide, with both positive and negative 
allosteric modulation of GABAARs by DBI reported. Surprisingly, the present results provide 
support for both conclusions within the hippocampus, with a loss of DBI leading to an 
enhancement of inhibition in CA1 and an attenuation of inhibition in DG. Furthermore, these data 
indicate that the loss of DBI leads to both pre- and postsynaptic alterations of GABAergic 
transmission in the hippocampus. Although the mechanisms behind this diametric modulation 
remain elusive, some potential hypotheses have emerged. GABAARs are pentameric hetero-
oligomers in which subunit combinations are assembled from a set of 19 subunit possibilities 
(Olsen and Sieghart, 2009), leading to a large diversity of subunit compositions. Subunit 
composition directly influences the biophysical properties of GABAARs, including the single-
channel conductance and responsiveness to allosteric modulators (Hevers and Lüddens, 1998; 
Mody and Pearce, 2004). Therefore, it is plausible that DBI may exert its influence on different 
postsynaptic GABAAR subtypes in CA1 versus DG (Hörtnagl et al., 2013), and/or that the loss of 
DBI may lead to compensatory modifications in GABAAR subunit composition in each subregion. 
Another possibility is that DBI may be cleaved differently in CA1 compared to DG, and thus 
distinct DBI processing products may be produced in these regions. The manner in which the DBI 
peptide is endogenously cleaved has not been determined, and the enzymes responsible for 
cleavage are also unknown. Future experiments could utilize targeted analytical chemistry 
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techniques such as mass spectrometry to investigate the presence of specific DBI cleavage 
products in each hippocampal subregion.  
We originally hypothesized that cells from DBI-/- mice would be more sensitive to DZP 
due to a lack of competition at the BZ-binding site. However, we observed that CA1 and DG cells 
from both DBI+/+ and DBI-/- mice responded equally to DZP. One potential explanation for this 
result may be that the concentration of DZP was too robust, such that it saturated GABAergic 
synapses and masked a subtler effect. DZP may act via two separate mechanisms that depend on 
the concentration applied: a nanomolar component that depends on the γ2 subunit; and a 
micromolar component that does not require the γ2 subunit (Walters et al., 2000). We also found 
that responses to FLZ were not altered in mice genetically lacking DBI signaling, and that the 
administration of FLZ did not affect mIPSC properties of CA1 pyramidal cells from either 
genotype. However, we did observe an increase in mIPSC amplitude with both low- and high-dose 
FLZ application in DG granule cells from both DBI+/+ and DBI-/- mice. FLZ is a weak positive 
allosteric modulator of GABAARs containing certain subunit combinations, specifically 
combinations including the α2, α3, or α4 subunits (Ramerstorfer et al., 2010). α3 subunit-
containing receptors are rarely expressed in DG (Sperk et al., 1997). Therefore, these effects may 
be mediated by synapses expressing α2 or α4 subunit-containing receptors. However, α4 subunit-
containing receptors are insensitive to BZs (Chandra et al., 2006), thus raising the likelihood that 
the FLZ-induced increase in mIPSC amplitude is mediated by α2-containing receptors. This effect 
was only seen in DG, providing further support for future investigations into the subunit 
combinations of GABAARs in CA1 vs DG. The lack of differences seen between genotypes after 
pharmacological BZ-binding site manipulations of GABAARs suggests that the DBI-dependent 
modulation of inhibition in these regions is likely not endozepine-related. Rather, the observed 
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changes in synaptic inhibition in the DBI-/- mouse hippocampus may reflect other mechanisms, 
such as an alteration of a critical metabolic pathway or a DBI-dependent modification in neuronal 
development.  
Although DBI is primarily recognized as acting at the BZ-binding site to modulate 
GABAARs, DBI may also indirectly modulate inhibitory transmission via the mitochondrial 
benzodiazepine receptor, also known as translocator protein (TSPO) (Papadopoulos et al., 1991). 
The binding of DBI to TSPO has been demonstrated to stimulate neurosteroid biosynthesis 
(Korneyev et al., 1993). Neurosteroids are potent modulators of GABAARs (Belelli and Lambert, 
2005), and both positive and negative allosteric modulation of GABAARs by neurosteroids have 
been demonstrated (Wang, 2011). Therefore, it is possible that the effects seen in both 
hippocampal subregions after the genetic loss of DBI may be due to changes in the activity of 
TSPO, leading to alterations in neurosteroidogenesis and subsequent modulation of inhibition in 
the hippocampus. The lack of differences between DBI+/+ and DBI-/- mice in response to 
applications of a BZ-site agonist (DZP) and antagonist (FLZ) supports the possibility of an indirect 
neurosteroid-mediated modulation of GABAARs by DBI. Further investigations of the subunit 
composition of GABAARs in these regions and subunit-associated differences in DBI sensitivity 
may provide insight into these possibilities.  
Recent evidence supports a role for DBI in the regulation of neurogenesis. In the 
subgranular zone (SGZ), the region that produces granule cells in DG, DBI appears to critically 
regulate the balance between preserving the neural stem cell pool and the development of new 
granule cells. Specifically, genetic knockdown of DBI led to fewer neural stem cells and a shift 
towards mature granule cell development, while a genetic overexpression of DBI led to a greater 
neural stem cell population and a reduction in neurogenesis (Dumitru et al., 2017). Our 
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experiments were performed on constitutive DBI-/- mice, in which exon 2 of the Dbi gene is deleted 
throughout the lifespan. Therefore, it is possible that the development of hippocampal neurons is 
fundamentally altered to compensate for the lack of DBI signaling. In addition, other 
developmental compensations may arise in DBI-/- mice, as the Dbi gene appears to serve multiple 
cellular functions, including general housekeeping duties (Mandrup et al., 1992). Future studies 
could make use of more advanced transgenic technology to overcome these issues, such as utilizing 
an inducible DBI knockout mouse, a nervous system-specific transgenic mouse line, or using Cre-
dependent viral vectors for region-specific deletions.  
 In summary, the present results demonstrate that the genetic deletion of DBI signaling 
diametrically alters synaptic inhibition in the murine hippocampus in a subregion-specific manner. 
DBI-/- mice demonstrated an enhancement of inhibition in CA1 pyramidal cells, but displayed an 
attenuation of inhibition in DG granule cells. Presynaptic release probability remained constant in 
both genotypes, and DBI-/- mice did not differ from DBI+/+ mice in their response to BZ-binding 
site agonism or antagonism. These results lay the groundwork for future investigations into the 
role of DBI in the modulation of synaptic inhibition in the hippocampus.    
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Figure 2.1: Genetic loss of DBI increases mIPSC amplitude and frequency in CA1 pyramidal 
cells. (A) Representative mIPSC traces recorded from individual pyramidal cells from DBI+/+ (top 
traces) and DBI-/- mice (bottom traces). (B) Mean + SEM of mIPSC frequency in CA1 pyramidal 
cells from DBI+/+ (black bar, n=28 cells from 11 mice) and DBI-/- mice (white bar, n=27 cells from 
10 mice) (*p<0.05, Student’s t-test). Open circles represent values from individual cells. (C) 
Cumulative probability distributions comparing mIPSC amplitude in DBI+/+ (n=2800 events from 
28 cells from 11 mice) and DBI-/- mice (n=2700 events from 27 cells from 10 mice) (***p<0.001, 
KS test). (D) Averaged mIPSC traces from representative DBI+/+ and DBI-/- cells. (E) Cumulative 
probability distributions comparing mIPSC decay in CA1 pyramidal cells from DBI+/+ (n=2800 
events from 28 cells from 11 mice) and DBI-/- mice (n=2700 events from 27 cells from 10 mice). 

























Figure 2.2: Genetic loss of DBI decreases mIPSC amplitude in DG granule cells, but 
increases mIPSC decay. (A) Representative mIPSC traces recorded from individual granule cells 
from DBI+/+ (top traces) and DBI-/- mice (bottom traces). (B) Mean + SEM of mIPSC frequency 
in DG granule cells from DBI+/+ (black bars, n=43 cells from 15 mice) and DBI-/- mice (white bars, 
n=31 cells from 10 mice). Open circles represent values from individual cells. (C) Cumulative 
probability distributions comparing mIPSC amplitude in DBI+/+ (n=4025 events from 43 cells from  
mice) and DBI-/- mice (n=2929 events from 31 cells from 10 mice) (***p<0.001, KS test). (D) 
Averaged mIPSC traces from representative DBI+/+ and DBI-/- granule cells. (E) Cumulative 
probability distributions comparing mIPSC decay in DG granule cells from DBI+/+ (n=4025 events 
from 43 cells from 15 mice) and DBI-/- mice (n=2929 events from 31 cells from 10 mice) 
(***p<0.001, KS test). (F) Averaged mIPSC traces from representative DBI+/+ and DBI-/- granule 





































Figure 2.3: No differences between DBI+/+ and DBI-/- mice in paired-pulse ratio of evoked 
IPSCs. (A) Mean + SEM of PPR from eIPSCs in CA1 pyramidal cells from DBI+/+ (black bar, 
n=8 cells from 7 mice) and DBI-/- mice (white bar, n=8 cells from 5 mice). Open circles represent 
values from individual cells. (B) Averaged PPR traces from representative DBI+/+ (left) and DBI-
/- (right) pyramidal cells, normalized to peak amplitude of the first response. Black dots indicate 
times of electrical stimulus application; stimulus artifacts are truncated for clarity. (C) Mean + 
SEM of PPR from eIPSCs in DG granule cells from DBI+/+ (black bar, n=17 cells from 8 mice) 
and DBI-/- mice (white bar, n=18 cells from 8 mice). Open circles represent values from individual 
cells. (D) Averaged PPR traces from representative DBI+/+ (left) and DBI-/- (right) granule cells, 
normalized to peak amplitude of the first response. Black dots indicate times of electrical stimulus 
application; stimulus artifacts are truncated for clarity. (E-F) Mean + SEM of the coefficient of 
variation of eIPSCs in CA1 pyramidal cells (E) and DG granule cells (F) from DBI+/+ (black bars, 
n=17 cells from 8 mice) and DBI-/- mice (white bars, n=18 cells from 8 mice). Open circles 








Figure 2.4: No differences between genotypes in mIPSC amplitude or decay after diazepam 
application in CA1 pyramidal cells. (A) Representative mIPSC traces from individual CA1 
pyramidal cells before (CON) and during DZP treatment from DBI+/+ (top) and DBI-/- (bottom) 
mice. (B) mIPSC amplitude in individual CA1 pyramidal cells from DBI+/+ (left, n=8 cells from 4 
mice) and DBI-/- mice (right, n=9 cells from 5 mice) before (CON) and during DZP treatment 
(*p<0.05, paired t-test). (C) Mean + SEM of the percentage change in mIPSC amplitude after 
diazepam application in CA1 pyramidal cells from DBI+/+ (black bar) and DBI-/- mice (white bar). 
Open circles represent values from individual cells. (D) Averaged mIPSC traces from 
representative CA1 pyramidal cells before (CON) and during DZP treatment, normalized to peak 
amplitude, from DBI+/+ (left) and DBI-/- mice (right). (E) mIPSC decay in individual CA1 
pyramidal cells from DBI+/+ (left) and DBI-/- mice (right) before (CON) and during DZP treatment 
(*p<0.05, paired t-test). (F) Mean + SEM of the percentage change in mIPSC decay after DZP 
application in CA1 pyramidal cells from DBI+/+ (black bar) and DBI-/- mice (white bar). Open 












Figure 2.5: No differences between genotypes in mIPSC amplitude or decay after diazepam 
application in DG granule cells. (A) Representative mIPSC traces from individual DG granule 
cells before (CON) and during DZP treatment from DBI+/+ (top) and DBI-/- mice (bottom). (B) 
mIPSC amplitude in individual DG granule cells from DBI+/+ (left, n=9 cells from 3 mice) and 
DBI-/- mice (right, n=7 cells from 2 mice) before (CON) and during DZP treatment (*p<0.05, 
paired t-test). (C) Mean + SEM of the percentage change in mIPSC amplitude after DZP 
application in DG granule cells from DBI+/+ (black bar) and DBI-/- mice (white bar). Open circles 
represent values from individual cells. (D) Averaged mIPSC traces from representative DG 
granule cells before (CON) and during DZP treatment, normalized to peak amplitude, from DBI+/+ 
(left) and DBI-/- mice (right). (E) mIPSC decay in individual DG granule cells from DBI+/+ (left) 
and DBI-/- mice (right) before (CON) and during DZP treatment (*p<0.05, paired t-test). (F) Mean 
+ SEM of the percentage change in mIPSC decay after DZP application in DG granule cells from 


























Figure 2.6: Flumazenil does not change mIPSC amplitude or decay in CA1 pyramidal cells 
from either genotype. (A) mIPSC amplitude in individual CA1 pyramidal cells from DBI+/+ (left, 
n=9 cells from 5 mice) and DBI-/- mice (right, n=7 cells from 3 mice) before (CON) and during 1 
µM FLZ treatment. (B) Mean + SEM of the percentage change in mIPSC amplitude after 1 µM 
FLZ application in CA1 pyramidal cells from DBI+/+ (black bar) and DBI-/- mice (white bar). Open 
circles represent values from individual cells. (C) mIPSC decay in individual CA1 pyramidal cells 
from DBI+/+ (left) and DBI-/- mice (right) before (CON) and during 1 µM FLZ treatment. (D) Mean 
+ SEM of the percentage change in mIPSC decay after 1 µM FLZ application in CA1 pyramidal 














Figure 2.7: Both 5 nM and 1 µM flumazenil increase mIPSC amplitude in DG granule cells 
with no effect on decay. (A) mIPSC amplitude in individual DG granule cells from DBI+/+ (left, 
n=9 cells from 4 mice) and DBI-/- mice (right, n=8 cells from 3 mice) before (CON) and during 1 
µM FLZ treatment (*p<0.05, paired t-test). (B) mIPSC amplitude in individual DG granule cells 
from DBI+/+ (left, n=10 cells from 4 mice) and DBI-/- mice (right, n=9 cells from 3 mice) before 
(CON) and during 5 nM FLZ treatment (**p<0.01). (C) Mean + SEM of the percentage change in 
mIPSC amplitude after either 1 µM or 5 nM FLZ application in DG granule cells from DBI+/+ 
(black bars) and DBI-/- mice (white bars). Open circles represent values from individual cells. (D) 
mIPSC decay in individual DG granule cells from DBI+/+ (left, n=9 cells from 4 mice) and DBI-/- 
mice (right, 8 cells from 3 mice) before (CON) and during 1 µM FLZ treatment. (E) mIPSC decay 
in individual DG granule cells from DBI+/+ (left, n=10 cells from 4 mice) and DBI-/- mice (right, 
n=9 cells from 3 mice) before (CON) and during 5 nM FLZ treatment. (F) Mean + SEM of the 
percentage change in mIPSC decay after either 1 µM or 5 nM FLZ application in DG granule cells 
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Learning and memory are fundamental processes that are disrupted in many neurological disorders 
including Alzheimer’s disease and epilepsy. The hippocampus plays an integral role in these 
functions, and modulation of synaptic transmission mediated by γ-aminobutyric acid (GABA) 
type-A receptors (GABAARs) impacts hippocampus-dependent learning and memory. The protein 
diazepam binding inhibitor (DBI) differentially modulates GABAARs in various brain regions, 
including hippocampus, and changes in DBI levels may be linked to altered learning and memory. 
The effects of genetic loss of DBI signaling on these processes, however, have not been 
determined. In these studies, we examined male and female constitutive DBI knockout mice and 
wild-type littermates to investigate the role of DBI signaling in modulating multiple forms of 
hippocampus-dependent spatial learning and memory. DBI knockout mice did not show impaired 
discrimination of objects in familiar and novel locations in an object location memory test, but did 
exhibit reduced time spent exploring the objects. Multiple parameters of Barnes maze 
performance, testing the capability to utilize spatial reference cues, were disrupted in DBI 
knockout mice. Furthermore, whereas most wild-type mice adopted a direct search strategy upon 
learning the location of the target hole, knockout mice showed higher rates of using an inefficient 
random strategy. In addition, DBI knockout mice displayed typical levels of contextual fear 
conditioning, but lacked a sex difference observed in wild-type mice. Together, these data suggest 
that DBI selectively influences certain forms of spatial learning and memory, indicating novel 
roles for DBI signaling in modulating hippocampus-dependent behavior in a task-specific manner. 
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3.1: Significance Statement 
The diazepam binding inhibitor (DBI) peptide is implicated in both normal and 
pathological functions in the central nervous system. In the hippocampus, DBI modulates GABAA-
receptor mediated transmission and may thus be involved in shaping hippocampus-dependent 
behavioral tasks. However, the impacts of the genetic loss of DBI signaling on hippocampal 
learning and memory in mice have not been investigated. In these studies, we demonstrate that 
DBI knockout mice display task-specific impairments in different assays of spatial and contextual 
learning and memory. These data offer further support for a critical role of DBI in proper learning 
and memory functions. 
 
3.2: Introduction 
The processes of learning and memory are indispensable to proper cognitive function and 
are impaired in a variety of neurological disorders, including Alzheimer’s disease, other forms of 
dementia, and epilepsy. Decades of research has established that the hippocampus plays imperative 
roles in these functions (Scoville and Milner, 1957; Zola et al., 2000; Burgess et al., 2002; Ergorul 
and Eichenbaum, 2004). Although learning and memory have been rigorously studied over the 
years, elucidation of the myriad molecular players involved in hippocampus-dependent learning 
and memory remains incomplete.  
 The γ-aminobutyric acid (GABA) neurotransmitter system is critically involved in 
hippocampal function, and manipulations of GABA transmission have been linked to alterations 
in learning and memory. For example, injections of muscimol, a GABAA receptor (GABAAR) 
agonist, into dorsal hippocampus blocks long-term memory of object location (Haettig et al., 
2011), and mice with a genetic deletion of the GABAAR α5 subunit display enhanced performance 
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in the Morris water maze task of spatial memory (Collinson et al., 2006). Treatment with 
benzodiazepines, which exert effects via allosteric modulation of GABAARs, impacts multiple 
measures of spatial memory (Kant et al., 1996; Hogan et al., 2005; Joksimović et al., 2013; Timić 
et al., 2013). Furthermore, mice with a point mutation that renders α5-containing GABAARs 
insensitive to benzodiazepines show improved performance in trace fear conditioning (Crestani et 
al., 2002). These findings suggest that modulatory actions on GABAARs, and specifically at the 
benzodiazepine binding site, can have profound impacts on hippocampal learning and memory. 
 Diazepam binding inhibitor (DBI), also known as acyl-CoA binding protein, is a 10-kDa 
protein that was first identified for its ability to displace diazepam from GABAAR benzodiazepine 
binding sites (Guidotti et al., 1983). DBI protein immunoreactivity is present in several brain areas, 
including the hippocampus (Ball et al., 1989; Ferrarese et al., 1989). Importantly, DBI can 
modulate GABAARs in various brain regions. Negative allosteric modulation of GABAARs by 
DBI was seen in cultured spinal neurons (Bormann, 1991) and in transit-amplifying cells of the 
subventricular zone (Alfonso et al., 2012). In the thalamic reticular nucleus, however, DBI acts as 
a positive allosteric GABAAR modulator (Christian and Huguenard, 2013; Christian et al., 2013), 
indicating that the modulatory effects of DBI are region-specific. In this regard, our lab recently 
demonstrated hippocampal subregion-specific alterations in GABAAR-mediated transmission in 
DBI knockout (DBI-/-) mice (Courtney and Christian, 2018), suggesting that DBI may play a role 
in hippocampus-dependent learning and memory processes. DBI may also modulate GABA 
transmission via mechanisms independent of actions at GABAAR benzodiazepine binding sites. 
For example, DBI may upregulate biosynthesis of neurosteroids, another class of GABAAR 
allosteric modulators, by acting as an endogenous ligand of the mitochondrial benzodiazepine 
receptor (also known as 18kDa translocator protein, TSPO) (Papadopoulos et al., 1991; Korneyev 
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et al., 1993). Furthermore, DBI could modulate neuronal and/or glial function through effects on 
lipid metabolism and other intracellular actions (Bouyakdan et al., 2015; Neess et al., 2015), and 
the Dbi gene also has ubiquitous housekeeping functions (Mandrup et al., 1992). DBI is thus 
capable of exerting multiple biological actions that are poised to have impacts on neural cellular 
and synaptic physiology and thus modulate complex behaviors.  
Interactions between DBI and GABAARs may influence many behavioral abnormalities 
(Costa and Guidotti, 1991). Notably, cerebrospinal fluid levels of DBI are elevated in patients with 
depression, anxiety, and hepatic encephalopathy (Barbaccia et al., 1986; Rothstein et al., 1989). 
Furthermore, studies of animal behavior suggest a role for DBI in various hippocampus-dependent 
tasks. For example, a DBI-overexpressing transgenic mouse line displays impaired learning 
performance on the Morris water maze (Siiskonen et al., 2007). Additionally, 
intracerebroventricular injection of DBI reverses a corticotropin-releasing hormone receptor-
mediated enhancement in contextual fear conditioning (Sherrin et al., 2009). However, 
investigations into the role of DBI in hippocampus-dependent cognitive tasks using mice with 
genetic removal of DBI are lacking. Therefore, the primary purpose of the present studies was to 
identify the behavioral phenotypes of a constitutive DBI knockout mouse (Neess et al., 2011) to 
determine roles for DBI signaling in a variety of hippocampus-dependent behaviors. We 
hypothesized that mice with a genetic knockout of DBI would display impaired performance 
compared with wild-type mice with functional DBI signaling. We employed three well-validated 
assays of hippocampal learning and memory: object location memory (OLM) (Sharma et al., 2010; 
Vogel‐Ciernia and Wood, 2014); Barnes maze (Barnes, 1979; Holmes et al., 2002); and contextual 
fear conditioning (Curzon et al., 2009). These tasks were selected to assess multiple forms of 
hippocampal-dependent spatial and contextual learning and memory. Our results indicate that mice 
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with a genetic loss of DBI display differential performance across the tasks compared with control 
mice, providing novel evidence of a role for DBI in modulating specific forms of hippocampus-
dependent learning and memory, most notably spatial navigation memory.  
 
3.3: Materials and Methods 
3.3.1: Mice 
 All animal procedures were approved by the Institutional Animal Care and Use Committee 
of the University of Illinois at Urbana-Champaign. DBI heterozygous (DBI+/-) and homozygous 
knockout (DBI-/-) founder mice on the C57BL/6BomTac background (Neess et al., 2011) were 
acquired from Dr. Susanne Mandrup (University of Southern Denmark). Re-derivation of the 
colony and backcrossing onto the C57BL/6J background were described previously (Ujjainwala 
et al., 2018). Breeding pairs of DBI+/- males and females yielded DBI+/+, DBI+/-, and DBI-/- pups, 
and genotypic identities were confirmed via PCR as previously described (Neess et al., 2011). 
Mice used in the present experiments were produced in the fifth and sixth filial generations of this 
colony after backcrossing was completed. Mice were bred and housed on a 14:10 h light:dark cycle 
with food and water available ad libitum. At weaning, mice were group housed (up to 5 mice per 
cage) with littermates of the same sex. A total of 34 mice were used for all three behavioral tests, 
consisting of 16 males (DBI+/+ n=9, DBI-/- n=7) and 18 females (DBI+/+ n=9, DBI-/- n=9). An 
additional 12 mice (males: DBI+/+ n=3, DBI-/- n=3; females DBI+/+ n=3, DBI-/- n=3) were used as 
unshocked controls in fear conditioning. For female mice, the estrous cycle stage was recorded by 
examination of vaginal cytology (Li et al., 2017) on each first day of testing for OLM, Barnes 
maze, and contextual fear conditioning. A Fisher’s exact test demonstrated that the proportions of 
the estrous cycle stages were not significantly different between DBI+/+ and DBI-/- mice on any of 
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the three tests (OLM: odds ratio=4, p=0.33; Barnes maze: odds ratio=0.64, p=1; contextual fear 
conditioning: odds ratio=1, p=1), so all females tested were included in all analyses. Mice were 
postnatal days (P) 50-250 old at the time of testing. OLM testing was performed when mice were 
P57-199, Barnes maze testing was performed when mice were P85-230, and contextual fear 
conditioning was performed when mice were P92-248 (Table 1). Two-way ANOVA of age with 
genotype and sex as factors showed a main effect of sex on all three tests (P<0.025 for all tests), 
in which female mice were older than male mice by an average of 40.5 days.  
 
3.3.2: Behavioral testing 
Experiments were performed between 10 a.m. and 2 p.m., relative to 7 p.m. lights off, in 
accordance with other studies testing hippocampus-dependent behavior (Paylor et al., 1994; Patil 
et al., 2009; Kleschevnikov et al., 2012). For all tasks, mice were tested in arenas with ambient 
light levels between 0.1-0.2 mW. Animals were tested in order of litter date of birth. Although the 
mice were not intentionally randomized for testing, the heterozygote breeding strategy created a 
nearly random mixture of genotype and sex combinations. All mice were tested on all behavioral 
tests described (excluding the unshocked control animals for contextual fear conditioning), 
performed in the following order: (1) OLM; (2) Barnes maze; and (3) contextual fear conditioning, 
with 1 to 30 days in between tests (Table 1). This order was chosen so that the task with the least 
complexity was performed first (OLM), followed by the more complex Barnes Maze. Contextual 
fear conditioning was performed last to prevent the possibility of retained fear behavior influencing 
performance on the other tasks. This serial testing paradigm significantly diminishes the inter-





 The following procedure was adapted from previous reports (Bevins and Besheer, 2006; 
Roozendaal et al., 2010; Barrett et al., 2011; McQuown et al., 2011; Kleschevnikov et al., 2012; 
Vogel-Ciernia et al., 2013; Bui et al., 2018). On the day of testing, mice were brought to the testing 
room, weighed, and placed individually into clean cages with fresh bedding to habituate for 30 
minutes. A clear, glass-walled 25 cm x 25 cm terrarium without bedding was used as the testing 
chamber. Prior to the start of each phase and experiment, the testing chamber and objects were 
cleaned with 70% ethanol. Each test consisted of two phases: the acquisition phase and the testing 
phase. The testing area was an enclosed space isolated from the rest of the laboratory room by 
opaque curtains hanging from the ceiling. Each mouse was tested individually, and mice were left 
undisturbed for the duration of the testing. Prior to the acquisition phase, two identical plastic 
objects were placed diagonally from each other in opposite corners, approximately 6 cm away 
from each wall, and secured into place using Velcro. The objects used were triangular in shape, 
with each side 4.5 cm in length.   
Following acclimation to the testing room, mice began the acquisition phase. Each mouse 
was individually placed in the center of the testing chamber with the two objects present and 
allowed to explore freely for 10 minutes. The activity of the mouse was recorded using a video 
camera. Mice were then returned to the home cage and colony. The testing phase occurred 24 
hours following the acquisition phase. Prior to beginning the testing phase, one object was moved 
to the corner vertically opposite from its initial location, while the other object remained in its 
former location. The moved object was counterbalanced across subjects. During the testing phase, 
mice were placed into the center of the testing chamber and allowed to explore the chamber for 3 
minutes. The percentage of time spent exploring either object was recorded and scored from the 
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video. Interaction with an object was defined as nose sniffing and head orientation within <1.0 cm 
of an object, without any further interaction with the object (e.g., biting or climbing). The 
discrimination index (DI) was computed as DI(%)=((Tnew-Told)/(Tnew+Told))*100, Tnew 
representing the amount of time spent interacting with the moved object and Told representing the 
time spent interacting with the unmoved object. Side preference for the acquisition phase was 
calculated using the same DI equation as above, replacing Tnew with interaction with the object on 
the left and Told with interaction with the object on the right. For analyses, all video identities were 
coded and randomized, and scorers were blinded to genotype and sex.  
 
3.3.4: Barnes maze 
 The following procedure was adapted from previous reports (Harrison et al., 2009; Patil et 
al., 2009; Rosenfeld and Ferguson, 2014). In the Barnes maze test, mice use extra-maze cues 
located around the testing room to learn how to escape from the open maze to a dark “escape box” 
located underneath the platform. The custom-built Barnes maze consisted of a circular grey, type 
1 PVC sheet 91.44 cm in diameter and 91.44 cm from the ground, with 20 equally spaced holes 
(each 5.08 cm in diameter) located 2.85 cm from the edge of the maze. Each hole was left open 
during each trial with exception of the target hole, under which was a black cast acrylic escape box 
(5.08 x 10.16 x 4.76 cm) to which mice had direct access. Because the escape box was located 
directly under the maze, mice could not visually identify the location of the escape hole from most 
points on the maze. Prior to each trial, the escape box was cleaned with 70% ethanol and filled 
with approximately 2.5 cm of fresh bedding. Three extra-maze cues were placed approximately 
38.1 cm away from the edges of the maze in the cardinal directions surrounding the maze. 
Extramaze cues were similar in size yet distinctive from one another, and included a patterned 
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throw pillow, a stuffed animal toy, and a colorful printed image. The experimenter acted as the 
fourth cue during the trials by sitting in a chair in a consistent place. 
 Prior to testing, each mouse was brought to the testing room, weighed, and individually 
placed in a clean cage with fresh bedding to habituate for 30 minutes. Directly before the start of 
each trial, mice that were not immediately undergoing testing were moved from the testing room 
to a different laboratory room (“waiting room”) to prevent them from being prematurely exposed 
to the buzzer (see below). At the conclusion of the 4 trials, the test mouse was returned to the 
waiting room, and the next mouse to undergo testing was moved from the waiting room into the 
testing room. Mice were transported in covered cages at all times.   
 For the pre-training trial (day 0), the mouse was placed in the center of the maze in a black 
opaque cylindrical start chamber (10.2 cm in diameter), and a buzzer tone (85 dB) and light 
(positioned directly above the maze) were turned on. The buzzer was emitted via two speakers 
positioned near the maze. After 10 seconds elapsed, the start chamber was lifted and the mouse 
was gently guided into the escape box. After the mouse entered the escape box, the buzzer and 
light were turned off and a square lid was placed over the hole. The mouse remained in the hole 
for 2 minutes and was returned to the habituation cage following the trial.  
 On days 1-4, training trials began with the mouse in the center of the maze under the same 
start chamber that was used during the pre-training trial. 10 seconds following the onset of the 
light and buzzer, the chamber was lifted and the mouse was allowed to freely explore the maze. 
The trial ended after the mouse entered the escape box, or if 3 minutes elapsed. After all four paws 
of the mouse entered the escape box, the light and buzzer were immediately turned off and the 
mouse was allowed to stay in the box for 1 minute. If the mouse left the escape box, it was gently 
guided back in. Mice underwent 4 trials per day for 4 days; each trial was separated by a 15-minute 
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inter-trial interval. During the inter-trial interval of one mouse, up to two more mice would be run. 
The maze was cleaned with 70% ethanol following each trial, and the maze was rotated after each 
mouse had undergone a trial in order to eliminate any odor cues still present on the maze. The 
target box was subsequently moved to compensate for the maze rotation.  
 On day 5, mice underwent one probe trial. The purpose of this trial was to evaluate the 
short-term retention memory the subjects had for the target hole. During the probe trial, the escape 
box under the target hole was removed. The probe trial began similarly to the pre-training and 
training trials and the mouse was allowed to explore the maze for 90 seconds under the buzzer and 
light aversive stimuli.  
 Trials were recorded using TopScan video tracking software (CleverSys, Reston, VA). 
During analysis of videos, scorers were blinded to mouse genotype and sex. From the training 
trials, latency to enter the escape tunnel, primary latency, distance travelled, search strategy, and 
number of total errors were analyzed. Errors were identified as nose pokes over any hole that was 
not defined as the target hole. The definition for primary latency, the first uninterrupted 3-second 
interaction with the target hole, was adapted from a previous report (Harrison et al., 2006). The 
search strategy was divided into 3 categories: 1) direct, navigating directly to the target or adjacent 
hole with 3 or fewer errors without crossing the center of the maze more than once; 2) serial, 
searching consecutive holes in a clockwise or counterclockwise manner starting at least 2 holes 
away from the target hole; 3) random, unorganized search that involves crossing through the center 
of the maze. Each mouse was classified into a single strategy for each trial. For analysis of the 





3.3.5: Contextual fear conditioning 
 The following procedure was adapted from a previous report (Clark et al., 2008). Prior to 
testing, each mouse was brought to the testing room, weighed, and individually placed in a clean 
cage with fresh bedding to habituate to the room for 30 minutes. Mice that were not being tested 
were separated from the testing area by an opaque curtain, and were placed on a different table 
than that holding the fear conditioning apparatus. The contextual fear conditioning experiment 
took place over the span of 2 days: the training phase (day 1) and the testing phase (day 2). On day 
1, mice were individually placed in a fear conditioning chamber with a metal grid floor that 
delivers shock stimuli under the control of a digital timer (Med Associates, St. Albans, VT) (Clark 
et al., 2008; Kohman et al., 2012). Mice were allowed to explore the chamber for 3 minutes. During 
the training phase, mice received one footshock (0.5 mA, 2-second duration) (Clark et al., 2008; 
Curzon et al., 2009) at 120 seconds and a second shock at 150 seconds. 30 seconds after the final 
shock, mice were returned to the habituation cage, then returned to the home cage and colony. 24 
hours later, mice were placed in the same chamber as above for a 3-minute test in the absence of 
a shock. Control animals were not shocked on either day. Between days and test subjects, the 
chamber, grid, and the area under the grid were cleaned with 70% ethanol.  
 Trials were recorded using TopScan video tracking software. The total percentage of time 
spent freezing and distance traveled were recorded for each day. Recorders were blinded to 
genotype and sex of the test subjects for analysis.  
 
3.3.6: Statistical analysis  
In the OLM task, both the percentage of time spent sniffing and the DI were analyzed using 
a three-way repeated measures analysis of variance (ANOVA), with day as the repeated within-
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subjects factor and sex and genotype as between-subjects factors. For situations in which a 
significant interaction involving day was detected, the analysis was further broken down for each 
individual day using two-way ANOVA with sex and genotype as between-subjects factors.  
In the Barnes Maze, latency, primary latency, distance traveled, and number of errors 
(averaged across 4 trials per day) over 4 consecutive days were analyzed using three-way repeated 
measures ANOVA with day as the repeated within-subjects factor and sex and genotype as 
between-subjects factors. In cases where sex or the interaction between sex and other variables 
were insignificant, 2-way repeated measures ANOVAs (with day and genotype as factors) were 
applied. Search strategy was assessed using a logistic regression with sex and genotype as 
between-subjects factors and day as a within-subjects factor. The probabilities of using the direct, 
serial or random strategy were analyzed separately. For these analyses, the deviance is reported 
instead of the F statistic.  Comparisons of the probability of using each search strategy between 
genotypes within days, or within genotypes between day 1 to day 4, were made using Fisher’s 
exact tests. For the probe trial, a three-way repeated measures ANOVA was performed with hole 
as the repeated within-subjects factor and sex and genotype as between-subjects factors. When 
required, all pairwise comparisons were made using Fisher’s least significant difference (LSD) 
post hoc tests for all Barnes maze parameters.  
For the contextual fear conditioning task, freezing behavior and total distance traveled were 
analyzed using three-way repeated measures ANOVA with day as the repeated measure and sex 
and genotype as between-subjects factors. Due to significant interactions involving day, both 
freezing behavior and total distance were subsequently analyzed independently by day using two-
way ANOVA with sex and genotype as between-subjects factors. Fisher’s LSD post hoc tests were 
used for pairwise comparisons of means.   
  
 67 
Age was included as a covariate in all statistical analyses due to the large age range. In all 
parametric analyses, if skewness was outside the range of -1 to 1, the data were square root- or 
log-transformed, depending on which method produced skewness nearest zero, to improve the 
normality assumption. Statistical analyses were performed using SAS version 9.4 (SAS Institute 
Inc., Cary, NC), OriginPro2016 (OriginLab, Northampton, MA), or R software. P<0.05 was 
considered statistically significant.  
 
3.4: Results  
3.4.1: Genetic loss of DBI does not impact contextual OLM  
DBI+/+ and DBI-/- mice were first tested on the OLM test. Animals were evaluated for the 
total percentage of time spent interacting with both objects, as well as the DI between the two 
objects. No effect of age was detected for either variable. For the percentage of time spent 
interacting with both objects, a three-way repeated measures ANOVA showed a main effect of 
genotype (F1,29=19.0, P<0.0002) (Figure 3.1A), in which DBI-/- mice spent less time interacting 
with the objects than did DBI+/+ mice. Additionally, a main effect of sex was detected (F1,29=6.3, 
P=0.02) (Figure 3.1B), in which male mice spent more time investigating the objects than did 
females, independent of genotype. No main effect of day and no interactions were significant, 
indicating that the effects were similar on both days and that the main effects of genotype and sex 
were independent of each other.  
We next sought to determine if DBI+/+ and DBI-/- mice displayed differences in the ability 
to identify an object in a novel location on day 2 vs. day 1. To see if either genotype displayed an 
inherent side preference on day 1, paired t-tests were performed to see if the DI of each mouse was 
statistically different from 0 (with 0 indicating no side preference). Neither DBI+/+ mice (P=0.35) 
nor DBI-/- mice (P=0.91) displayed a side preference on day 1. Next, three-way repeated measures 
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ANOVA of the DI yielded a significant main effect of day (F1,30=8.5, P=0.007); no other 
significant main effects or interactions were present (Figure 3.1C). These results indicate that the 
animals learned the task, and that no differences were observed between genotypes or sex in the 
magnitude of the DI. Overall, these data suggest that the lack of DBI signaling may lead to a 
decrease in overall object investigation levels, but does not lead to a deficit in OLM. 
 
3.4.2: Genetic loss of DBI impairs long-term spatial navigation memory in the Barnes maze 
The mice were next tested on the Barnes maze to determine if the loss of DBI signaling 
impairs spatial navigation memory. Although the Morris water maze is more commonly used to 
test spatial relational memory, the Barnes maze assay was chosen because it is less stressful than 
the Morris water maze and recapitulates ethological features relevant to terrestrial rodents 
(Harrison et al., 2009). Furthermore, we observed that DBI-/- mice have difficulty swimming and 
are unable to reliably complete the Morris water maze (unpublished observations), prompting our 
use of a land-based maze. For all Barnes maze outcome variables, no main effects of sex or 
interactions involving sex were found. Therefore, all analyses were collapsed across sex to 
examine the effects of genotype. For latency to reach the target hole, two-way repeated measures 
ANOVA showed main effects of day (F3,96=46.43, P<0.0001), genotype (F1,31=8.3, P=0.007), and 
a day-by-genotype interaction (F3,96=5.77, P=0.001) (Figure 3.2A). Pairwise post hoc 
comparisons using Fisher’s LSD showed significantly increased latency for DBI-/- mice on days 2 
(P<0.02), 3 (P<0.001), and 4 (P=0.001) compared with DBI+/+ mice (Figure 3.2A). Notably, some 
mice would reach the target hole as expected, but would not physically enter the hole, a 
phenomenon previously observed by other groups (Harrison et al., 2006; Patil et al., 2009). 
Therefore, in addition to latency, we also analyzed the primary latency, defined as the time needed 
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to first reach the target hole and remain at the target for at least 3 seconds. The primary latency 
data displayed a positively skewed residual distribution, so a log transformation was used to 
improve normality. As with latency, two-way repeated measures ANOVA of primary latency 
showed main effects of day (F3,96=45.87, P<0.0001) and genotype (F1,31=4.18, P=0.049), as well 
as a day-by-genotype interaction (F3,96=2.76, P=0.047) (Figure 3.2B). Fisher’s LSD comparisons 
showed that DBI-/- mice displayed increased latency on day 4 (P=0.008) compared with DBI+/+ 
mice. No effect of age was seen for either latency or primary latency. Together, the latency and 
primary latency data revealed that DBI-/- mice took significantly longer to reach the target hole 
than did DBI+/+ mice across the four days, suggesting impaired spatial memory.    
We next investigated whether DBI+/+ and DBI-/- mice differed in the number of errors made 
during the task, defined as the number of visits to holes other than the target hole. The residual 
distribution was slightly positively skewed, so a square root transformation was used to improve 
normality. An age effect was detected, in which older animals displayed significantly fewer errors 
than younger animals (F1,31=7.4, P=0.01). After correcting for age, two-way repeated measures 
ANOVA of the transformed data revealed a main effect of day (F3,96=26.14, P<0.0001) and a day-
by-genotype interaction (F3,96=5.24, P<0.003), indicating that DBI-/- mice had a higher rate of 
errors as the days progressed than did DBI+/+ mice. Fisher’s LSD comparisons revealed that DBI-
/- mice made significantly more errors on day 4 than did DBI+/+ mice (P<0.02) (Figure 3.2C). We 
also analyzed the total distance that the mice traveled on the maze. Two-way repeated measures 
ANOVA showed a significant effect of day (F3,96=92.55, P<0.0001) and a day-by-genotype 
interaction (F3,96=3.56, P<0.02), demonstrating that DBI+/+ and DBI-/- mice traveled different 
distances in the maze as the days progressed (Figure 3.2D). Fisher’s LSD comparisons showed 
that DBI-/- mice traveled a greater distance than DBI+/+ mice did on days 3 (P<0.02) and 4 (P<0.02). 
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No effect of age was detected. These data are in agreement with the increased latency, primary 
latency, and number of errors displayed by the DBI-/- mice. Altogether, the phenotypic differences 
observed in these four parameters of Barnes maze testing provide evidence for impaired spatial 
navigation memory in mice with a genetic loss of DBI signaling.   
We next investigated whether the genetic loss of DBI signaling impacted the search 
strategy used by the mice to exit the maze (Figure 3.3). Search strategy is an important indicator 
of the ability of mice to use the external visual cues to solve the task, thereby signaling intact long-
term spatial memory (Patil et al., 2009). All individual trials for each mouse were analyzed post 
hoc and scored for one of three possible search strategies: direct, serial, or random (see Materials 
and Methods for a complete description of strategy criteria). No effect of age was detected for any 
of the three strategies. Logistic regression analysis yielded main effects of day for the direct and 
random search strategies (Deviance3=62.3, P<0.0001 and Deviance3,=105.4, P<0.0001, 
respectively) (Figure 3.3), indicating that the mice shifted their search strategy as the days 
progressed independent of genotype. Specifically, the probability of using the direct strategy 
increased and the probability of using the random strategy decreased across days. To confirm this, 
Fisher’s exact tests were run on days 1 and 4 for both direct and random search strategies. For the 
direct search strategy, both DBI+/+ (P<0.0001) and DBI-/- mice (P=0.0002) displayed an increase 
in the probability of using this strategy on day 4 compared with day 1. Concomitantly, both DBI+/+ 
(P<0.0001) and DBI-/- mice (P<0.0001) displayed a decrease in the probability of using the random 
search strategy across days, suggesting that both genotypes learned and used the external visual 
cues by switching from a random to direct strategy. However, logistic regression analysis also 
yielded a main effect of genotype (Deviance1=4.65, P=0.04) for the direct strategy and a day-by-
genotype interaction for the random strategy (Deviance3=8.2, P=0.04) (Figure 3.3), indicating that 
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differences were present between DBI+/+ and DBI-/- mice in the use of these search strategies over 
the course of the task. In confirmation of this effect, a Fisher’s exact test revealed that DBI-/- mice 
used the direct search strategy significantly less than DBI+/+ mice did on day 4 (P<0.03). No 
significant effects were observed for the serial strategy. Taken together, both genotypes displayed 
the ability to learn the task, as evidenced by the shift from random to direct search strategies. In 
comparison to DBI+/+ mice, however, DBI-/- mice displayed a reduced rate of using the visual cues 
necessary for the direct strategy, providing further support of a role for DBI signaling in spatial 
navigation memory.  
 Finally, to investigate long-term spatial memory retention, DBI+/+ and DBI-/- mice were 
analyzed on a probe trial in which the escape box was removed from the target hole. Three-way 
repeated measures ANOVA on the number of visits made to each hole showed a significant effect 
of hole (F19,570=32.83, P<0.0001) and a significant genotype-by-hole interaction (F19,570=1.82, 
P=0.018).  A Fisher’s LSD post hoc test revealed that DBI-/- mice made significantly fewer visits 
to the target hole during the probe trial than did DBI+/+ mice (P<0.0001) (Figure 3.4). No effect 
of age was detected, and no significant differences between genotypes were seen in the number of 
visits to any of the other 19 holes, further suggesting that DBI-/- mice displayed a specific deficit 
in long-term spatial memory.     
In summary, mice with a genetic lack of DBI signaling on average took longer to escape 
the maze, made more performance errors, traveled a greater distance, displayed decreased aptitude 
in learning external visual cues, and displayed impaired long-term retention of the target hole 
location. These data thus provide evidence for a role of DBI signaling in long-term spatial 




3.4.3: Genetic loss of DBI abolishes sex differences in contextual fear conditioning  
DBI+/+ and DBI-/- mice were also assessed on a third hippocampus-dependent assay of 
learning and memory, contextual fear conditioning. To determine if mice associated the 
environmental context with a subsequent foot shock, mice were placed in a testing chamber on 
day 1 and footshocked at two separate intervals. On day 2, mice were placed within the same 
testing chamber and not shocked. Two outcome variables were evaluated: 1) percentage of time 
spent freezing; and 2) total distance traveled. No effect of age was detected for either variable. For 
the time spent freezing (Figure 3.5A), overall three-way repeated measures ANOVA found a 
significant effect of day (F1,30=118.9, P<0.0001), a significant interaction between sex and 
genotype (F1,29=5.3 P=0.029) and a day-by-sex-by-genotype interaction (F1,30=6.0, P=0.02); 
therefore, the data were analyzed separately for each day. On day 1, two-way ANOVA of freezing 
behavior detected no significant main effects or interactions. On day 2, two-way ANOVA of 
freezing behavior found no main effect of sex (F1,29=1.42, P=0.07) nor genotype (F1,29=0.00, 
P=0.96), but there was a significant sex-by-genotype interaction (F1,29=5.3, P=.03). Fisher’s LSD 
post hoc tests revealed that DBI+/+ males displayed more robust freezing behavior than did DBI+/+ 
females (P<0.05), but no differences between sexes were observed in the DBI-/- mice. This finding 
suggests that DBI+/+ males formed stronger associations between the context and the foot-shock 
than did females, confirming previous results in both mice (Wiltgen et al., 2001; Villasana et al., 
2010) and rats (Maren et al., 1994; Kudo et al., 2004). This effect of sex was lost in DBI-/- mice 
(Fisher’s LSD: P>0.2) (Figure 3.5A). In addition, although there was not a significant difference 
in freezing between DBI+/+ and DBI-/- males (P>0.1), the effect between genotypes was borderline 
significant for female mice (P=0.056), with DBI-/- females showing a trend towards increased 
freezing.      
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It is conceivable that DBI-/- mice may display altered baseline freezing behavior compared 
with DBI+/+ mice. To investigate this possibility, we tested three additional mice of each genotype 
and sex combination that did not receive any footshocks on either day. A three-way repeated 
measures ANOVA of the data from unshocked controls showed no main effects of day, genotype, 
sex, or any interactions (Figure 3.5B), indicating that the phenotypic differences seen in the 
shocked mice on day 2 were not due to a characteristic disparity in baseline freezing behavior.   
 For the total distance traveled in the chamber, an overall three-way repeated measures 
ANOVA of the data from shocked mice revealed a significant effect of day (F1,29=322.6, 
P<0.0001), a significant genotype-by-sex interaction (F1,30=7.0, P=0.013), and a significant day-
by-genotype interaction (F1,30=6.5, P=0.016) (Figure 3.5C). Therefore, the data were analyzed 
separately for each day. Two-way ANOVA of distance traveled on day 1 did not yield a main 
effect of sex (F1,29=3.17, P=0.09) nor a sex-by-genotype interaction (F1,29=1.4, P=0.24), but there 
was a significant main effect of genotype (F1,29=8.8, P=0.006), in which DBI-/- mice traveled a 
shorter distance than did DBI+/+ mice. On day 2, two-way ANOVA found no main effects of sex 
(F1,29=0.51, P=0.48) nor genotype (F1,29=0.68, P>0.42), but there was a significant sex-by-
genotype interaction (F1,29=7.5, P=0.01). A Fisher’s LSD post hoc test demonstrated greater 
distance traveled by females than males in the DBI+/+ genotype (P<0.04). However, although the 
sex difference observed in DBI+/+ mice was lost in DBI-/- mice, it was nearly reversed (Fisher’s 
LSD: P=0.054), with DBI-/- females showing a trend towards shorter distances traveled compared 
to males.  In addition, within males, the DBI-/- mice traveled a greater distance than DBI+/+ mice 
(P<0.02), but no differences between genotypes were observed for females, and the trend was in 
the opposite direction. The data for distance traveled by the shocked mice on both days support 
the effects seen in freezing behavior. For the unshocked controls, an overall three-way repeated 
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measures ANOVA of distance traveled showed no main effects of day, genotype, sex, or any 
interactions (Figure 3.5D), suggesting that DBI-/- mice do not display inherent locomotor 
impairment. Overall, these results indicate a potential role for DBI in regulating a sexually 
dimorphic circuit mediating contextual fear conditioning. 
 
3.5: Discussion 
 In these studies, we sought to determine the effects of genetic loss of DBI signaling in mice 
on performance in multiple hippocampus-dependent tasks of spatial and contextual learning and 
memory. Our data show that the loss of DBI plays a selective role in hippocampus-dependent 
behaviors, modulating performance in a task-specific manner. We found no significant differences 
between DBI+/+ and DBI-/- mice in the DI of OLM, although DBI-/- mice showed lower degrees of 
total object exploration. In the Barnes maze task, we found that DBI-/- mice showed inferior 
learning of spatial reference cues necessary for the memory of the escape hole location. 
Furthermore, our results indicate that DBI-/- mice did not simply fail to associate entering the 
escape box with completion of the trial, as analysis of search strategy demonstrated that these mice 
showed lower rates of relying on extra-maze cues to locate the escape box. Analysis of the 
contextual fear conditioning task revealed an intriguing sex-by-genotype interaction on day 2, with 
a sex effect existing in DBI+/+ mice that was not observed in DBI-/- mice. These results potentially 
suggest a role for DBI in maintaining and modulating sexually dimorphic fear behavior in mice. 
Taken together, these results provide evidence of a role for DBI in modulating various 
hippocampus-dependent assays of learning and memory. These effects are task-specific, showing 
genotype and sex-dependent deficiencies in some, but not all, behavioral paradigms. 
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The hippocampus has long been associated with multiple forms of spatial knowledge 
(O’Keefe and Nadel, 1978; Gray and McNaughton, 1983). Several assays of spatial memory in 
rodents have been invented with varying degrees of complexity and differential requirements of 
hippocampal engagement. Each of the paradigms examined in this study require the animal to use 
the learned information in a distinctive way. For example, spatial relational memory is a 
hippocampus-demanding form of spatial knowledge that relies on the animal to encode geometric 
relationships of intra- and extra-maze cues, and to apply this knowledge to locate the target from 
multiple viewpoints (Eichenbaum, 2000). With a specific goal in place, tasks such as the Barnes 
maze and the Morris water maze force the animal to use various strategies employing the given 
cues to solve the maze. Conversely, tasks such as OLM and contextual fear conditioning rely on 
the subject forming a cognitive map of the environment by investigating cues and forming 
associations. These representations do not necessarily require a flexible use of the learned 
information regarding the setting (Sutherland and Rudy, 1989; Moses and Ryan, 2006). 
Furthermore, tasks involving detection of novelty, such as OLM, are fairly simple and useful in 
investigating spatial cognitive mapping rather than spatial reference memory (Sharma et al., 2010). 
In addition, multiple studies have implicated the basolateral amygdala and the retrosplenial cortex 
in influencing contextual fear conditioning (Phillips and LeDoux, 1992; Sparta et al., 2014), and 
inactivation of the dorsal hippocampus was shown to lead to only a ~35% impairment in contextual 
fear conditioning (Desmedt et al., 2003), suggesting that other brain regions play critical roles 
influencing this task. Therefore, it is reasonable to expect that impairments in some hippocampus-
dependent tasks do not necessarily correlate to deficits in others.   
 Recent evidence supports a role for DBI in the regulation of neurogenesis in the dentate 
gyrus of the hippocampus (Dumitru et al., 2017). Specifically, DBI appears to control the balance 
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between preserving the neural stem cell population and facilitating development of new granule 
cells. Importantly, disruption of neurogenesis in the dentate gyrus selectively impairs performance 
in the Morris water maze. This effect, however, was not seen in either contextual fear conditioning 
or tasks involving identification of a novel environment (Drapeau et al., 2003; Dupret et al., 2008). 
Therefore, it is possible that the lack of DBI signaling may disrupt hippocampal neurogenesis, thus 
specifically impacting behavioral tasks that require spatial reference memory over other 
neurogenesis-independent forms of memory. Our results, demonstrating a specific impairment in 
mice lacking DBI on performance in the Barnes maze, but not in OLM nor contextual fear 
conditioning, support this conclusion. In addition, it is noteworthy that the impairment of spatial 
memory seen here upon genetic removal of DBI signaling is similar to the effect seen previously 
with transgenic overexpression of DBI (Siiskonen et al., 2007). These results suggest that DBI 
levels may need to be strictly regulated to ensure proper neural function, and that a disruption of 
this balance in either direction can lead to cognitive deficits, particularly in spatial memory. 
Further work is needed to uncover the complex role of DBI in the hippocampus, with a potential 
focus on how learning and memory may depend on the regulation of hippocampal DBI levels and 
its subsequent impact on neurogenesis.  
 We recently reported that DBI-/- mice lack the typical sex difference in social interest seen 
in DBI+/+ mice, in which males display higher levels of social interest than females, suggesting 
that DBI may play a role in developing and/or maintaining sexually dimorphic circuits underlying 
social behavior (Ujjainwala et al., 2018). In the present studies, DBI+/+ male mice exhibited greater 
freezing levels compared with females in contextual fear conditioning, and this sex effect was 
diminished and nearly reversed in DBI-/- mice. The current study thus provides further evidence 
that DBI may play a role in mediating behaviors that show established sex differences. These 
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results may be explained by, for example, DBI impacting the formation and maintenance of critical 
sexually dimorphic circuits and/or the sex-specific production of certain GABAAR-modulating 
neurosteroids. In the latter regard, DBI can potentially upregulate steroid hormone biosynthesis 
through actions at the mitochondrial benzodiazepine receptor TSPO (Papadopoulos et al., 1991; 
Korneyev et al., 1993), although the role of TSPO in this process has recently come into question 
(Morohaku et al., 2014). Furthermore, within the hippocampus, testosterone and/or its metabolites 
generated by 5-reduction, dihydrotestosterone and 3α-androstanediol, can improve performance 
in spatial tasks and contextual fear conditioning in rats and modulate hippocampal synaptic spine 
density (Frye and Lacey, 2001; Isgor and Sengelaub, 2003; Leranth et al., 2003; Edinger et al., 
2004). Dbi mRNA expression in at least some areas of the mouse brain is androgen-sensitive 
(Compere et al., 2006), and seminal vesicle weights, a proxy of circulating testosterone levels, are 
not different in DBI-/- male mice (Ujjainwala et al., 2018). Therefore, it is also possible that some 
of the observed effects of genetic loss of DBI represent impaired mediation of certain effects of 
testosterone in the hippocampus and associated brain structures.  
 The OLM task relies on the testing groups displaying similar levels of interaction with the 
objects on both days of the test. In our studies, DBI+/+ and DBI-/- mice did not show similar levels 
of investigation on either day 1 or day 2. Therefore, it is difficult to ascertain whether the lack of 
a genotype effect in the DI is a secondary consequence of differences in object interest. It may be 
useful in future studies to utilize a behavioral assay that does not depend on innate object interest. 
The reduced levels of interest of DBI-/- mice in the OLM task recapitulate findings we recently 
reported in an odor discrimination task (Ujjainwala et al., 2018), in which DBI-/- mice could 
discriminate between social and non-social odors, but showed reduced investigation of cotton 
swabs containing only water. The reduced level of investigation displayed in these behavioral tests 
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could potentially reflect an overall disinterest in various novel tasks and objects. Mouse models of 
anhedonia have been shown to exhibit decreased interest across multiple parameters (Nestler and 
Hyman, 2010; Dedic et al., 2011), and it is possible that the genetic lack of DBI modulates 
pathways or substrates associated with anhedonia. Interestingly, although a sex difference was 
present for the percentage of time interacting with the objects during the OLM task, this effect 
appears to be primarily driven by the low interaction time of the DBI-/- females rather than DBI+/+ 
females. DBI+/+ females do not differ from DBI+/+ males, and display higher interaction times than 
DBI-/- males, suggesting that the lack of DBI signaling is likely a more critical factor than sex in 
overall investigation levels in the OLM task.  
Several potential alternative explanations for our results exist. Although extensive 
backcrossing onto the original C57BL/6BomTac background was performed when this knockout 
line was first developed (Neess et al., 2011), it is possible that genetic material linked to the 
knockout region may still exist in DBI-/- mice. However, since heterozygote breeding was utilized 
during backcrossing onto the C57BL/6J strain in our colony, it is unlikely that the behavioral 
differences seen between DBI+/+ and DBI-/- mice are due to off-target genetic variations related to 
the creation of the knockout. It is also possible that the results seen in these tasks may be explained 
by impaired visual acuity or locomotor impairment in DBI-/- mice. As mentioned previously, DBI-
/- mice display difficulty swimming and have demonstrated the inability to consistently complete 
four consecutive daily trials in the Morris water maze. It should be noted that DBI-/- mice are 
phenotypically distinguishable by varying degrees of alopecia and distinctly oily fur (Bloksgaard 
et al., 2012), which may be debilitating to swimming ability, for example by decreasing the ability 
of the mice to regulate body temperature in an aquatic environment. In previous studies, DBI-/- 
mice did not display large degrees of locomotor impairment on a rotarod task (Ujjainwala et al., 
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2018) or in open field tests (Budry et al., 2016), and in the present studies, DBI-/- mice traveled the 
same distance as DBI+/+ mice did on day 1 of the Barnes maze task, and greater distances on 
subsequent days. In addition, the overall distance traveled by the unshocked control DBI-/- mice in 
the contextual fear conditioning task was not statistically different from the values of the 
unshocked DBI+/+ mice (see Figure 3.5D). Therefore, these mice do not appear to have a gross 
locomotor impairment, and it appears more likely that the swimming impairment is related to the 
distinct skin condition. However, the visual acuity of DBI-/- mice compared to their DBI+/+ 
counterparts remains untested and may be a target of future experimentation. In the contextual fear 
conditioning task, in which each mouse received shocks of the same intensity, one possible 
explanation for the differences seen between groups could be attributed to varying degrees of shock 
sensitivity. Although we did not test whether DBI-/- mice show altered shock sensitivity, it is a 
variable to consider when evaluating data in fear conditioning assays. In addition, it should be 
noted that the unshocked control mice were tested as a separate cohort, and these animals did not 
previously undergo the OLM or Barnes maze tasks. Although the unshocked mice performed as 
expected and clearly displayed phenotypic differences compared to the shocked mice, the cohort 
difference should be considered when making direct comparisons between the two groups.  
In summary, the goal of these studies was to determine the effects of genetic loss of DBI 
in mice on performance in multiple hippocampus-dependent behavioral tasks of spatial memory 
correlates. Our data indicate that DBI-/- mice show an impairment in Barnes maze learning, but 
perform similarly to DBI+/+ mice in OLM, suggesting a role for DBI in specific forms of spatial 
navigation memory. In addition, we observed that the loss of DBI appears to negate an established 
sex difference in contextual fear conditioning response, providing further evidence of a potential 
role of DBI in mediating sex differences in certain behaviors. Overall, this work provides novel 
  
 80 
evidence that DBI is a modulator of hippocampus-dependent learning and memory, and supports 
further investigation into the roles that DBI plays in cognition.  
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Figure 3.1: DBI-/- mice show diminished investigation of objects, but no alterations in OLM. 
a, Mean ± SEM of percentage time sniffing both objects on days 1 and 2 in male and female DBI+/+ 
and DBI-/- mice. Black bars: DBI+/+ mice; open bars, DBI-/- mice. Open circles represent individual 
data values. b, Percentage time sniffing both objects on days 1 and 2, with data for DBI+/+ and 
DBI-/- mice combined. c, Discrimination index (DI) on days 1 and 2, with one object moved to a 




























Figure 3.2: DBI-/- mice display impaired performance on multiple parameters of the Barnes 
maze. Analysis of values from DBI+/+ (closed circles) and DBI-/- mice (open circles) over the 
course of 4 days (each circle represents the average of 4 trials for an individual mouse). Red lines 
represent Mean ± SEM. a, Latency to enter escape box. b, Primary latency to interact with target 
hole. The data were log-transformed to improve normality for statistical analysis; the raw data are 
presented here. c, Number of errors made. The data were square root-transformed to improve 
normality for statistical analysis; the raw data are presented here. d, Total distance traveled during 
duration of test.  significant effect of genotype; $, significant effect of day; +, significant day-
by-genotype interaction; see Results for exact p-values for each parameter. *,**,***, significant 
difference between DBI+/+ and DBI-/- mice on given days (P < 0.05, P < 0.01, P < 0.001, 
respectively); #, ##, ###, significant difference compared with day 1 within the same group (P < 

























Figure 3.3: DBI-/- mice show curtailed adoption of direct search strategy by day 4. Percentage 
of DBI+/+ and DBI-/- mice using each search strategy (direct: blue bars; serial: orange bars; random: 
gray bars) over the course of 4 days (each day represents the average of 4 trials). Δ significant 
effect of genotype (P < 0.05); $, significant effect of day (P < 0.0001); +, significant day-by-
genotype interaction (P < 0.05) for the indicated search strategies; *, significant difference in use 
of direct search strategy between DBI+/+ and DBI-/- mice on day 4 (P < 0.05); ###, ####, significant 

























Figure 3.4: DBI-/- mice display impaired performance in the probe trial of the Barnes maze 
test. Mean ± SEM of number of nose pokes (visits) into each hole during probe trial. Hole 0 is the 
target hole, with positive values progressing clockwise from the target hole. Open circles represent 
individual data values for number of visits to the target hole by each mouse. ****, significant 




























Figure 3.5: DBI-/- mice lack sex effect seen in DBI+/+ mice in contextual fear conditioning. a, 
Mean ± SEM of percentage time that shocked DBI+/+ (black bars) and DBI-/- mice (open bars) 
spent freezing on both days of the fear conditioning task. Open circles represent individual data 
values. b, Percentage time that unshocked DBI+/+ and DBI-/- mice spent freezing on both days of 
the task. c, Distance traveled by the shocked mice on both days of the fear conditioning task. d, 
Distance traveled by the unshocked mice on both days of the task. * Significant difference between 
DBI+/+ and DBI-/- mice (P < 0.05); # Significant difference between sexes within respective 
















Table 1: Age of mice on individual behavioral tasks. Postnatal age (days) at which each 
individual mouse started each behavioral task, broken down by genotype and sex. Mouse identities 
indicate cage number and ear tag. 
Age at Testing 
Group Object Location 
Memory 
Barnes Maze Fear Conditioning 
DBI+/+ Males     
666 L P199 P214 P229 
690 R P193 P224 P243 
708 R P189 P219 P232 
780 N P113 P149 P155 
780 L P113 P149 P155 
780 R P113 P149 P155 
808 N P92 P134 P164 
808 L P92 P134 P164 
820 2R P126 P140 P148 
DBI+/+ Females    
645 L P189 P196 P234 
642 R P187 P216 P231 
657 L P190 P215 P230 
676 N P182 P197 P212 
688 N P187 P218 P244 
706 N P189 P219 P232 
706 L+R P189 P219 P232 
809 N P92 P140 P164 
862 N P84 P86 P100 
DBI-/- Males    
647 R P187 P216 P231 
654 N P190 P221 P229 
654 R P190 P221 P229 
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690 L+R P193 P224 P243 
855 L P73 P85 P108 
855 R P73 P85 P108 
861 N P57 P87 P95 
DBI-/- Females    
645 N P189 P196 P234 
657 R P190 P222 P230 
655 N P191 P229 P249 
655 L P191 P229 P249 
665 L P192 P214 P228 
665 R P192 P208 P228 
688 R P187 P218 P244 
688 L+R P187 P218 P244 
688 2L+R P187 P225 P244 


























CHAPTER 4: EVALUATING THE EFFICACY OF OPTO1AR ACTIVATION IN 
ASTROCYTES IN MODULATING BASAL HIPPOCAMPAL SYNAPTIC EXCITATION 
AND INHIBITION 
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Astrocytes play active roles at synapses and can monitor, respond, and adapt to local 
synaptic activity. To investigate this relationship, more tools that can selectively activate native G 
protein signaling pathways in astrocytes with both spatial and temporal precision are needed. Here, 
we tested AAV8-GFAP-Optoα1AR-eYFP (Optoα1AR), a viral vector to enable activation of Gq 
signaling in astrocytes via light-sensitive α1-adrenergic receptors. To determine if stimulating 
astrocytic Optoα1AR modulates hippocampal synaptic transmission, recordings were made in 
CA1 pyramidal cells with surrounding astrocytes expressing Optoα1AR, channelrhodopsin 
(ChR2), or GFP. Both high-frequency (20 Hz, 45-ms light pulses, 5 mW, 5 min) and low-
frequency (0.5 Hz, 1-s pulses at increasing 1, 5, and 10 mW intensities, 90 s per intensity) blue 
light stimulation were tested. 20 Hz Optoα1AR stimulation increased both inhibitory and 
excitatory postsynaptic current (IPSC and EPSC) frequency, and the mIPSC effect was largely 
reversible within 20 min. By contrast, low-frequency stimulation of Optoα1AR did not modulate 
either IPSCs or EPSCs, whereas the same stimulation of astrocytic ChR2 was effective. These data 
demonstrate that Optoα1AR activation in astrocytes changes synaptic excitation and inhibition in 
a stimulation-sensitive manner, demonstrating the efficacy and utility of GFAP-Opto1AR as a 







4.1: Introduction  
 
Astrocytes can detect synaptic signaling through G protein-coupled receptor (GPCR) 
activation (Haydon, 2001; Araque et al., 2014) and respond to local neuronal activity with transient 
increases in intracellular Ca2+ levels (Agulhon et al., 2008; Bazargani and Attwell, 2016). As 
influential components of the tripartite synapse, astrocytes engage in extensive and specific 
bidirectional communication with synapses (Araque et al., 1999; Perea et al., 2009; Santello et al., 
2012). In the hippocampus, many studies investigating astrocyte-neuron interactions have 
demonstrated astrocyte-specific modulation of excitatory transmission and/or plasticity (Jourdain 
et al., 2007; Perea and Araque, 2007; Navarrete and Araque, 2010; Panatier et al., 2011; Boddum 
et al., 2016; Adamsky et al., 2018; Covelo and Araque, 2018; Durkee et al., 2019; Mederos et al., 
2019). Evidence for astrocytic regulation of basal synaptic inhibition remains limited, although 
previous studies have suggested a role for astrocyte-mediated modulation of fast synaptic 
inhibition in multiple brain areas including hippocampus, cortex, and thalamus (Christian and 
Huguenard, 2013; Mederos and Perea, 2019). For example, mechanical stimulation of astrocytes 
leads to glutamate release and a strengthening of inhibition that is dependent upon astrocytic Ca2+ 
signaling and AMPA/NMDA receptors (Kang et al., 1998). In addition, activation of somatostatin-
positive interneurons stimulates the release of ATP/adenosine from astrocytes and subsequent 
enhancement of inhibition via A1 adenosine receptors (Matos et al., 2018), suggesting that 
astrocytes can modulate both inhibitory and excitatory synaptic transmission.   
Historically, the study of neuron-astrocyte interactions has been hampered by the limited 
availability of tools that selectively modulate astrocytic GPCR signaling with precise spatial and 
temporal control. Several studies have utilized Designer Receptors Exclusively Activated by 
Designer Drugs (DREADDs) for specific manipulation of astrocytes (Agulhon et al., 2013; Yang 
  
 90 
et al., 2015; Chen et al., 2016; Martin-Fernandez et al., 2017; Adamsky et al., 2018). DREADDs 
are well-suited for this purpose as they provide targeted activation of GPCR-mediated endogenous 
intracellular cascades native to astrocytes. A limitation of DREADDs, however, is the relative lack 
of temporal regulation of the activation of GPCR-mediated signaling. To overcome this drawback, 
in many studies the light-gated nonspecific cation channel channelrhodopsin-2 (ChR2) has been 
inserted into astrocyte membranes for improved temporal control (Gourine et al., 2010; Perea et 
al., 2014; Yamashita et al., 2014; Masamoto et al., 2015; Cui et al., 2016; Tan et al., 2017; Octeau 
et al., 2019). ChR2 activation, however, produces robust depolarization that likely exceeds that 
endogenously produced in astrocytes, and increases extracellular K+ levels (Octeau et al., 2019). 
Furthermore, ChR2 activation does not recapitulate a physiologically relevant signaling cascade 
to drive intracellular Ca2+ elevations in astrocytes (Xie et al., 2015). Therefore, there remains a 
need for optical tools that allow for precise spatial and temporal stimulation of astrocytes with 
improved physiological relevance. Progress has been made in this regard with the recent 
development of an astrocyte-specific melanopsin coupled to the Gq intracellular pathway (Mederos 
et al., 2019). The use of OptoXRs (Airan et al., 2009) has emerged as another potential solution, 
and stimulation of Optoα1 adrenergic receptor (Optoα1AR)-derived constructs can drive Ca2+ 
elevations in cultured astrocytes (Figueiredo et al., 2014) and stimulate memory enhancement in 
vivo (Adamsky et al., 2018).  
Here, we generated a novel adeno-associated virus (AAV) construct, AAV8-GFAP-
Optoα1AR-eYFP, to efficiently insert Optoα1AR specifically into astrocytes. We report that 
stimulation of astrocytic Optoα1AR modulates basal synaptic transmission in CA1, and this 
response depends on the properties of the light stimulation. These data suggest that this vector may 




4.2.1: Astrocyte-specific expression of optogenetic constructs 
 AAV8 vectors driven by the astrocyte-specific GFAP promoter were individually injected 
bilaterally into dorsal CA1 of wild-type C57BL/6J mice. For each mouse, one of three constructs 
was used: GFAP-Optoα1AR-eYFP (Optoα1AR), GFAP-hChR2(H134R)-eYFP (ChR2), and 
GFAP-GFP (GFP). To confirm the astrocyte-specificity of these vectors, immunohistochemistry 
was performed for the neuronal marker NeuN. Colocalization was not observed between NeuN 
staining of CA1 pyramidal cells and the GFP or eYFP fluorescent tags of any AAV used (Figure 
4.1), indicating a lack of neuronal expression of the optogenetic constructs.  
   
4.2.2: High-frequency (20 Hz) optogenetic stimulation of Optoα1AR in astrocytes produces a 
sustained modulation of sIPSC frequency  
 High-frequency optical stimulation of astrocytes using Gq-coupled melanopsin enhances 
inhibitory transmission in the medial prefrontal cortex (Mederos et al., 2021), and 20 Hz 
stimulation of a similar OptoGq construct in CA1 astrocytes improves memory performance in 
vivo (Adamsky et al., 2018). To examine if 20 Hz activation of Optoα1AR in astrocytes modulates 
basal synaptic inhibition in hippocampus, whole-cell patch clamp recordings of spontaneous 
inhibitory postsynaptic currents (sIPSCs) were made in CA1 pyramidal cells. Slices containing 
astrocytes expressing either Optoα1AR or control GFP were exposed to 20 Hz blue light 
stimulation at 5 mW intensity for 5 minutes (closely resembling in vivo experiments described in 
ref. 8) (Figure 4.2A). First, we investigated the impact of 20 Hz activation of Optoα1AR or GFP 
in astrocytes in modulating hippocampal inhibitory transmission. 20 Hz stimulation of the 
Optoα1AR group led to an overall increase in sIPSC frequency compared to baseline when the 
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analysis incorporated all sIPSCs recorded during the duration of light stimulation together (t=-
2.73, p=0.015, n=16 cells from 5 mice, 9 of 16 cells displaying >20% increase), and this effect 
was not seen in the control GFP group (t=0.67, p=0.51, n=8 cells from 2 mice) (Figure 4.2B, 
4.2C). To investigate the time course of the effect, sIPSC frequency was subdivided into 30-s bins. 
This analysis, however, did not yield a significant difference in sIPSC frequency for any 30-s bin 
compared to baseline in either the Optoα1AR group (p=0.40) or the GFP group (p=0.86) (Figure 
4.2D), reflecting the variability in time course of the effect within individual cells. In addition, 
sIPSCs from the Optoα1AR group displayed no overall change in amplitude during 20 Hz 
stimulation compared to baseline (t=0.18, p=0.86) (Figure 4.2E). When subdivided into 30-s 
intervals, however, sIPSC amplitude reached its average maximum at 60-90 s into the light 
stimulation, and its average minimum at 240-300 s, with significant differences in amplitude 
between these maximum and minimum timepoints (p=0.02) (Figure 4.2F, top). By contrast, GFP 
controls did not demonstrate any changes in sIPSC amplitude either overall (t=-0.01, p=0.99) or 
across time (p=0.86) (Figure 4.2E; 4.2F, bottom).  
An important advantage of using optogenetic tools is the temporal precision of activation 
(Deisseroth, 2015), and Optoα1AR expression in neurons allows for spatiotemporally precise 
manipulation of biochemical signaling and modulation of behavior in vivo (Airan et al., 2009). In 
theory, this temporal control could allow for cellular modulation to be reversible at short 
timescales. To test for this possibility, we recorded sIPSCs for 20 additional min following 
cessation of the 20 Hz light stimulation in a subset of cells in slices expressing Optoα1AR or GFP 
in astrocytes. In these cells, 20 Hz stimulation of Optoα1AR resulted in a trend for increased sIPSC 
frequency during the final minute of stimulation compared to baseline (p=0.06, n=13 cells), similar 
to the modulation of sIPSC frequency observed in the full group (Figure 4.2C). Contrary to our 
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prediction, however, cells from the Optoα1AR group maintained an increased level of sIPSC 
frequency at 20 min post-stimulation (p=0.02 compared to baseline, 8 of 13 cells displaying >20% 
increase) (Figure 4.2G). This finding suggests that 20 Hz stimulation of Optoα1AR in astrocytes 
can exert long-lasting modulation of synaptic inhibition. In cells from the GFP group, by contrast, 
no changes in sIPSC frequency were seen either during the final minute of 20 Hz stimulation or at 
20 min post-stimulation (n=7 cells from 2 mice) (Figure 4.2G). Additionally, there were no 
significant changes in sIPSC amplitude either during the light stimulation or at 20 min afterwards 
in cells from the Optoα1AR or GFP groups (Figure 4.2H). Altogether, these data suggest that 
high-frequency stimulation of Optoα1AR in astrocytes can modulate hippocampal synaptic 
inhibition, and that this modulation is sustained for at least 20 minutes following termination of 
the stimulation.    
 
4.2.3: High-frequency (20 Hz) optogenetic stimulation of Optoα1AR in astrocytes enhances 
activity-independent hippocampal synaptic inhibition     
To determine if the effects of 20 Hz stimulation of astrocytic Optoα1AR on hippocampal 
synaptic inhibition require presynaptic input, miniature inhibitory postsynaptic currents (mIPSCs) 
were recorded under the same stimulation paradigm in the presence of tetrodotoxin (TTX, 0.5 M) 
to prevent action potential firing (Figure 4.3A). mIPSCs recorded from the Optoα1AR group 
displayed an increase in frequency in response to 5 min of 20 Hz light stimulation (t=-3.91, 
p=0.002, n=14 cells from 6 mice, 10 of 14 cells displaying >20% increase) (Figure 4.3B). The 
increase in frequency was first visible after 2 minutes of light stimulation (p=0.01) and peaked 
within 4 minutes of stimulation (p<0.001) (Figure 4.3C, top). No increase in mIPSC frequency 
was seen in the control GFP group (t=-0.84, p=0.42, n=13 cells from 5 mice) (Figure 4.3B), 
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suggesting that 20 Hz stimulation of Optoα1AR can acutely elicit an activity-independent 
mechanism producing increased frequency of GABA release onto CA1 pyramidal cells. mIPSC 
amplitude was not affected by light stimulation in the Optoα1AR group (t=-0.98, p=0.34) (Figure 
4.3D). Additionally, no differences in mIPSC amplitude were observed over time (Figure 4.3E, 
top). However, there was an increase in mIPSC amplitude in cells from the GFP group (t=-4.10, 
p<0.001) (Figure 4.3D) that appeared within the first 30 s of light stimulation (Figure 4.3E, 
bottom). This effect may reflect a non-specific artifact of exciting GFP in astrocytes in the absence 
of an opsin, underscoring the necessity for fluorophore-only controls in optogenetic experiments. 
It should be noted, however, that this effect reflected a very small (~2 pA) average increase, and 
the mean amplitude of events during the light stimulation was similar between groups.   
To determine if 20 Hz stimulation of astrocytic Optoα1AR leads to a sustained increase in 
mIPSC frequency, a subset of cells from the Optoα1AR and GFP groups were recorded for 20 
additional min following cessation of the light stimulation. In cells from the Optoα1AR group, an 
increase in mIPSC frequency was observed during the last minute of 20 Hz light stimulation 
(p<0.001, 9 of 9 cells displaying >30% increase compared to baseline), and at 20 min following 
cessation of the stimulation (p=0.03, 7 of 9 cells displaying >20% increase compared to baseline) 
(Figure 4.3F). However, in contrast to the sIPSCs, 6 of 9 cells displayed a reduction in frequency 
at 20 minutes post-stimulation compared to the last minute of stimulation, and this reduction was 
greater than 50% in 5 of these 6 cells (Figure 4.3F). These data suggest that while 20 Hz 
stimulation of Optoα1AR in astrocytes leads to a sustained increase in mIPSC frequency, this 
activity-independent modulation is reversible to an extent that is not seen when firing activity is 
unblocked. In cells from the GFP group, no differences were seen in mIPSC frequency during light 
stimulation nor at 20 min after (9 cells from 4 mice) (Figure 4.3F). Additionally, there was no 
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effect of 20 Hz stimulation on mIPSC amplitude in the Optoα1AR group at either timepoint. 
However, as observed in the full GFP mIPSC group, there was a small increase in mIPSC 
amplitude in the subgroup of cells recorded after light stimulation (p<0.01), and this increase 
persisted for at least 20 min (p<0.01). (Figure 4.3G). Altogether, these data indicate that high-
frequency stimulation of Optoα1AR in astrocytes modulates activity-independent synaptic 
inhibition. In addition, although this stimulation drives an increase in mIPSC frequency that is 
both acute and sustained, this change appears more reversible than that observed when action 
potential firing is intact.   
 
4.2.4: High-frequency (20 Hz) optogenetic stimulation of Optoα1AR in astrocytes modulates 
activity-independent hippocampal glutamatergic transmission      
 Previous studies using Gq-coupled optogenetic or chemogenetic tools have demonstrated 
that activation of this pathway in astrocytes can modulate basal excitatory neurotransmission in 
the hippocampus (Adamsky et al., 2018; Mederos et al., 2019). As we had observed differences in 
IPSC frequency in response to 20 Hz stimulation of Optoα1AR in astrocytes, we sought to 
determine whether the same stimulation modulates mEPSCs recorded from CA1 pyramidal cells 
(Figure 4.4A). In the Optoα1AR group, this stimulation produced an increase in mEPSC 
frequency compared to baseline (t=-5.04, p<0.001, n=10 cells from 4 mice) (Figure 4.4B). The 
increase in frequency was first visible after 90 s of light stimulation (p=0.005) and was within 0.12 
Hz of peak frequency at this time (90 s mean=2.77 + 0.46 Hz; peak mean=2.89 + 0.33 Hz) (Figure 
4.4C, top), suggesting that activation of Optoα1AR in astrocytes may modulate glutamatergic 
transmission on a faster timescale compared to the effects on GABAergic transmission. No change 
in mIPSC frequency was observed in the control GFP group (t=0.13, p=0.91, n=6 cells from 4 
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mice) (Figure 4.4B, 4.4C bottom). Additionally, mEPSC amplitude was not changed in the 
Optoα1AR group either as compared to baseline (t=-0.56, p=0.59) (Figure 4.4D) or across time 
(Figure 4.4E, top), and no difference in amplitude was observed in the GFP group (t=-0.63, 
p=0.56) (Figure 4.4D, 4.4E). These data demonstrate that 20 Hz stimulation of Optoα1AR in 
astrocytes is capable of modulating hippocampal glutamatergic transmission.  
 
4.2.5: Low-frequency (0.5 Hz) optogenetic stimulation of astrocytic ChR2, but not Optoα1AR, 
modulates hippocampal synaptic inhibition 
 Responses to optogenetic stimulation are shaped by a combination of the properties of the 
light stimulation, the kinetics of opsin activation, and the cell expressing the opsin. The Optoα1AR 
is coupled to a GPCR signaling cascade, which has slower kinetics of activation and deactivation 
than ionotropic opsins and thus may have a broader range of effective stimulation parameters. 
Therefore, we tested whether an alternative stimulation paradigm of longer pulses delivered at a 
lower frequency for a shorter period of time would elicit similar results as the 20 Hz stimulation. 
Recordings of sIPSCs or sEPSCs were made in CA1 pyramidal cells as before, and slices 
containing astrocytes expressing either Optoα1AR or control GFP were exposed to 0.5 Hz blue 
light stimulation at successive 1, 5, or 10 mW intensities for 90 s per intensity, with 2 min between 
stimulations (Figure 4.5A). Following 0.5 Hz stimulation of slices in the Optoα1AR group, there 
was no change in sIPSC frequency compared to baseline at any stimulation intensity or timepoint 
(Figure 4.5B and 4.5C, middle) (n=10 cells from 6 mice). Additionally, there was no difference 
in sIPSC frequency in response to light stimulation between the Optoα1AR and GFP groups 
(Figure 4.5B and 4.5C, top) (GFP n=10 cells from 4 mice).  
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As a positive control to ensure that the 0.5 Hz stimulation of astrocytes is capable of driving 
alterations in hippocampal synaptic transmission, additional cells were recorded in slices with 
astrocytes expressing the nonspecific cation channel ChR2. The ChR2 group displayed increased 
IPSC frequency following 1 mW-intensity stimulation compared to baseline (p=0.002) (n=7 cells 
from 4 mice, 4 of 7 cells responding with >50% frequency increase), as well as compared to the 
GFP group at 1 mW and 5 mW (p<0.001, respectively) (Figure 4.5B and 4.5C, bottom), 
confirming that 0.5 Hz light delivery to astrocytes expressing ChR2 can modulate hippocampal 
synaptic transmission. Notably, the strength of this ChR2-mediated effect diminished over time 
despite an increase in stimulation intensity; there was no significant difference compared to 
baseline at 5 mW intensity, nor compared to either baseline or to the GFP group at 10 mW 
stimulation, indicating a potent rundown of the effect within minutes that increased light intensity 
did not overcome. Furthermore, no differences were detected in sIPSC amplitude in any 
experimental group at any stimulation intensity (F=0.76, p=0.55) (Figure 4.5D). Together, these 
data indicate that 0.5 Hz optogenetic stimulation of the nonspecific cation channel ChR2 in 
astrocytes modulates sIPSC frequency in CA1 hippocampal pyramidal cells, but the same 
stimulation of Optoα1AR to trigger the Gq signaling cascade in astrocytes is not effective.  
 
4.2.6: Low-frequency (0.5 Hz) optogenetic stimulation of astrocytic ChR2, but not Optoα1AR, 
modulates hippocampal glutamatergic transmission  
 To determine if low-frequency 0.5 Hz stimulation modulates glutamatergic transmission 
in the hippocampus, sEPSCs were recorded from CA1 pyramidal cells (Figure 4.6A). Similar to 
the data for sIPSCs, 0.5 Hz stimulation of slices in the Optoα1AR group did not result in an overall 
difference in sEPSC frequency compared to baseline at any stimulation intensity (Figure 4.6B, 
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middle) (n=10 cells from 5 mice). In addition, no differences in sEPSC frequency were detected 
between the Optoα1AR and GFP groups at any stimulation intensity timepoint (Figure 4.6B, top) 
(GFP n=10 cells from 4 mice). However, as with sIPSCs, the ChR2 group displayed an increase 
in sEPSC frequency following 1 mW stimulation as compared to baseline (p=0.04), and compared 
to GFP controls at both 1 mW (p<0.001) and 5 mW intensities (p=0.02) (n=9 cells from 4 mice, 5 
of 9 cells responding with >50% frequency increase) (Figure 4.6B, bottom). This effect also 
diminished over time, with no difference in response to 10 mW stimulation compared to baseline 
or compared to control GFP. In contrast to the findings for sIPSCs, however, analysis of sEPSC 
amplitude with 0.5 Hz stimulation yielded significant effects at 1 mW (p=0.03) and 10 mW 
(p<0.001) intensities compared to GFP controls (Figure 4.6C). These data indicate that low-
frequency 0.5 Hz blue light stimulation does not modulate basal excitatory synaptic transmission 
in CA1 pyramidal cells when Optoα1AR is expressed in astrocytes, but in the case of astrocytic 
ChR2, this same stimulation produces increased sEPSC frequency and amplitude.   
In 5 of 9 cells, 0.5 Hz stimulation of ChR2 in astrocytes when recording sEPSCs also 
resulted in the development of an inward tonic current that did not appear when recording sIPSCs. 
Furthermore, this ChR2-mediated tonic current displayed two unique temporal profiles: a slow 
tonic current that peaked in amplitude during the first 30 s of 0.5 Hz light exposure (Figure 4.7A, 
top); and an acute tonic current that fluctuated with the on/off stimulation of the light (Figure 
4.7A, middle and bottom). The amplitude of the slow tonic current ranged from 31.98-191.71 
pA, with a mean time to peak amplitude of 15.09 s following 1 mW 0.5 Hz stimulation (Figure 
4.7B). The acute tonic current was largest during the initial 10 s of 0.5 Hz light stimulation (mean 
43.61 + 20.81 pA), but recovered to 47.54% of max amplitude within 30 s of stimulation (mean 
22.88 + 6.96 pA) (Figure 4.7C). Additionally, a strong linear correlation was observed between 
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the amplitude of the slow tonic current and phasic sEPSC frequency, as cells with the highest 
phasic sEPSC frequency displayed the greatest amplitude of the slow tonic current (r=0.99, 




In these studies, we tested whether stimulation of the Gq-coupled opsin, Optoα1AR, can 
modulate basal synaptic transmission in hippocampal CA1 when expressed in astrocytes. The 
results indicate that optical stimulation of astrocytic Optoα1AR is capable of modulating synaptic 
transmission, including basal GABAergic inhibition, in hippocampus. Furthermore, these effects 
are stimulation-specific; a high-frequency (20 Hz) stimulation of Optoα1AR in astrocytes 
effectively modulated hippocampal transmission, whereas a low-frequency 0.5 Hz stimulation of 
Optoα1AR had no effect on modulating IPSCs or EPSCs. The lack of response to 0.5 Hz 
stimulation was in contrast to large changes seen with low-frequency stimulation of astrocytes 
expressing the nonspecific cation channel ChR2. 20 Hz stimulation of astrocytic Optoα1AR led to 
increases in the frequency of sIPSCs, mIPSCs, and mEPSCs, and the increase in mIPSC frequency 
displayed a trend for reversibility within 20 min. Altogether, these studies provide evidence for 
stimulation-specific effects of astrocytic Optoα1AR in modulating both GABAergic and 
glutamatergic transmission in hippocampal CA1. The AAV-GFAP-Optoα1AR vector presented 
here may thus be a useful tool in probing astrocytic modulation of local synaptic transmission. 
 Currently, the Gq-coupled DREADD, hM3Dq (Roth, 2016), is the most commonly used 
tool for targeted activation of astrocytes due to its ease of use and physiological relevance when 
inserted into astrocytes and activated by clozapine-N-oxide (CNO) or other similar ligand. The 
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Optoα1AR vector employed here may be used as an alternative to hM3Dq for astrocyte stimulation 
by activating the same endogenous pathway with improved temporal specificity. As CNO is 
typically administered over an extended period of time, and the effects of hM3Dq activation can 
be long-lasting, one must consider the temporal distinction between experiments that activate 
astrocytes using DREADDs versus optogenetic tools. The present study reinforces that the 
frequency and duration of optical stimulation paradigms should be carefully considered when 
using optogenetic constructs to interrogate roles for astrocytes in modulating synaptic 
transmission. For example, in a prior study, sustained optical stimulation of CA1 astrocytes 
expressing Gq-coupled melanopsin at 7 mW for 1 s or 3 s was insufficient to modulate sEPSCs. 
However, stimulation lengths of 5 s and 10 s led to transient increases in sEPSC amplitude, and 
stimulation lengths of 20 s and 60 s induced sustained increases in sEPSC amplitude (Mederos et 
al., 2019). The effects on excitatory transmission observed here in response to 20 Hz, 5 mW 
stimulation of Optoα1AR are in line with these previously described effects of astrocyte-expressed 
melanopsin and extend the effects of activation of Gq signaling in astrocytes to modulation of 
synaptic inhibition as well. In the present studies, however, 0.5 Hz stimulation (repeated 1-s light 
pulses delivered over 90 s) of astrocytic Optoα1AR at intensities up to 10 mW did not alter EPSC 
frequency or amplitude, suggesting that the efficacy of activating Optoα1AR in yielding changes 
in nearby synaptic transmission is stimulation-sensitive. 
The 0.5 Hz stimulation paradigm was designed in an attempt to mimic the relatively slow 
activation kinetics of astrocytic GPCRs, as well as the temporal dynamics of astrocytic Ca2+ 
signaling, which are generally seconds in length (Haustein et al., 2014; Srinivasan et al., 2015). It 
should be noted, however, that recent work has identified Ca2+ signals in astrocyte microdomains 
with ms timescales in vivo (Stobart et al., 2018). By contrast, the 20 Hz stimulation was chosen to 
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closely mimic light delivery used in previous in vivo experiments testing a similar Optoα1AR 
opsin expressed in astrocytes (Adamsky et al., 2018). For the 0.5 Hz stimulation, however, it is 
possible that the escalating-intensity stimulation paradigm used in the present studies masked a 
potential effect of the higher light intensities. In addition, it is important to note that the stimulation 
paradigms used in these experiments are just two of many possible options, and the two stimulation 
paradigms used here differed in the total time of stimulation and whether or not there was an 
escalation of the stimulation intensity. Therefore, it is possible that the temporal frequency of the 
stimulation intensity is not the sole cause for the differences seen in astrocytic Optoα1AR 
modulation of hippocampal transmission. The present studies were also performed at room 
temperature to reduce the frequency of synaptic currents and more readily enable acquisition of 
unitary PSCs, and temperature is known to impact GPCR kinetics. Note, however, that the 20 Hz 
stimulation paradigm, which demonstrated efficacy at room temperature in the present 
experiments, was adapted from previous in vivo work using a similar Optoα1AR in astrocytes 
(Adamsky et al., 2018). 
The present study reports modulation of basal synaptic inhibition by astrocytes using an 
optogenetic tool designed to harness physiologically relevant endogenous pathways in astrocytes. 
High-frequency stimulation of Optoα1AR in astrocytes resulted in elevated mIPSC frequency, 
which suggests a potential Ca2+-dependent release of a signaling molecule from astrocytes that 
acts upon presynaptic terminals of interneurons, subsequently increasing the probability of GABA 
release at inhibitory synapses. As mIPSC amplitude was not changed, quantal size does not appear 
to have been affected. Purinergic signaling is potential mediator of this response; astrocytes release 
ATP/adenosine in a Ca2+-dependent manner, and ATP/adenosine has been shown to modulate both 
basal excitatory neurotransmission (Di Castro et al., 2011; Panatier et al., 2011) as well as 
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heterosynaptic depression (Serrano et al., 2006; Andersson et al., 2007; Boddum et al., 2016) in 
the hippocampus. Purinergic signaling can also modulate inhibitory transmission; for example, 
endogenous P2Y1 receptor activation in hippocampal interneurons leads to increased interneuron 
excitability, subsequently increasing feed-forward inhibition onto CA1 pyramidal cells. Both 
anatomical and functional evidence (a high density of astrocyte processes surrounding 
hippocampal interneurons and enhanced intracellular Ca2+ transients, respectively) suggests that 
these effects are driven by astrocyte-derived ATP (Bowser and Khakh, 2004). Additionally, 
astrocytic release of ATP/adenosine upregulates synaptic inhibition from somatostatin 
interneurons onto pyramidal cells in the hippocampus (Matos et al., 2018). Furthermore, Gq 
pathway stimulation in astrocytes in the central amygdala leads to Ca2+-dependent release of 
ATP/adenosine and an enhancement of inhibition through activation of neuronal A2A receptors 
(Martin-Fernandez et al., 2017). These effects were deemed to be mediated presynaptically, in line 
with the increase in mIPSC frequency seen in the present studies. It is important to note that all 
recordings in this study were made in the absence of synaptic blockers; EPSCs and IPSCs were 
biophysically isolated only in the recorded cell. Though recordings made from slices in the absence 
of synaptic blockers may be more representative of in vivo conditions, the recordings represent the 
net result of both excitatory and inhibitory network activity, making the underlying mechanisms 
difficult to pinpoint. In addition, other potential mechanisms may be considered. For example, 
astrocytes provide metabolic support to neurons, and disruption of metabolic processes such as 
glycolysis and oxidative phosphorylation can alter presynaptic vesicular release (Sobieski et al., 
2017). Future studies should also consider the potential impact that optical tools may have on the 
important metabolic roles of astrocytes.  
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Low-frequency stimulation of ChR2 in astrocytes not only altered phasic synaptic 
excitation but produced a tonic inward current as well. Of note, a similar slow inward current with 
superimposed sEPSCs has also been shown after ChR2 activation in astrocytes in the striatum (Cui 
et al., 2016). Mechanistically, the tight correlation between tonic current amplitude and sEPSC 
frequency in the presence of light stimulation suggests that stimulation of ChR2 in astrocytes 
causes the release of glutamate from astrocytic stores, flooding synaptic clefts with glutamate and 
increasing synaptic EPSC frequency at least in part via increased binding events onto postsynaptic 
ionotropic glutamate receptors. Subsequent glutamate spillover could then drive the tonic inward 
current, possibly via activation of extrasynaptic NMDA receptors (Angulo et al., 2004; Fellin et 
al., 2004; Le Meur et al., 2007), which can be activated despite a hyperpolarized holding potential 
and the presence of Mg2+ in the extracellular solution (Fellin et al., 2004). However, stimulation 
of astrocytic ChR2 can also increase local neuronal excitability independently of astrocytic 
glutamate release. For example, ChR2 stimulation in striatal astrocytes leads to local neuronal 
depolarization attributed solely to transient increases in extracellular K+ (Octeau et al., 2019).    
 The present study used a novel variant of Optoα1AR (Airan et al., 2009) packaged in 
AAV8 and driven by a GFAP promoter for astrocyte-specificity. Optoα1AR canonically drives 
Ca2+ elevations via activation of endogenous Gq, leading to the release of Ca2+ from IP3-dependent 
intracellular stores, as previously demonstrated both in HEK cells (Airan et al., 2009) and cultured 
astrocytes (Figueiredo et al., 2014). Therefore, although it is unlikely that the present results are 
due to a Ca2+-independent mechanism triggered in the astrocytes, we cannot discount this 
possibility. One potential explanation for the stimulation-specific modulation of hippocampal 
synaptic transmission seen here is that the 0.5 Hz stimulation of Optoα1AR may be insufficient to 
drive consistent increases in astrocytic intracellular Ca2+ levels as compared to the high-frequency 
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20 Hz stimulation, thus failing to trigger Ca2+-dependent release of signaling molecules. Future 
studies using the GFAP-Optoα1AR construct could compare the properties of astrocytic Ca2+ 
elevations following exposure to varying stimulation paradigms.    
 In summary, the goal of these experiments was to evaluate the efficacy of activating 
Optoα1AR in astrocytes in modulating basal synaptic transmission. The present data indicate that 
high-frequency blue light activation of Optoα1AR in astrocytes can effectively modulate basal 
synaptic inhibition as well as excitation in the hippocampus. By contrast, low-frequency 0.5 Hz 
stimulation of astrocytic Optoα1AR did not affect glutamatergic or GABAergic transmission, 
although this stimulation produced robust responses when ChR2 was expressed in astrocytes. 
Overall, this work suggests that activation of AAV-transduced Optoα1AR in astrocytes can 
effectively alter local synaptic transmission, indicating that this vector should be a useful tool in 




All animal procedures were approved by the Institutional Animal Care and Use Committee 
of the University of Illinois at Urbana-Champaign (protocols 17161 and 20110). Male and female 
C57BL/6J mice were either bred on site or obtained from the Jackson Laboratory at 6-8 weeks of 
age. Mice were group-housed (up to five mice per cage) in a 14/10 h light:dark cycle with food 






4.4.2: Viral vectors 
The pAAV-GFAP-OptoA1-eYFP plasmid was constructed by replacing the CaMKIIa 
promoter in pAAV-CaMKIIa-OptoA1-eYFP by a 2.2 Kb GFAP promoter and verified by Sanger 
sequencing. The map and sequence information are available at: 
web.stanford.edu/group/dlab/optogenetics/sequence_info.html#optoxr. AAV-8 (Y733F), referred 
to here as AAV8, was produced by the Stanford Neuroscience Gene Vector and Virus Core. In 
brief, AAV8-GFAP-OptoA1-eYFP was produced by standard triple transfection of AAV 293 cells 
(Agilent). At 72 h post-transfection, the cells were collected and lysed by a freeze-thaw procedure. 
Viral particles were then purified by an iodixanol step-gradient ultracentrifugation method. The 
iodixanol was diluted and the AAV was concentrated using a 100-kDa molecular mass–cutoff 
ultrafiltration device. Genomic titer was determined by quantitative PCR. The virus was tested in 
cultured neurons for expected expression patterns prior to use in vivo. AAV8-GFAP-
hChR2(H134R)-eYFP and AAV8-GFAP-eGFP were obtained from the UNC Vector Core. All 
vectors were diluted in 0.9% sterile saline to a final titer of 1x1012 for injections; all dilutions were 
performed immediately prior to injection.  
 
4.4.3: Stereotaxic virus injections 
Stereotaxic injections were performed in mice aged postnatal day (P)42 to P90. Animals 
were anesthetized using 2-3% oxygen-vaporized isoflurane anesthesia (Clipper Distributing 
Company) and were placed in a stereotactic apparatus (Kopf Instruments). Carprofen (5 mg/kg, 
Zoetis) was administered subcutaneously at the beginning of surgery for analgesia. Viral vectors 
were loaded into a 10-μl Nanofil syringe with a 33-gauge needle, and injections were carried out 
using a Micro4 injection pump controller (World Precision Instruments). Viruses were bilaterally 
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injected (1 μl per site) into dorsal hippocampal CA1 (coordinates: 1.8 mm posterior and 1.3 mm 
lateral to bregma; 1.3 mm ventral to the cortical surface) at a rate of 0.12 μl/min. After each 
injection, the syringe was left in place for 3-5 min to allow for diffusion of the viral vector and 
minimize reflux along the injection track. Incisions were closed using Perma-Hand silk sutures 
(Ethicon). Following surgery completion, 2.5% lidocaine + 2.5% prilocaine cream (Hi-Tech 
Pharmacal) and Neosporin antibiotic gel (Johnson and Johnson) were applied to the incision site.  
 
4.4.4: Brain slice preparation 
Acute brain slices were prepared at ages P80-P145, with a range of 26-71 days after 
stereotaxic virus injection. Mice were anesthetized via intraperitoneal injection of pentobarbital 
(Vortech Pharmaceuticals, 55 mg/kg)  as performed previously (Christian and Huguenard, 2013; 
Christian et al., 2013; Courtney and Christian, 2018) and euthanized by decapitation. Brains were 
immediately dissected and placed in an ice-cold oxygenated (95% O2/5% CO2) high-sucrose 
slicing solution containing (in mM) 254 sucrose, 11 glucose, 2.5 KCl, 1.25 NaH2PO4, 10 MgSO4, 
0.5 CaCl2, and 26 NaHCO3. 300 μm-thick coronal slices through dorsal hippocampus were 
prepared using a Leica VT1200S vibratome (Leica Biosystems). Slices were hemisected, 
transferred to a holding chamber, and incubated in an oxygenated artificial cerebrospinal fluid 
(ACSF) solution containing (in mM) 126 NaCl, 2.5 KCl, 10 glucose, 1.25 NaH2PO4, 1 MgSO4, 2 
CaCl2, and 26 NaHCO3 at ~298 mOsm. For all experiments, slices were incubated in ACSF for 60 






4.4.5: Patch clamp electrophysiology 
Slices were placed in a fully submerged recording chamber on the stage of an upright 
BX51WI microscope (Olympus America) and continuously superfused with oxygenated ACSF at 
a rate of 2.5 ml/min at room temperature. Recordings were made using a MultiClamp 700B 
amplifier, Digidata 1550 digitizer, and Clampex 10 software (Molecular Devices). Recording 
pipettes were prepared from thick-walled borosilicate glass using a P-1000 micropipette puller 
(Sutter Instruments). For all experiments, access resistance was monitored every 2-5 minutes. Only 
cells that displayed a low and stable access resistance (Ra <20 MΩ; <20% change in Ra for the 
duration of the experiment) were kept for analyses. There were no differences between groups in 
access resistance, input resistance, or cell capacitance.  
For voltage-clamp recordings, pipettes were pulled to have an open-tip resistance of 2-5 
MΩ when filled with an internal solution containing (in mM): 130 Cs-gluconate, 8 CsCl, 2 NaCl, 
10 HEPES, 4 EGTA, 4 Mg-ATP, 0.3 GTP, adjusted to 290 mOsm and pH 7.3. Individual neurons 
were selected for their pyramidal shape using differential infrared contrast optics through either a 
sCMOS camera (OrcaFlash 4.0LT, Hamamatsu) or a Retiga R1 CCD camera (Teledyne 
Photometrics). Slices were screened for GFP expression by brief epifluorescence illumination at 
470 nm, and only neurons with nearby astrocytes displaying fluorescence were subsequently 
recorded. Excitatory and inhibitory postsynaptic currents (EPSCs/IPSCs) were recorded in the 
absence of synaptic blockers. EPSCs were recorded at a membrane holding potential (Vm) of -70 
mV, whereas IPSCs were recorded at Vm = 0 mV. The efficacy of this recording paradigm in 
isolating EPSCs and IPSCs, respectively, was confirmed by the abolishment of currents following 
application of glutamate receptor blockers APV and DNQX with Vm = -70 mV, as well as the 
abolishment of currents following application of the GABAA receptor blocker picrotoxin with Vm 
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= 0 mV. Each cell was randomly assigned for recording of either EPSCs or IPSCs. Only one cell 
was recorded per slice. For miniature PSC (mEPSC/mIPSC) recordings, 0.5 μM tetrodotoxin 
(TTX, Abcam) was added to the bath ACSF. For optogenetic activation, 473 nm blue laser light 
(Laserglow Technologies) was delivered through an optical fiber 200 μm in diameter (FT200EMT, 
Thorlabs) placed directly above stratum radiatum/stratum pyramidale at the surface of the slice. 
Two stimulation paradigms were used: 1) 20 Hz (45-ms pulses at 5 mW intensity, 5 min in 
duration, 90% duty cycle; partially adapted from in vivo experiments in Adamsky et al., 2018); 2) 




 At 3 weeks after AAV injection, animals were euthanized via intracardiac perfusion with 
20 mL of 0.1M PBS, followed by 20 mL of 4% paraformaldehyde (PFA). Brain tissue was then 
collected, fixed in 4% PFA for 24 h at 4°C, and preserved in 30% sucrose solution with 0.5% 
sodium azide until sectioning. 40 μm-thick coronal sections were prepared using a freezing 
microtome (SM 2010R, Leica Biosystems). Hippocampal sections were washed 3 times with 0.01 
M PBS for 5 min each at room temperature on a shaker at 140 rpm, then incubated for 1 h in a tris-
buffered saline (TBS)-based blocking solution (10% normal donkey serum, 0.1% Triton X-100, 
2% bovine serum albumin). Sections were then incubated with primary antibody (anti-NeuN rabbit 
polyclonal [1:1000, Sigma ABN78]) for 48 h at 4°C on a shaker. Sections were then washed in 
PBS and incubated with DyLight 594-conjugated goat anti-rabbit secondary antibody (1:1000, 
Vector Laboratories DI-1594) for 2 h on a shaker at room temperature. Tissue was mounted on 
charged glass slides and coverslipped using Vectashield Hardset Antifade Mounting Medium with 
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DAPI (Vector Laboratories, H-1500). Image acquisition was performed using a BX43 
epifluorescence microscope equipped with a Q-Color 3 camera (Olympus) and QCapture Pro 7 
software (Teledyne Photometrics).  
 
4.4.7: Data analysis and statistics 
 Postsynaptic currents were analyzed using Stimfit software (Guzman et al., 2014) or a 
custom analysis package in IGOR Pro (WaveMetrics) (DeFazio et al., 2014). Passive electrical 
properties were calculated using Clampfit 10.4 (Molecular Devices). Data from Stimfit/IGOR 
were transferred to OriginPro 2016 (OriginLab, Northampton, MA, USA) or RStudio for statistical 
analysis. Normality assumptions were evaluated using Shapiro-Wilk tests or through analysis of 
QQ plots, in which normality was confirmed when data points were closely aligned with reference 
lines. Within-group comparisons for the 20 Hz stimulation experiments (before/after light 
stimulation) were made using paired t-tests. 20 Hz PSC recordings compared within the same cells 
over multiple timepoints were analyzed using one-way repeated-measures ANOVA (with time as 
the repeated factor) with Fisher’s LSD post-hoc tests. Comparisons for 0.5 Hz stimulation 
experiments were made using two-way repeated-measures ANOVA (opsin and stimulation 
intensity as factors) with Fisher’s post-hoc tests. Pearson’s correlation coefficient (r) was used to 
measure the linear correlation between tonic current amplitude and EPSC frequency. P<0.05 was 
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Figure 4.1: AAV8-GFAP-Optoα1AR-eYFP selectively targets astrocytes in hippocampal 
CA1. Example immunohistochemical images displaying astrocytic targeting of optogenetic 
constructs. (A) AAV8-GFAP-GFP (left) and AAV8-GFAP-GFP merged with neuronal marker 
NeuN (right). s.o., stratum oriens; s.p., stratum pyramidale; s.r., stratum radiatum. Scale bar, 40 
μm. (B) AAV8-GFAP-Optoα1AR-eYFP (left) and AAV8-GFAP-Optoα1AR-eYFP merged with 
NeuN (right). (C) AAV8-GFAP-hChR2(H134R)-eYFP (left), and AAV8-GFAP-hChR2(H134R)-





Figure 4.2: High-frequency (20 Hz) stimulation of astrocytic Optoα1AR increases sIPSC 
frequency. (A) Schematic representation of 20 Hz stimulation paradigm. (B) Representative 
sIPSC traces from individual pyramidal cells before (left) and during (right) 20 Hz stimulation of 
GFP (left two traces) or Optoα1AR (right two traces) in astrocytes. Insets represent expanded 
sections from underlined portion of trace. Scale bars: 50 pA, 1 s; inset: 50 pA, 200 ms. (C) Mean 
+ SEM of sIPSC frequency before (Base) and during the full duration of 20 Hz stimulation (Light)  
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Figure 4.2 (continued): 
of GFP (left) or Optoα1AR (right) in astrocytes. Lines represent individual cells. (D) Mean + SEM 
of sIPSC frequency across time of Optoα1AR (top) and GFP (bottom) during 20 Hz stimulation. 
Lines represent individual cells. Note that lines are used to enable identification of the same cells 
across the time points; increased slope at end of baseline period does not represent an increase in 
frequency prior to light delivery. (E) Mean + SEM of sIPSC amplitude before (Base) and during 
the full duration of 20 Hz stimulation (Light) of GFP (left) or Optoα1AR (right) in astrocytes. 
Lines represent individual cells. (F) Mean + SEM of sIPSC amplitude across time in the Optoα1AR 
(top) and GFP (bottom) groups during 20 Hz stimulation. Lines represent individual cells. Note 
that lines are used to enable identification of the same cells across the time points; increased slope 
at end of baseline period does not represent an increase in frequency prior to light delivery. (G) 
Mean + SEM of sIPSC frequency before (Base), during the final minute of 20 Hz stimulation (5’), 
and 20 minutes following 20 Hz stimulation (20’) of GFP (left) or Optoα1AR (right) in astrocytes. 
Lines represent individual cells. (H) Mean + SEM of sIPSC amplitude before (Base), during the 
final minute of 20 Hz stimulation (5’), and 20 minutes following 20 Hz stimulation (20’) of GFP 
(left) or Optoα1AR (right) in astrocytes. Lines represent individual cells. *, p<0.05 vs. baseline 





Figure 4.3: High-frequency (20 Hz) stimulation of astrocytic Optoα1AR increases mIPSC 
frequency. (A) Representative mIPSC traces from individual pyramidal cells before (left) and 
during (right) 20 Hz stimulation of GFP (left two traces) or Optoα1AR (right two traces) in 
astrocytes. Insets represent expanded sections from underlined portion of trace. Scale bars: 20 pA, 
500 ms; inset: 20 pA, 100 ms. (B) Mean + SEM of mIPSC frequency before (Base) and during the 
full duration of 20 Hz stimulation (Light) of GFP (left) or Optoα1AR (right) in astrocytes. Lines  
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Figure 4.3 (continued): 
represent individual cells. (C) Mean + SEM of mIPSC frequency across time in the Optoα1AR 
(top) and GFP (bottom) groups during 20 Hz stimulation. Lines represent individual cells. Note 
that lines are used to enable identification of the same cells across the time points; increased slope 
at end of baseline period does not represent an increase in frequency prior to light delivery. (D) 
Mean + SEM of mIPSC amplitude before (Base) and during the full duration of 20 Hz stimulation 
(Light) of GFP (left) or Optoα1AR (right) in astrocytes. Lines represent individual cells. (E) Mean 
+ SEM of mIPSC amplitude across time in the Optoα1AR (top) and GFP (bottom) groups during 
20 Hz stimulation. Lines represent individual cells. Note that lines are used to enable identification 
of the same cells across the time points; increased slope at end of baseline period does not represent 
an increase in frequency prior to light delivery. (F) Mean + SEM of mIPSC frequency before 
(Base), during the final minute of 20 Hz stimulation (5’), and 20 minutes following 20 Hz 
stimulation (20’) of GFP (left) or Optoα1AR (right) in astrocytes. Lines represent individual cells. 
Dotted lines represent 6 cells that showed reversibility of effect. (G) Mean + SEM of mIPSC 
amplitude before (Base), during the final minute of 20 Hz stimulation (5’), and 20 minutes 
following 20 Hz stimulation (20’) of GFP (left) or Optoα1AR (right) in astrocytes. Lines represent 





Figure 4.4: High-frequency (20 Hz) stimulation of astrocytic Optoα1AR increases mEPSC 
frequency. (A) Representative mEPSC traces from individual pyramidal cells before (left) and 
during (right) 20 Hz stimulation of GFP (left two traces) or Optoα1AR (right two traces) in 
astrocytes. Insets represent expanded sections from underlined portion of trace. Scale bars: 20 pA, 
500 ms; inset: 20 pA, 100 ms. (B) Mean + SEM of mEPSC frequency before (Base) and during 
the full duration of 20 Hz stimulation (Light) of GFP (left) or Optoα1AR (right) in astrocytes. 
Lines represent individual cells. (C) Mean + SEM of mEPSC frequency across time in the 
Optoα1AR (top) and GFP (bottom) groups during 20 Hz stimulation. Lines represent individual 
cells. Note that lines are used to enable identification of the same cells across the time points; 
increased slope at end of baseline period does not represent an increase in frequency prior to light 
delivery. (D) Mean + SEM of mEPSC amplitude before (Base) and during the full duration of 20 
Hz stimulation (Light) of GFP (left) or Optoα1AR (right) in astrocytes. Lines represent individual 
cells. (E) Mean + SEM of mEPSC amplitude across time in the Optoα1AR (top) and GFP (bottom) 
groups during 20 Hz stimulation. Lines represent individual cells. Note that lines are used to enable  
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Figure 4.4 (continued): 
identification of the same cells across the time points; increased slope at end of baseline period 
does not represent an increase in frequency prior to light delivery. *, **, ***, p<0.5, p<0.01, 














Figure 4.5: Low-frequency (0.5 Hz) blue light stimulation of astrocytes expressing ChR2, but 
not Optoα1AR, increases sIPSC frequency. (A) Schematic representation of 0.5 Hz light 
stimulation paradigm. (B) Representative sIPSC traces from individual pyramidal cells before 
(left) and during (right) 0.5 Hz blue light stimulation delivered to slices expressing GFP (top), 
Optoα1AR (middle), or ChR2 (bottom) in astrocytes. Insets represent expanded sections from 
underlined portion of trace. Scale bars – GFP and Optoα1AR: 50 pA, 1 s; inset: 50 pA, 200 ms; 
ChR2: 100 pA, 1s; inset: 100 pA, 200 ms. (C) Mean + SEM of sIPSC frequency across time of 
GFP (top), Optoα1AR (middle), and ChR2 (bottom) groups during 0.5 Hz stimulation. Lines 
represent individual cells. Note that lines are used to enable identification of the same cells across 
the time points; increased slope at end of baseline period does not represent an increase in 
frequency prior to light delivery. (D) Mean + SEM of sIPSC amplitude in GFP (left), Optoα1AR 
(middle), and ChR2 (right) groups across stimulation intensities. Lines represent individual cells. 







Figure 4.6: Low-frequency (0.5 Hz) stimulation of astrocytes expressing ChR2, but not 
Optoα1AR, increases sEPSC frequency and amplitude. (A) Representative sEPSC traces from 
individual pyramidal cells before (left) and during (right) 0.5 Hz blue light stimulation delivered 
to slices expressing GFP (top), Optoα1AR (middle), or ChR2 (bottom) in astrocytes. Insets 
represent expanded sections from underlined portion of trace. Scale bars – GFP and Optoα1AR: 
20 pA, 1 s; inset: 20 pA, 200 ms; ChR2: 50 pA, 1s; inset: 50 pA, 200 ms. (B) Mean + SEM of 
sEPSC frequency across time of GFP (top), Optoα1AR (middle), and ChR2 (bottom) groups 
during 0.5 Hz stimulation. Lines represent individual cells. (C) Mean + SEM of sEPSC amplitude 
of GFP (left), Optoα1AR (middle), and ChR2 (right) groups across stimulation intensities. Lines 
represent individual cells. B = baseline. *, p<0.05 vs. baseline values. #, ###, p<0.05, p<0.001 vs. 








Figure 4.7: Low-frequency (0.5 Hz) stimulation of astrocytes expressing ChR2 induces both 
slow and acute tonic inward currents. (A) Representative sEPSC trace from an individual 
pyramidal cell during 0.5 Hz blue light stimulation delivered to slices expressing astrocytic ChR2. 
Insets represent expanded sections from underlined portion of trace. Blue lines indicate times of 
light stimulation. Scale bars: top, 50 pA, 5 s; middle: 50 pA, 1 s; bottom: 50 pA, 200 ms. (B) Mean 
+ SEM (red markers) of the maximum amplitude of the slow tonic current (left) and time to max 
amplitude of slow tonic current (right). Dots represent individual cells (5 cells in which tonic 
currents were elicited, out of 9 recorded). (C) Mean + SEM (red markers) of the average acute 
tonic current during first 30 s of blue light exposure. Dots and connected lines represent individual 
cells. (D) Slow tonic current amplitude plotted in relation to the frequency of phasic sEPSCs in 
the same cells. Dots represent individual cells; linear regression line of best fit indicates strong 


















CHAPTER 5: DISCUSSION  
Hippocampal synaptic transmission is continuously regulated by a range of signaling 
molecules and cell types. The overall goal of this dissertation was to investigate the mechanisms 
by which hippocampal synaptic transmission is modulated by both the peptide diazepam binding 
inhibitor and by stimulation of local astrocytes. In Chapter 2, I used a constitutive DBI knockout 
(DBI-/-) mouse line to investigate how the genetic loss of DBI signaling alters synaptic inhibition 
in CA1 pyramidal cells and dentate gyrus (DG) granule cells. In Chapter 3, I continued to use the 
DBI-/- mice to examine the extent to which a deficiency in DBI signaling alters performance in 
both hippocampal-dependent and hippocampal-independent behavioral tasks. In Chapter 4, I 
utilized a novel astrocyte-specific Gq-coupled opsin GFAP-Optoα1AR-eYFP (Optoα1AR) to 
interrogate how optogenetic stimulation of astrocytes modulates synaptic excitation and inhibition 
in hippocampal CA1. Altogether, the data within this dissertation demonstrate that genetic loss of 
DBI alters hippocampal synaptic inhibition and hippocampal-dependent behavioral tasks, and that 
optogenetic activation of Optoα1AR in astrocytes modulates hippocampal synaptic excitation and 
inhibition.   
DBI is a multifaceted protein that exerts context-specific biological actions. The Dbi gene 
is considered to serve ubiquitous housekeeping functions (Mandrup et al., 1992), and DBI plays 
influential roles in lipid metabolism (Bouyakdan et al., 2015; Neess et al., 2015). Within the brain, 
DBI can modulate inhibitory neurotransmission both directly and indirectly, and direct allosteric 
modulation of GABAARs by DBI or its processing products can result in either an increase 
(Christian and Huguenard, 2013; Christian et al., 2013) or decrease (Alfonso et al., 2012; Dumitru 
et al., 2017) in inhibitory strength in different brain regions. Intriguingly, the data presented in 
Chapter 2 demonstrate the potential presence of both mechanisms within specific subregions of 
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the hippocampus. Specifically, genetic loss of DBI signaling enhances mIPSC frequency and 
amplitude in CA1 pyramidal cells, suggesting that DBI may endogenously act as a negative 
allosteric modulator in this region. By contrast, loss of DBI signaling leads to a reduction of mIPSC 
amplitude in granule cells, indicating that DBI may be a positive modulator of GABAARs in DG. 
However, whether these diametric alterations in hippocampal synaptic inhibition by DBI are due 
to direct actions on GABAARs or via indirect mechanisms remains unclear.   
  It is well established that DBI can directly modulate inhibition via positive or negative 
allosteric modulation of the GABAAR (Christian and Huguenard, 2013; Christian et al., 2013; 
Dumitru et al., 2017). However, the mechanisms underlying the diametric, subregion-specific 
modulation of inhibition in the hippocampus remain unknown. The biophysical properties of 
GABAAR are determined by their specific subunit compositions (Mody and Pearce, 2004). 
Therefore, it is possible that DBI acts upon GABAARs that incorporate different subunits in CA1 
compared to DG, as these two regions display variability in GABAAR subunit composition 
(Hörtnagl et al., 2013). Furthermore, DBI has a number of known cleavage products, all of which 
are biologically active and capable of modulating GABAergic transmission. However, the manner 
in which the DBI peptide is endogenously cleaved has not been determined. Therefore, it is 
possible that DBI may be cleaved differently in CA1 compared to DG, and thus distinct DBI 
cleavage products may be acting upon GABAARs in these regions.  
Although DBI is primarily recognized for acting as an allosteric modulator of GABAARs 
via the BZ-specific binding site, the data presented here suggest that DBI signaling may modulate 
hippocampal synaptic transmission in an indirect fashion. In both regions of the hippocampus, 
principal cells from mice lacking DBI signaling did not differ from cells from WT mice in their 
responsiveness to applications of either the BZ-binding site antagonist flumazenil or the BZ-site 
  
 123 
agonist diazepam. This finding indicates that endogenous DBI is not directly competing with these 
drugs for binding at hippocampal GABAARs, thus suggesting an alternative mechanism of action. 
A plausible mode of indirect modulation of inhibitory transmission by DBI is via the mitochondrial 
benzodiazepine receptor, otherwise known as translocator protein (TSPO) (Papadopoulos et al., 
1991; Korneyev et al., 1993). The binding of DBI to TSPO can upregulate the biosynthesis of 
neurosteroids, the generation of which are known to modulate GABAARs in both a positive and 
negative manner (Wang, 2011). Thus, it is possible that DBI does not directly bind to GABAARs 
on principal cells in CA1 or DG, but instead modulates hippocampal synaptic inhibition via 
indirect changes in neurosteroidogenesis.  
The data in Chapter 3 illustrate that mice with genetic loss of DBI signaling display 
impaired performance in several aspects of the Barnes Maze task, but not in the object location 
memory task, indicating an impairment specifically in spatial memory. As with the impacts on 
synaptic transmission, however, it is unclear whether the effects of DBI on spatial memory are due 
to direct modulation of GABAARs or to indirect mechanisms. In addition, it is possible that DBI 
modulates spatial memory indirectly. For example, recent work demonstrates that DBI plays an 
important role in the regulation of postnatal neurogenesis in DG (Dumitru et al., 2017). Disruption 
of neurogenesis impairs memory performance specifically in the Morris Water maze task but not 
in other hippocampal-dependent tasks (Drapeau et al., 2003; Dupret et al., 2008), consistent with 
the data presented here. Therefore, one potential explanation of the data could be that the removal 
of DBI signaling critically disrupts hippocampal neurogenesis, and this disruption subsequently 
impairs spatial memory performance in the Barnes maze task.  
Though not conclusively established in vivo, DBI is thought to be endogenously secreted 
primarily by astrocytes. DBI is released via an unconventional autogaphy-related mechanism in 
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rat cultured astrocytes (Loomis et al., 2010), and pharmacological inhibition of astrocyte function 
results in a loss of the positive endozepine function in the thalamic reticular nucleus (Christian and 
Huguenard, 2013), suggesting that DBI in this region is astrocyte-derived. However, several 
important questions, such as whether astrocytes are direct sources of DBI in the hippocampus, or 
if astrocyte-derived DBI critically modulates spatial memory, remain untested. To better 
understand the role of astrocytes in DBI-dependent modulation of synaptic transmission and/or 
learning and memory, we could make further use of the DBIfl/fl line to create an astrocyte-specific 
knockout of DBI. This mouse line has previously been used to interrogate roles for astrocytic DBI 
in modulating anxiety-like behaviors (Budry et al., 2016), and would be a good first step in 
evaluating the role of astrocyte-derived DBI in modulating hippocampal circuitry and behavior. In 
addition, astrocytes release several known signaling molecules, such as glutamate and ATP, in a 
Ca2+-dependent manner. Whether DBI is also released in a Ca2+-dependent fashion is currently 
unclear. To potentially test this, chemogenetic or optogenetic tools (such as Optoα1AR) could be 
used to drive intracellular Ca2+ increases in astrocytes, and DBI release and/or potential DBI-
mediated effects could be subsequently evaluated. However, as DBI is currently believed to be 
secreted via an unconventional mechanism that bypasses the endoplasmic reticulum, Ca2+-
dependent release of DBI by astrocytes is unlikely. This is further supported by the fact that 
astrocytic GABABR activation, which drives intracellular Ca2+ elevations and Ca2+-dependent 
glutamate release (Mederos et al., 2021), was demonstrated to inhibit DBI release in culture 
(Masmoudi et al., 2005). Despite this, it would be intriguing to better understand if there is a 
connection between intracellular Ca2+ signaling in astrocytes and DBI, and if Ca2+ signaling alters 
the mechanisms behind the secretion or action of DBI in various brain regions.   
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In Chapter 4, I demonstrate that optogenetic stimulation of GFAP-Optoα1AR-eYFP 
(Optoα1AR) is capable of modulating both synaptic excitation and inhibition in the hippocampus. 
However, only a high-frequency stimulation paradigm (20 Hz stimulation at 5 mW intensity for 5 
minutes) induced alterations in synaptic transmission; a low-frequency stimulation paradigm (0.5 
Hz stimulation at successive 1, 5, and 10 mW stimulations for 90 s per stimulation) did not 
modulate synaptic transmission compared to optogenetic stimulation of control GFP. These data 
demonstrate that Optoα1AR may prove useful as a tool to investigate roles for astrocytes in 
modulating synaptic transmission.  
The Optoα1AR construct is designed to activate the endogenous Gq intracellular signaling 
pathway in astrocytes upon blue-light stimulation, subsequently leading to the release of Ca2+ from 
IP3-dependent intracellular stores. However, we remain limited in our understanding of the 
mechanisms underlying how optical stimulation of GFAP-Optoα1AR in astrocytes modulates 
synaptic transmission. Specifically, the experiments within Chapter 4 do not provide direct 
confirmation that optical activation of the Gq intracellular signaling pathway takes place in 
astrocytes, or that said activation of the Gq pathway induces transient elevations in intracellular 
Ca2+ in astrocytes. Despite these limitations, it is unlikely that our results are due to a Gq- or Ca2+-
independent mechanism, as optical stimulation of Optoα1AR drives intracellular Ca2+ increases in 
HEK cells (Airan et al., 2009) and in cultured astrocytes (Figueiredo et al., 2014). Furthermore, 
although high-frequency stimulation of Optoα1AR in astrocytes modulates synaptic inhibition, the 
downstream mechanisms underlying this effect remain unclear. Two primary (and not mutually 
exclusive) hypotheses have emerged, both of which involve the Ca2+-dependent release of 
signaling molecules from astrocytes that act upon presynaptic terminals of interneurons, 
modulating subsequent GABA release onto CA1 pyramidal cells. The first hypothesis is the release 
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of ATP/adenosine from astrocytes, which has been previously demonstrated to modulate 
excitatory transmission (Di Castro et al., 2011; Panatier et al., 2011) and heterosynaptic 
transmission (Serrano et al., 2006; Andersson et al., 2007; Boddum et al., 2016) in the 
hippocampus. Accumulating evidence also implicates astrocyte-derived ATP/adenosine in 
modulating inhibitory transmission in the hippocampus (Bowser and Khakh, 2004; Matos et al., 
2018) and in the amygdala (Martin-Fernandez et al., 2017), highlighting purinergic signaling as a 
potential mediator of this response. The second potential mechanism is astrocytic release of 
glutamate; recent evidence from the medial prefrontal cortex demonstrated that astrocyte-derived 
glutamate stimulates PV+ interneurons and enhances synaptic inhibition in pyramidal cells via 
presynaptic mGluRs (Mederos et al., 2021).  
Perhaps the most intriguing finding of this study is that high-frequency (20 Hz) stimulation 
of Optoα1AR was capable of modulating both synaptic excitation and inhibition, but low-
frequency (0.5 Hz) stimulation yielded no effect. The 20 Hz stimulation was adapted to mimic a 
similar paradigm used to optogenetically activate a similar OptoGq construct in hippocampal 
astrocytes in vivo, in which 5 minutes of 20 Hz stimulation was sufficient to improve cognitive 
performance in a contextual memory task (Adamsky et al., 2018). Conversely, the 0.5 Hz 
stimulation was designed in an attempt to cater to both the slow activation kinetics of GPCRs that 
are endogenously native to astrocytes, as well as to the relatively slow duration of astrocytic 
intracellular Ca2+ signaling. While the frequency of the optical stimulation was the major point of 
adjustment between these two paradigms, it is possible that other facets of the stimulation may 
play a pivotal role in activating astrocytic Optoα1AR, such as the duration of the optical 
stimulation. While the total length of the blue light exposure was similar between the two 
stimulation paradigms, the total exposure duration for the 0.5 Hz stimulation was 30 seconds fewer 
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compared to the 20 Hz stimulation. Furthermore, under the 20 Hz stimulation, an increase in IPSC 
frequency was first evident after 2 minutes on average, whereas the stimulation for each escalating 
light intensity only lasted 90 seconds for the 0.5 Hz paradigm. Therefore, it is possible that a more 
prolonged duration of low-frequency stimulation could induce similar modulation to synaptic 
transmission to what was seen following 20 Hz stimulation.  
As stated previously, the data presented here do not directly demonstrate that optogenetic 
activation of Optoα1AR induces intracellular Ca2+ elevations in astrocytes. In a collaboration with 
Dr. Stephen Boppart’s laboratory, I spent several months attempting to demonstrate the efficacy 
of the optical construct by performing two-photon Ca2+ imaging in astrocytes from acute slices. 
However, due to the COVID-19 pandemic, I was not able to complete these experiments. 
Additionally, there were technical limitations that significantly hampered the success of these 
studies and ultimately prevented these experiments from being performed. In brief, due to the 
spectral overlap between the excitation wavelengths of Optoα1AR and commonly used genetically 
encoded calcium indicators such as GCaMP, a red-shifted Ca2+ indicator was required to properly 
perform the imaging experiments. Unfortunately, red-shifted calcium indicators such as RCaMP 
and jRGECO are significantly inferior to the GCaMP family in terms of both effectiveness and 
availability, and a published astrocyte-specific red-shifted Ca2+ indicator does not currently exist. 
To circumvent this, I acquired an unpublished astrocyte-specific version of RCaMP (GFAP-
RCaMP1.07) as a gift from Dr. Jill Stobart (University of Manitoba), and was in the process of 
troubleshooting the indicator before the pandemic-related laboratory closures. As a result of these 
closures, I was unable to complete these experiments. 
The studies in this dissertation leave several outstanding questions that should be addressed 
in future experiments. For investigations of DBI, the overarching goal of future studies should be 
  
 128 
to determine whether the synaptic and behavioral effects observed are due to DBI directly 
modulating GABAARs or due to indirect mechanisms. While the data indicate that the synaptic 
effects of DBI are not due to direct GABAAR modulation, future experiments could utilize mass 
spectrometry to investigate if specific DBI processing products in each hippocampal subregion 
underlie the diametric effects seen. Additionally, the potential neurosteroid-induced indirect 
modulation of hippocampal inhibition by DBI could be tested by recording inhibitory currents 
from DBI+/+ and DBI-/- mice in the presence of the 5α-reductase inhibitor finasteride. Furthermore, 
to evaluate potential direct actions of DBI in modulating behavior, DBI-/- and DBI+/+ mice could 
be run on the Barnes maze task following intraperitoneal injection of a sub-sedative dose of 
diazepam. If differences between the genotypes in spatial memory performance are present, it 
would likely be due to competition for binding at GABAARs, suggesting direct modulation of 
GABAARs by DBI. Alternatively, the potential neurogenesis-induced indirect modulation of 
hippocampal-dependent behavior could be investigated using Cre-lox recombination along with 
the floxed DBI mouse line (DBIfl/fl) (Neess et al., 2013), in which exon 2 of DBI is flanked by loxP 
sites. Using this mouse line along with a ligand-dependent Cre recombinase (such as CreERT2) 
(Feil et al., 2009), DBI can be specifically deleted in adulthood via tamoxifen administration, thus 
allowing for intact neurogenesis until the onset of the inducible knockout.     
 For the experiments involving astrocytic Optoα1AR, two separate but related questions 
remain unknown. First, what is the physiological mechanism that drives Optoα1AR-mediated 
modulation of hippocampal synaptic transmission? Second, how do the various properties of 
optical stimulation paradigms induce and/or alter these mechanisms? The first question can be best 
answered by performing experiments using pharmacological agents targeted to the aforementioned 
hypotheses. Specifically, recordings could be made in the presence of inhibitors for purinergic 
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receptors and/or mGluRs. The second question could be addressed by performing additional 
experiments in which each variable of the overall stimulation paradigm (stimulation frequency, 
stimulation intensity, duration, etc.) is carefully and systematically evaluated. Furthermore, these 
two questions could be evaluated in concert by utilizing two-photon Ca2+ imaging to better 
understand how optogenetic activation of Optoα1AR modulates Ca2+ signaling in astrocytes. For 
example, it is possible that the 20 Hz stimulation of Optoα1AR is sufficient to drive Ca2+-
dependent release of signaling molecules from astrocytes, but the 0.5 Hz stimulation paradigm is 
not sufficient. Together, these investigations would greatly enhance our understanding on how 
optogenetic activation of Optoα1AR impacts astrocyte biology. 
Overall, the data contained within Chapters 2 and 3 present novel evidence that the genetic 
removal of DBI signaling modules hippocampal synaptic inhibition and hippocampal-dependent 
spatial learning and memory. In addition, the experiments in Chapter 4 demonstrate that the 
astrocyte-specific Optoα1AR construct is capable of modulating both synaptic excitation and 
inhibition in the hippocampus following high-frequency stimulation. Future studies of how DBI 
modulates hippocampal function should investigate whether the reported phenotypes are due to 
DBI is acting directly on GABAARs or through other indirect mechanisms. Additionally, future 
studies that utilize Optoα1AR to study astrocyte-neuron interactions should look to better 
understand the precise biological mechanisms in astrocytes that result from different optical 
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Abstract 
Neuropsychiatric disorders in which reduced social interest is a common symptom, such 
as autism, depression, and anxiety, are frequently associated with genetic mutations affecting 
GABAergic transmission. Benzodiazepine treatment, acting via GABAA receptors, improves 
social interaction in male mouse models with autism-like features. The protein diazepam binding 
inhibitor (DBI) can act as an endogenous benzodiazepine, but a role for DBI in social behavior has 
not been described. Here we investigated the role of DBI in the social interest and recognition 
behavior of mice. The responses of DBI wild-type and knockout male and female mice to 
ovariectomized female wild-type mice (a neutral social stimulus) were evaluated in a 
habituation/dishabituation task. Both male and female knockout mice exhibited reduced social 
interest, and DBI knockout mice lacked the sex difference in social interest levels observed in 
wild-type mice, in which males showed higher social interest levels than females. The ability to 
discriminate between familiar and novel stimulus mice (social recognition) was not impaired in 
DBI-deficient mice of either sex. DBI knockouts could learn a rotarod motor task, and could 
discriminate between social and non-social odors. Both sexes of DBI knockout mice showed 
increased repetitive grooming behavior, but not in a manner that would account for the decrease 
in social investigation time. Genetic loss of DBI did not alter seminal vesicle weight, indicating 
that the social interest phenotype of males lacking DBI is not due to reduced circulating 
testosterone. Together, these studies reveal a novel role of DBI in driving social interest and 
motivation.     
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A.1: Introduction   
Social interaction and recognition are complex fundamental processes that enable 
communication, both verbal and nonverbal, with others of the same species. These interactions are 
facilitated by forming social relationships and are reliant upon an organism’s ability to establish 
social memory of conspecifics (Ferguson et al., 2002; van der Kooij and Sandi, 2012). Importantly, 
mental health disorders that are commonly characterized by altered social interest and motivation, 
such as autism, depression, and anxiety, show prominent sex differences (Baron-Cohen et al., 
2011; Loke et al., 2015). In rodents, males typically display higher levels of social interest 
compared to females, spotlighting sex differences that may naturally exist in social investigation 
and behavior (Bluthe and Dantzer, 1990; Ferguson et al., 2000; Bodo and Rissman, 2008; Holmes 
et al., 2011; Tejada and Rissman, 2012; Karlsson et al., 2015). 
Autism, depression, and anxiety are also highly associated with genetic mutations affecting 
-aminobutyric acid (GABA) synaptic transmission and GABA type-A receptors (GABAARs) 
(Luscher et al., 2011; Smith and Rudolph, 2012; Braat and Kooy, 2015). Mice with reduced 
expression of glutamic acid decarboxylase 67, a key enzyme mediating GABA synthesis, display 
reduced sociability and impaired processing of both social and non-social odors (Sandhu et al., 
2014). Furthermore, low-dose benzodiazepine treatment, acting via GABAARs, can improve social 
interaction in male mouse models with autism-like features (Han et al., 2012b, 2014). Conversely, 
acute administration of the benzodiazepine binding site antagonist flumazenil can decrease social 
interaction between male rats (File et al., 1986), although increased social investigation in 
aggressive mice treated with flumazenil has also been observed (Uhlířová et al., 2004). Together, 
these findings indicate that endogenous benzodiazepine (endozepine) actions may modulate 
sociability. Diazepam binding inhibitor (DBI), also known as acyl-CoA binding protein, is a 10-
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kDa protein initially identified through its ability to displace diazepam from GABAAR 
benzodiazepine binding sites (Guidotti et al., 1983). High concentrations of Dbi mRNA expression 
or DBI protein immunoreactivity have been demonstrated in several brain regions (Ball et al., 
1989; Ferrarese et al., 1989; Costa and Guidotti, 1991). Our recent work demonstrated that DBI 
acts as a positive allosteric endozepine by potentiating GABAAR-mediated inhibitory synaptic 
currents in the thalamic reticular nucleus (Christian and Huguenard, 2013; Christian et al., 2013), 
although negative allosteric actions of DBI on GABAARs have also been described (Macdonald et 
al., 1986; Bormann, 1991; Alfonso et al., 2012). DBI also plays a critical role in lipid metabolism 
(Neess et al., 2015) and the Dbi gene may serve ubiquitous housekeeping functions (Mandrup et 
al., 1992), suggesting multiple pathways by which DBI can affect neural circuits and behavior. 
Although precise roles for endogenous DBI actions in various behaviors remain unclear, 
both clinical and animal studies support roles for DBI in modulating behaviors in both normal and 
pathological states. DBI levels in cerebrospinal fluid are elevated in patients with depression (Roy 
et al., 1989) and dementia (Ferrarese et al., 1990), suggesting the possibility of a role of DBI in 
various cognitive impairments. In addition, a DBI-overexpressing transgenic mouse displays 
impaired hippocampus-dependent learning and memory (Siiskonen et al., 2007). DBI may also 
play roles in contextual fear conditioning and conditioned place preference behaviors (Liu et al., 
2005; Sherrin et al., 2009). Central administration of DBI or a smaller cleavage product, 
octadecaneuropeptide, increases aggression in mice (Kavaliers and Hirst, 1986; Costa and 
Guidotti, 1991) and anxiety in both rats and mice (Guidotti et al., 1983; de Mateos-Verchere et al., 
1998). A recent study, however, indicated that genetic loss of DBI does not alter performance in 
assays of anxiety-like behavior in mice such as the elevated plus maze or the open field test (Budry 
et al., 2016). Furthermore, social isolation decreases Dbi mRNA expression in the mouse 
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hypothalamus (Dong et al., 1999). A role for DBI in modulating social investigation behavior, 
however, has not been explored.  
The goal of this study was to evaluate the effects of genetic loss of DBI signaling on social 
interactions in mice. We hypothesized that the absence of DBI signaling by genetic knockout 
would lead to dysfunctional social behavior when compared to wild-type mice of the same sex. 
We utilized a habituation/dishabituation test to investigate both social interest and social 
recognition behavior, and employed other assessments of odor discrimination, motor function, and 
repetitive grooming behavior. Our results reveal a role for DBI in boosting social interest levels in 
mice, with stronger effects in males compared to females.  
 
A.2: Materials and Methods  
A.2.1: Mice  
All animal procedures were approved by the Institutional Animal Care and Use Committee 
of the University of Illinois at Urbana-Champaign. DBI heterozygous (DBI+/-) and homozygous 
knockout (DBI-/-) founder mice on the C57BL/6Bom background, with targeted deletion of exon 
2 of the Dbi gene on chromosome 1, were obtained from Dr. Susanne Mandrup (University of 
Southern Denmark). The production of these mice by the Mandrup laboratory was described 
previously (Neess et al., 2011). At the University of Illinois, embryos generated from crossing 
DBI+/- and DBI-/- males with C57BL/6J females (Jackson Laboratory, Bar Harbor, ME) were 
surgically transferred to pathogen-free Swiss Webster females (Envigo) and carried to term to re-
derive the colony. Re-derivation was performed by the Transgenic Mouse Facility of the Roy J. 
Carver Biotechnology Center (Fuming Pan, Director). Re-derived DBI+/- male mice were 
backcrossed with C57BL/6J females for 3 more generations in our colony. The number of 
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backcrossing generations was determined in consultation with Jackson Laboratories based on the 
strong genetic similarity between the C57BL/6Bom and C57BL/6J strains. Breeding pairs to 
generate experimental mice consisted of DBI+/- females crossed with DBI+/- males, yielding DBI+/+, 
DBI+/-, and DBI-/- pups as previously described (Neess et al., 2011). Mice used in the present 
experiments were produced in the first to fourth filial generations of this colony after backcrossing 
was completed. Mice were bred and housed on a 14:10 light:dark cycle with food and water 
available ad libitum. At weaning, mice were group housed (up to 5 mice per cage) with littermates 
of the same sex. A total of 39 mice were used in these studies, consisting of 19 males (DBI+/+ 
n=11; DBI-/- n=8) and 20 females (DBI+/+ n=11; DBI-/- n=9). Mice were 50-250 days old at the 
time of testing. No significant correlation was seen between age and performance on the conducted 
tests. In addition, mice were weighed at the time of social testing (described in further detail 
below); body weights of DBI+/+ and DBI-/- mice of the same sex were not different (P>0.4).  
Stimulus animals for the social habituation/dishabituation test were two ovariectomized 
(OVX) female wild-type mice. OVX surgery was performed under isoflurane (Clipper Distributing 
Company, St. Joseph, MO) inhalation anesthesia. Bupivacaine (0.25%, 7 l; Hospira, Lake Forest, 
IL) was infiltrated into each surgical site to provide long-acting postoperative analgesia. The same 
two OVX females were used as stimulus mice in all social habituation/dishabituation tests in this 
study and housed together in the same cage in a different room than the DBI+/+ and DBI-/- test mice.  
Behavioral experiments were performed between 10 a.m. and 2 p.m., relative to 7 p.m. 
lights-off, in accordance with previous findings that testing mouse social behaviors in a novel 
environment during the light phase does not significantly compromise results (Yang et al., 2008). 
All mice were tested on all behavioral tests described, performed in the following order: 1) rotarod; 
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2) social habituation/dishabituation; and 3) odor discrimination, with 1-70 days in between tests. 
Mean inter-test intervals were not different between groups. 
 
A.2.2: Rotarod test 
Rotarod testing was performed using published procedures (Merritt and Rhodes, 2015). 
Mice were placed on the Rotarod apparatus starting at 0 rotations per minute (rpm). Up to four 
mice were tested simultaneously. Once all mice were placed on dowel, the start switch was turned 
on to rotate the dowel at a constant acceleration rate (30 rpm). The latency of the mice to fall off 
was recorded by photobeam counters and noted by an experimenter using a stopwatch. Each mouse 
underwent 4 trials per day for 4 consecutive days. Between each trial, the dowel was wiped with 
Clidox (Pharmacal Research Laboratories, Waterbury, CT) and dried with a paper towel. 
Additionally, bedding in each chamber was replaced between testing of different mice to eliminate 
any residual olfactory cues and mouse droppings.  
 
A.2.3: Social habituation/dishabituation test  
The following procedure was adapted from previous reports (Tejada and Rissman, 2012; 
Wolstenholme et al., 2013). On the day of testing, mice were brought to the testing room, weighed, 
and placed in a testing cage with fresh bedding to acclimate for 30 min. An inverted wire holding 
cell, cleaned with 70% ethanol prior to each testing period, was placed in the cage for 10 min, 
during which the test mouse could explore and habituate to the holding cell. A stimulus OVX 
female mouse was then placed in the holding cell for 1 min (trial), and removed for the following 
9 min (inter-trial interval) before it was re-introduced. During the 1-min trial, the test mouse could 
sniff the stimulus mouse through the wires, but physical contact was minimized to nose-to-nose 
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touching. This procedure was repeated until the test mouse had experienced eight trials with the 
same stimulus mouse. For the 9th trial, a novel stimulus OVX mouse was placed in the holding cell 
for 1 min and then removed.  
 Trials 1-8 represent the habituation portion of the experiment, evaluating interest in a 
familiar stimulus over time. Trial 9 represents the dishabituation portion of the experiment, as the 
recognition of a novel mouse highlights the ability of the test mouse to discriminate between old 
and new social stimuli (Ferguson et al., 2002). Each 90-min testing period was recorded in 10-min 
video clips, with each clip representing a trial and its subsequent inter-trial period. The amount of 
time spent sniffing the stimulus mouse was scored from the video clips. Sniffing was defined as 
direct contact of the subject’s nose with the wire holding cage or stimulus animal. For analysis, all 
clip identities were coded and randomized, and scorers were blind to trial number, genotype, and 
sex. 
 
A.2.4: Odor discrimination test  
The following procedure was adapted from previous reports (Srivastava et al., 2012; 
Arbuckle et al., 2015). All odors were freshly prepared on the day of testing. Two non-social odors 
were prepared using a 1:100 dilution of almond or banana extract (McCormick and Co., Sparks, 
MD) in distilled water, and were stored in 15 mL conical tubes. A third non-social odor contained 
only water. Social odors were prepared using two cages containing the same sex and number of 
mice as the test mouse’s home cage. Cages from which social odor would be obtained were not 
cleaned for 3 d prior to the experiment to allow for sufficient odor accumulation. Three cotton 
swabs were wiped across the bottom of each designated cage in a zigzag fashion and stored in two 
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large glass jars, one for each set of social odors. Between each test, the jars containing social odors 
were washed with laboratory detergent to eliminate any residual odors from previous trials.  
Mice were brought to the testing room, weighed, and placed into a testing cage with fresh 
bedding to acclimate for 45 min. For testing, cotton swabs containing either non-social (50 l of 
water or diluted almond/banana odorant) or social odors were inserted through the water bottle 
opening of the wire cage lid until ~2.5 cm of the cotton end extended into the cage. Mice were 
exposed to the odor for 2-min trials with a 1-min inter-trial interval between each presentation of 
the subsequent odor. This procedure continued until each odor was presented three times, in the 
following order: water, almond, banana, social 1, and social 2. All tests were video recorded, and 
sniffing behavior was quantified post hoc. Sniffing behavior was defined as orientation of the test 
animal towards the cotton swab with its nose ~2 cm or closer to the tip of the swab. Video scorers 
were blinded to sex and genotype of the test mice.  
 
A.2.5: Evaluation of repetitive self-grooming  
Repetitive self-grooming was quantified using the video clips from the social 
habituation/dishabituation test, and time spent grooming repetitively was measured using the 9-
min inter-trial intervals, when test mice were undisturbed. Repetitive grooming was identified as 
a period >10 s spent grooming with no more than a 5-s interval between grooming spurts. These 
criteria were chosen based on average grooming times previously exhibited in C57BL/6J mice 
(Silverman et al., 2010). The inter-trial periods following social trials 1, 4, and 8 were quantified 
to represent early, middle, and late time-points in the habituation/dishabituation test. Video scorers 




A.2.6: Seminal vesicle dissection and measurement 
 To assess endocrine status of male mice, body weight was measured and seminal vesicles 
dissected and immediately weighed at the time of euthanasia. For euthanasia, mice were sedated 
with pentobarbital (50 mg/kg i.p.) and decapitated. Seminal vesicle weight values were normalized 
to body weight for each mouse. 
 
A.2.7: Statistical analysis 
Statistical analysis was performed using SAS version 9.4. Latency to fall off the rotarod 
(averaged across the 4 trials per day) over 4 consecutive days was analyzed using repeated 
measures AVOVA with day entered as a within-subjects factor, and sex and genotype as between-
subjects factors.  Duration of social interest was analyzed the same way over the 9 trials (familiar 
and novel mouse), and separately for only the first 8 trials (familiar mouse).  Social recognition 
was analyzed similarly except including only the 8th and 9th trials, to measure the increase in 
interest from familiar to novel mouse.  Total duration of grooming behavior was analyzed a similar 
way over the three inter-trial periods examined.  To determine if the animals can discriminate 
social from non-social odors, duration spent sniffing in the first trial of social odor 1 was compared 
to the first trial of the final non-social odor (banana) by entering the two trials as within-subject 
factors, and including sex and genotype as factors as in the previous analyses. The animals’ 
responses to each of the social odors were analyzed separately entering trial (1-3) as the within-
subject factor, and sex and genotype as factors following the other analyses. In cases where sex or 
the interaction between sex and the other variables were significant, these ANOVAs were followed 
by two-way repeated measures ANOVAs (with trial or day and genotype as factors) separated for 
each sex.  Tukey post hoc tests were used for pair-wise comparisons of means.  Student’s t-tests 
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were used to compare to compare seminal vesicle weight values normalized to body weight in 
males. In all analyses, P<0.05 was considered statistically significant.  
 
A.3: Results 
A.3.1: Genetic loss of DBI does not impair rotarod learning 
 DBI+/+ and DBI-/- mice were first tested using the rotarod test to assess gross motor ability 
and memory retention (Figure A.1). Overall analysis of the rotarod data showed no significant 
effect of sex or an interaction between sex and genotype, indicating that both sexes performed 
equally well on the task. Collapsed across sex, both DBI+/+ and DBI-/- mice displayed significantly 
improved performance across days as indicated by a significant main effect of day (F3,105=34.84, 
P<0.0001), suggesting that both genotypes learned the task. No main effect of genotype was 
detected. However, a significant interaction between genotype and day was detected (F3,105=5.70, 
P=0.0012), indicating that performance between DBI+/+ and DBI-/- mice was different across days. 
Tukey post hoc tests revealed that the two genotypes displayed similar performances on days 1-3, 
but DBI-/- mice displayed inferior performance on day 4 compared to DBI+/+ mice (P=0.0028). 
This result suggests that DBI-/- mice do not reach as high a performance level as DBI+/+ mice, but 
do retain memory of the task and do not revert to initial performance levels. Overall, these data 
indicate that the genetic loss of DBI does not impair motor learning, and demonstrate comparable 
initial motor performance by DBI+/+ and DBI-/- mice.  
 
A.3.2: Genetic loss of DBI reduces social interest in both males and females  
 To investigate the impact of a global genetic deletion of DBI on social investigation 
behavior, we tested DBI+/+ and DBI-/- mice on a social habituation/dishabituation assay. The ability 
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of the mice to habituate to a familiar conspecific and dishabituate to a novel conspecific reflects 
levels of social interest and social recognition, respectively. OVX females were used to provide 
neutral social stimuli and minimize sexual or aggressive responses. Overall analysis revealed a 
significant main effect of sex (F1,36=10.8, P=0.002) and an interaction between sex and genotype 
(F1,36=5.1, P=0.03), indicating a difference in social interest levels between males and females 
(Figure A.2). Therefore, males and females were analyzed separately. DBI-/- male mice spent 
significantly less time investigating both familiar and novel OVX mice compared to DBI+/+ males 
(Figure A.2A, C). We found a significant effect of trial (F8,136=17.9, P<0.0001) and genotype 
(F1,18=16.5, P=0.0007), but no interaction between the two. Thus, the social interest of male DBI-
/- mice was significantly and equally impaired across all trials compared to DBI+/+ mice. DBI-/- 
female mice also exhibited a reduction in social interest compared to DBI+/+ females (Figure 
A.2B). Because the female data were positively skewed, we used a square root transformation to 
normalize the data. We found a significant effect of trial (F8,143=28.1, P<0.00001), genotype 
(F1,18=4.80, P=0.04), and trial-by-genotype interaction (F8,143=3.9, P=0.0004), indicating that 
female DBI-/- mice were impaired on specific trials compared to DBI+/+ females. Tukey post hoc 
analysis revealed a significant difference between genotypes on trials 4, 6, and 7 (all P<0.05), but 
not on other trials. Taken together, these results indicate a role for DBI signaling in modulating 
the motivation for social investigation in both males and females. 
Analysis of total time spent investigating the familiar mouse in trials 1-8 revealed that 
social interest levels in DBI-/- males and females of both genotypes were reduced compared to 
DBI+/+ males (Figure A.2C). Specifically, there was a significant effect of genotype (F1,36=16.1, 
P<0.001) and sex (F1,36=14.6, P<0.001) in the two-way ANOVA, and Tukey post hoc tests 
revealed that DBI+/+ males performed better than the other three groups (all P<0.05).  Note that 
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DBI-/- males displayed a level of social interest that was not different from DBI+/+ or DBI-/-females, 
and that DBI+/+ and DBI-/- females were not different from each other. These data suggest that the 
impact of a genetic loss of DBI on social interest is more severe in males than in females, and that 
DBI-/- mice lack the sex difference in social interest levels typical of DBI+/+ mice. 
 
A.3.3: Genetic loss of DBI does not impair social recognition in either sex 
 To determine whether genetic loss of DBI impairs social recognition, we analyzed the 
ability of mice to dishabituate from a familiar stimulus mouse to a novel mouse. We compared the 
difference in time spent sniffing the stimulus mouse in trial 8 compared to trial 9, which 
corresponded to the last exposure to the familiar stimulus mouse and the first exposure to the novel 
stimulus mouse, respectively. All mice displayed dishabituation from the familiar stimulus mouse 
to the novel stimulus mouse (Figure A.2A, B). Collapsed across genotypes, there was a significant 
effect of sex (F1,36=5.5, P=.03), trial (F1,34=82.9, P<0.0001), and marginally non-significant 
interaction of sex and trial (F1,34=2.8, P=0.10), indicating altered performance between males and 
females from trial 8 to trial 9. Due to this sex difference, males and females were analyzed 
separately. In males, there was a significant effect of trial (F1,17=34.3, P<0.0001) and genotype 
(F1,18=13.1, P=0.002), but no interaction between the two. In females, significant trial (F1,17=64.7, 
P<0.0001) and genotype (F1,18=4.4, P=0.05) effects were observed, but no interaction effect. The 
lack of an interaction effect in either males or females indicates that both DBI+/+ and DBI-/- mice 
responded similarly to the introduction of a new stimulus mouse, and investigation time by DBI-/- 
mice was reduced compared to DBI+/+ mice of the same sex. Furthermore, all groups showed 
similar values for the difference in investigation time in trial 9 compared to trial 8 (Table A.2). 
Specifically, two-way ANOVA revealed no significant effect of genotype (F1,36=0.12, P=0.73), 
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sex (F1,36=1.71, P=0.2), or interaction between sex and genotype (F1,36=0.03, P=0.87). Taken 
together, these data suggest that DBI-/- mice of both sexes retain social recognition abilities despite 
a reduction in social interest.  
 
A.3.4: Increased levels of repetitive self-grooming in both male and female DBI-/- mice  
 A distinctive characteristic of DBI-/- mice is a fur phenotype that is identifiable by weaning 
(Bloksgaard et al., 2012). The mice are oily to the touch and develop a reddish hue along with 
patchy alopecia. It is possible that DBI-/- mice may compensate for this fur condition with an 
increase in grooming behavior, thus potentially interfering with their ability to engage in social 
behavior. To account for this, we evaluated the repetitive grooming behavior of the mice as they 
performed the social habituation/dishabituation task, focusing on the inter-trial periods following 
trials 1, 4, and 8 to quantify grooming across early, middle, and late portions of the task (Figure 
A.3). Because overall analysis of the data showed large differences in the variances between 
groups, the data were transformed by adding the value 1 to the response and then taking the log 
base 10 to meet the equal variance assumption. Analysis of the transformed data revealed a 
significant interaction between sex, genotype, and trial (F2,70=4.0, P=0.02); therefore, the data were 
analyzed separately by sex. In males, there was a significant effect of trial (F2,34=5.8, P=0.007) and 
genotype (F1,17=32.2, P<0.0001) but no interaction between them, indicating that DBI-/- mice 
demonstrated higher levels of grooming at all trial points. In females, there was a significant effect 
of trial (F2,36=6.1, P=0.005), genotype (F1,18=72.7, P<0.0001), and an interaction of trial and 
genotype (F2,36=8.9, P<0.0001), suggesting differences in repetitive grooming between genotypes 
during certain trials. Tukey post hoc analysis revealed that DBI-/- females were different from 
DBI+/+ females during trials 1 and 4 (both P<0.0001), but not trial 8 (P>0.05). Although the loss 
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of DBI appears to induce a more severe reduction of social interest in male mice, both male and 
female mice exhibit increased levels of repetitive grooming. Therefore, it is unlikely that the 
increase in repetitive grooming behavior alone can account for the DBI-mediated impairment in 
social interest.  
 
A.3.5: DBI-/- mice can discriminate social vs. non-social odors  
The reduced degree of social interest displayed by the male DBI-/- mice could reflect an 
impaired receptivity to social odors. To test for this possibility, we evaluated the same cohort of 
mice on an odor discrimination task (Figure A.4). To determine if the animals can discriminate 
social from non-social odors, the time spent sniffing in the first trial of social odor 1 was compared 
to the first trial of the final non-social odor (banana), such that both the social and non-social odors 
were novel to the mouse. The analysis revealed a highly significant difference between the 
responses to the two odors (F1,34=62.4, P<0.0001), demonstrating that the animals were more 
interested in the social odors than the nonsocial odors. No significant effects of sex, genotype, or 
interactions between sex and genotype were detected, indicating that all mice demonstrated a 
preference for the social odor regardless of sex or genotype.    
 The animals’ responses to each of the social odors were analyzed separately. Across the 
three trials for social odor 1, we found a significant effect of trial (F2,68=14.3, P<0.0001), indicating 
that the mice habituated to the odor. Though the effect of the sex-by-genotype interaction was not 
significant (F1,34=3.3, P=0.08), it was close enough to justify separating the analysis by sex. In 
males, there was a significant effect of trial (F2,32=3.8, P=0.03), but not genotype, and no 
interaction of genotype and trial. Males thus demonstrated habituation to social odor 1, but 
performance was not different between DBI+/+ mice and DBI-/- mice. In females, there was a 
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significant effect of trial (F2,36=15.8, P<0.0001) and genotype (F1,18=4.7, P=0.04), indicating that 
both genotypes habituated to social odor 1, but that DBI-/- females spent less time investigating the 
odor than DBI+/+ females. No interaction between trial and genotype was detected in females. For 
social odor 2, the data were positively skewed, and therefore log transformed to improve normality. 
Analysis of the transformed data revealed a significant effect of trial (F2,68=9.6, P=0.0002) and 
genotype (F1,34=6.4, P=0.02). The effect of sex and the interactions were not significant. This result 
indicates that both males and females habituated to social odor 2, and that DBI-/- mice of both 
sexes spent less time investigating the odor than DBI+/+ mice.    
 As with social odor 2, responses to all three of the non-social odors were positively skewed 
and required a log transformation to normalize the data. For each of the non-social odors, there 
was a significant effect of trial (water: F2,68=25.0, P<0.0001; almond: F2,68=33.3, P<0.0001; 
banana: F2,68=18.6, P<0.0001), indicating that all mice demonstrated habituation to the non-social 
odors regardless of genotype. In the water trials, an effect of genotype was also observed (F1,34=8.6, 
P=0.006), with DBI-/- mice displaying less interest in the cotton swab compared to DBI+/+ mice. In 
the almond trials, we found an effect of genotype (F1,34=7.5, P=0.01) and a genotype-by-sex 
interaction (F1,34=4.7, P=0.04), indicating that males and females should be analyzed separately. 
When separated by sex, there was a significant effect of genotype in males (F1,16=11.4, P=0.004) 
but not in females. This result indicates that male DBI-/- mice spent less time investigating the 
almond odor than DBI+/+ males, a genotype difference that is not seen in females. In the banana 
trials, a genotype effect was also found (F1,34=6.8, P=0.01) but no effect of sex or any interactions, 





A.3.6: Seminal vesicle weights are not changed in DBI-/- males 
 Social behavior in male mice is modulated by testosterone feedback (Tejada and Rissman, 
2012; Karlsson et al., 2016), and the social interest phenotype of DBI-/- males is similar to that 
seen in castrated male wild-types (Bluthé et al., 1993; Karlsson et al., 2015). We thus postulated 
that the reduced social interest of DBI-/- male mice may reflect lower circulating testosterone 
levels. To evaluate the endocrine status of DBI+/+ and DBI-/- male mice, we measured the seminal 
vesicle weight normalized to overall body weight, a biomarker of circulating testosterone. Seminal 
vesicle weight was not different between the two genotypes (P=0.31), indicating that genetic loss 
of DBI does not significantly affect testosterone biosynthesis, and that the behavioral differences 
seen between these groups do not reflect lower circulating testosterone. 
 
A.4: Discussion  
In these studies, we sought to determine whether genetic loss of DBI affects social behavior 
in mice. Our data show an effect of genetic loss of DBI on social interest levels in mice, with a 
greater effect in males than in females. Moreover, we determined that DBI-/- mice of either sex can 
competently discriminate social vs. non-social odors, and that motor learning does not appear to 
be impaired by the genetic loss of DBI. These results suggest that the reduced social interest 
phenotype of DBI-/- males is not caused by impaired olfactory or pheromonal receptivity of social 
cues, or altered motor function that would reduce the propensity of mice to move around the testing 
cage. These data also demonstrate that DBI-/- mice of both sexes display increased repetitive 
grooming. The grooming phenotype, however, does not appear to be correlated to the degree of 
social interest; both male and female DBI-/- mice displayed increased baseline levels of grooming 
compared to respective DBI+/+ of the same sex when measured during the 9-min period following 
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the first presentation of a social stimulus mouse, a time point at which only DBI-/- males displayed 
reduced social interest compared to wild-types. Furthermore, a lack of change in seminal vesicle 
weight between DBI+/+ and DBI-/- males indicates that the differences in social interest between 
these genotypes are not reflective of lower circulating testosterone. Together, our results provide 
the first evidence of a role for DBI in modulating social behavior, and indicate a stronger 
phenotype in males compared to females.  
DBI-/- mice lack the typical sex difference in levels of social interest, suggesting that DBI 
may be involved in the development and/or maintenance of sexually dimorphic neural circuits 
mediating social behavior. In this regard, two neuropeptide systems are strong candidates as 
potential targets of DBI actions. The vasopressin system, which is integral in the regulation of 
social behavior (Dumais and Veenema, 2016), exhibits strong sexual dimorphism, with elevated 
vasopressin-immunoreactive fiber density in the lateral septum in male rats (De Vries et al., 1981) 
and mice (Gatewood et al., 2006) compared to female conspecifics. Furthermore, vasopressin V1b 
receptor knockout male mice show reduced interest in bedding soiled by either males or females 
(Wersinger et al., 2004). The vasopressin system may thus be a target of DBI-dependent 
modulation of social behavior. Oxytocin is another neuropeptide that may be critically involved in 
these behaviors. Recent studies indicate sex-specific relationships of oxytocin receptor expression 
in the amygdala to social interest, with social interest levels of male rats and mice being positively 
correlated to expression in the medial amygdala, and social interest in female rats being negatively 
correlated to expression in the central amygdala (Murakami et al., 2011; Dumais et al., 2013). 
Therefore, it would be interesting to investigate the structural and functional impacts of genetic 
loss of DBI on circuitry of these vasopressin and oxytocin systems implicated in social behavior.  
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 The recent findings that low-dose benzodiazepine treatment can improve social interest in 
male mice harboring genetic mutations associated with either Dravet syndrome or autism (Han et 
al., 2012b, 2014) indicate that positive allosteric modulation of GABAARs can promote social 
interest and motivation. The present results, demonstrating reduced social interest with loss of 
DBI, are thus in agreement with a model of DBI acting (at least on balance) via positive allosteric 
GABAAR modulation to boost social interest, and suggest a role for DBI endozepine actions in 
modulating social behavior. To date, the thalamic reticular nucleus remains the only brain area 
identified in which DBI is confirmed to act as a positive endozepine (Christian and Huguenard, 
2013; Christian et al., 2013), but it is highly likely that there are other discrete sites in the brain in 
which DBI exerts similar actions, in addition to sites of negative GABAAR modulation by DBI. 
Therefore, it will be interesting in the future to investigate region-specific and cell type-specific 
actions of DBI, particularly in circuits involved in social motivation, to further elucidate the 
potential contributions of DBI acting as an endozepine in the modulation of these behaviors. 
 Social interest levels in wild-type male mice are reduced upon castration, and restored with 
testosterone replacement (Bluthé et al., 1993; Tejada and Rissman, 2012; Karlsson et al., 2015). 
Testosterone is converted in the brain to estradiol via aromatization or to non-aromatizable 
androgens via 5- reduction (Naftolin and Ryan, 1975; Selmanoff et al., 1977), mediating effects 
by activation of estradiol and androgen receptors, respectively. Although the precise roles of 
estradiol and androgen receptors in mediating testosterone effects on social interest in mice are 
still a matter of some debate (Tejada and Rissman, 2012; Karlsson et al., 2016), the similar levels 
of social interest observed in DBI-/- males and both DBI+/+ and DBI-/- females suggested that the 
male-specific reduction in social interest may reflect lower circulating testosterone levels and/or 
altered neural response to testosterone feedback with the loss of DBI in males. The biosynthesis 
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of steroid hormones may be upregulated by DBI acting as an endogenous ligand of the 
mitochondrial benzodiazepine receptor, now referred to as 18 kDa translocator protein (TSPO) 
(Papadopoulos et al., 1991; Korneyev et al., 1993), although the role of TSPO activation in 
steroidogenesis has recently been called into question (Morohaku et al., 2014). Seminal vesicle 
weights, however, were not different in DBI-/- males compared to DBI+/+, suggesting that the 
reduction in social interest is not a proxy for altered testis production of testosterone. It is possible, 
however, that genetic loss of DBI alters neural expression of steroid conversion enzymes such as 
aromatase or 5- reductase, and/or estrogen or androgen receptors, but this has not been tested. 
On the other hand, murine Dbi mRNA expression in the ependyma surrounding the third ventricle 
is reduced upon castration, and this effect is reversed by androgen treatment (Compere et al., 
2006), indicating that neural Dbi gene expression is androgen-sensitive in mouse, as also 
demonstrated in human and rat tissues (Swinnen et al., 1996a, 1996b). Our findings of reduced 
social interest but unchanged seminal vesicle weight in males with genetic loss of DBI suggests 
that DBI may act as an intermediary in the male brain to at least partially effect the actions of 
testosterone on social behavior.      
The results of the odor discrimination task indicate that the ability to distinguish between 
social and non-social odors is largely intact in the genetic absence of DBI, although reduced 
investigation by DBI-/- mice of swabs containing either social or non-social odors was also 
observed. DBI promotes early postnatal neurogenesis in the mouse olfactory bulb (Alfonso et al., 
2012), and neurogenesis in the adult olfactory bulb appears to be important for murine odor 
discrimination (Gheusi et al., 2000; Moreno et al., 2009). These contributions of DBI to olfactory 
neurogenesis are thus likely related to the olfactory phenotype observed in the present studies. The 
DBI-/- mice, however, also displayed reduced interest in cotton swabs containing only water; this 
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effect was more prominent in males than in females. Therefore, the reduced degree of investigation 
of the odorants may also simply reflect a lower level of motivation for investigating the cotton 
swabs as objects. In relation to the social interest phenotype, however, it is important to note that 
all mice tested showed a prominent increase in the amount of time investigating the first social 
odor compared to the last non-social odor (banana). Therefore, the ability to discriminate between 
social and non-social odors is intact in DBI-/- mice of either sex, and the reduced degree of social 
interest observed in DBI-/- mice does not reflect an inability to correctly perceive and investigate 
social odorants. 
A secondary finding of this study is the presence of high levels of repetitive self-grooming 
behavior in the DBI-/- mice. An increase in the amount of repetitive self-grooming is commonly 
used as a parameter of autistic-like behavior in mice (Crawley, 2007; McFarlane et al., 2008). 
Presently, it is unclear whether the increase in repetitive grooming seen in DBI-/- mice reflects 
autistic-like stereotyped behavior or if it is largely a byproduct of the skin and fur phenotype of 
these mice. Topical treatment with Vaseline or latex restores hepatic fat levels of DBI-/- mice to 
DBI+/+ values (Neess et al., 2013), indicating that amelioration of the effects of DBI deficiency in 
the skin can have robust effects in other tissues. It is probable, however, that the application of a 
topical ointment would itself induce increased grooming behavior. Alternatively, generation of 
mouse models with DBI deleted only in the nervous system would help to resolve whether DBI 
acts in the brain to drive repetitive grooming and/or other stereotyped behaviors. 
In summary, our results indicate a novel role for DBI in boosting social interest. The effects 
of genetic loss of DBI on social interest do not appear to be a result of impaired olfactory 
discrimination, gross motor learning or movement ability, or a side effect of increased repetitive 
self-grooming. In addition, the apparent absence of a difference in circulating testosterone in males 
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lacking DBI, coupled with previous research indicating androgen-sensitivity of DBI gene 
expression, suggests that DBI may act to mediate at least some effects of testosterone in the brain. 
This work thus provides a basis for further investigation of the mechanisms by which DBI acts to 






















A.5: Figures and Tables 
 
 
Figure A.1: DBI+/+ and DBI-/- mice display similar gross motor coordination, but lack of DBI 
may impair motor memory retention on the rotarod task. Latency to fall (s) off the accelerating 
rotarod over the course of 4 days (each day the average of 4 trials). (A) Mean + SEM of latency to 
fall in DBI+/+ (filled squares) and DBI-/- (open squares) males. (B) Mean + SEM of latency to fall 
in DBI+/+ (filled circles) and DBI-/- (open circles) females. *** Main effect of day indicating 
significantly improved performance in both groups (P<0.001); # Difference between DBI+/+ and 














Figure A.2: DBI-/- mice of both sexes display impaired performance in the social 
habituation/dishabituation test. (A) Mean + SEM for time (s) spent investigating an OVX female 
by adult DBI+/+ (filled squares) and DBI-/- (open squares) males across all trials. Trials 1-8 
represent repeated presentation of the same stimulus mouse; trial 9 represents introduction of a 
novel stimulus mouse. (B) Mean + SEM for time (s) spent investigating an OVX female by adult 
DBI+/+ (filled circles) and DBI-/- (open circles) females across all trials. (C) Total time spent by 
DBI+/+ (filled bars) and DBI-/- (open bars) mice investigating the same stimulus mouse through the 
first eight trials. * A, B: Significant difference between DBI+/+ and DBI-/- mice across the task 
(P<0.001 males, P<0.05 females). Note that for males the difference is seen in all trials. C: 
Significant difference between DBI+/+ males and other three groups in overall time spent 
investigating across trials 1-8 (P<0.05). # Significant difference between DBI+/+ and DBI-/- females 








Figure A.3: DBI-/- mice display increased time spent in repetitive grooming compared to 
DBI+/+ mice. Mean + SEM for time (s) spent in repetitive grooming behavior by males (A; DBI+/+ 
filled squares, DBI-/- open squares) and females (B; DBI+/+ filled circles, DBI-/- open circles). * 
Significant difference between DBI+/+ and DBI-/- mice within each sex across all trials (males) and 



















Figure A.4: DBI+/+ and DBI-/- mice can distinguish social vs. non-social odors. Mean + SEM 
of time spent by males (A; DBI+/+ filled squares, DBI-/- open squares) and females (B; DBI+/+ filled 
circles, DBI-/- open circles) sniffing three non-social odors (water, almond, banana) and two social 
odors (swabs of used cages housing unfamiliar mice) during three consecutive presentations of 
each odor. * Significant difference in comparison of last non-social odor (banana) to social odor 1 
(****P<0.0001). # Significant effect of trial within the same odor (#P<0.05, ####P<0.0001). + 
















 Males Females 
DBI+/+ DBI-/- DBI+/+ DBI-/- 
Mean + SEM, 
difference in 
investigation 
time, trial 9 vs. 
trial 8 (s) 
 
 
15.25 + 2.33 
 
 
14.59 + 4.84 
 
 
20.92 + 4.09 
 
 
18.94 + 4.00 
Table A.1: Both male and female DBI+/+ and DBI-/- mice display comparable values for the 
difference in investigation time between trials 8 and 9 in the social habituation/dishabituation 
task. Mean + SEM time spent (s) investigating novel stimulus mouse (trial 9) compared to familiar 
stimulus mouse (trial 8). 
 
 
 
